OrphaCode,curie,label,descendent_OrphaCode,descendent_Name,genes_curie,genes_gene_symbol,genes_association_type,DisorderGeneAssociationStatus
2162,GARD:0006665,Holoprosencephaly,93924,Lobar holoprosencephaly,HGNC:9585,PTCH1,Disease-causing germline mutation(s) in,Assessed
79373,GARD:0006317,Ectodermal dysplasia,33364,Trichothiodystrophy,HGNC:16002,MPLKIP,Disease-causing germline mutation(s) in,Assessed
97245,GARD:0005898,Myopathy congenital,324604,Classic multiminicore myopathy,HGNC:12403,TTN,Disease-causing germline mutation(s) (loss of function) in,Assessed
2913,GARD:0004410,Polydactyly,93334,Postaxial polydactyly type A,HGNC:12926,ZNF141,Disease-causing germline mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,247262,Hyperphosphatasia-intellectual disability syndrome,HGNC:17893,PGAP2,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,280195,Septopreoptic holoprosencephaly,HGNC:9585,PTCH1,Disease-causing germline mutation(s) in,Assessed
86851,GARD:0008638,Acute leukemia of ambiguous lineage,589595,Mixed phenotype acute leukemia with t(v;11q23.3),HGNC:3765,FLT3,Disease-causing somatic mutation(s) in,Assessed
418,GARD:0001467,Congenital adrenal hyperplasia,325529,Non-classic congenital lipoid adrenal hyperplasia due to STAR deficency,HGNC:11359,STAR,Disease-causing germline mutation(s) (loss of function) in,Assessed
98722,GARD:0000802,Atrioventricular septal defect,576232,Partial atrioventricular septal defect with ventricular hypoplasia,HGNC:4173,GATA4,Disease-causing germline mutation(s) (loss of function) in,Assessed
52688,GARD:0007132,Myelodysplastic syndromes,98826,Refractory anemia,HGNC:25941,TET2,Disease-causing somatic mutation(s) in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,402023,Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13),HGNC:14959,RBM15,Part of a fusion gene in,Assessed
68356,GARD:0006895,Leukodystrophy,99854,Cree leukoencephalopathy,HGNC:3258,EIF2B2,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268377,Total spina bifida aperta,HGNC:26219,FUZ,Disease-causing germline mutation(s) in,Assessed
183660,GARD:0007628,Severe combined immunodeficiency,504523,Severe combined immunodeficiency due to LAT deficiency,HGNC:18874,LAT,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93926,Midline interhemispheric variant of holoprosencephaly,HGNC:11776,TGIF1,Disease-causing germline mutation(s) in,Assessed
289899,GARD:0009433,Organic acidemias,289916,Vitamin B12-unresponsive methylmalonic acidemia type mut0,HGNC:7526,MMUT,Disease-causing germline mutation(s) (loss of function) in,Assessed
3394,GARD:0004898,Soft tissue sarcoma,79105,Myxofibrosarcoma,HGNC:4010,FUS,Part of a fusion gene in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,309256,"Metachromatic leukodystrophy, late infantile form",HGNC:713,ARSA,Disease-causing germline mutation(s) (loss of function) in,Assessed
289899,GARD:0009433,Organic acidemias,314911,Severe Canavan disease,HGNC:756,ASPA,Disease-causing germline mutation(s) (loss of function) in,Assessed
86851,GARD:0008638,Acute leukemia of ambiguous lineage,98835,Acute undifferentiated leukemia,HGNC:7132,KMT2A,Part of a fusion gene in,Assessed
411709,GARD:0009228,Renal agenesis,93100,"Renal agenesis, unilateral",HGNC:9967,RET,Disease-causing germline mutation(s) in,Assessed
487,GARD:0006844,Krabbe disease,206436,Infantile Krabbe disease,HGNC:4115,GALC,Disease-causing germline mutation(s) in,Assessed
79225,GARD:0007672,Sphingolipidosis,206443,Late-infantile/juvenile Krabbe disease,HGNC:4115,GALC,Disease-causing germline mutation(s) in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",251510,"46,XY partial gonadal dysgenesis",HGNC:4173,GATA4,Disease-causing germline mutation(s) (loss of function) in,Assessed
319276,GARD:0009574,Clear cell renal cell carcinoma,404511,Clear cell papillary renal cell carcinoma,HGNC:26038,TMEM127,Major susceptibility factor in,Assessed
263,GARD:0006907,Limb-girdle muscular dystrophy,445110,Limb-girdle muscular dystrophy due to POMK deficiency,HGNC:26267,POMK,Disease-causing germline mutation(s) (loss of function) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:1787,CDKN2A,Disease-causing somatic mutation(s) in,Assessed
367,GARD:0002520,Glycogen storage disease type 4,308684,"Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form",HGNC:4180,GBE1,Disease-causing germline mutation(s) in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,402014,Acute myeloid leukemia with t(6;9)(p23;q34),HGNC:2768,DEK,Part of a fusion gene in,Assessed
823,GARD:0007673,Spina bifida,268758,Lumbosacral spina bifida cystica,HGNC:15511,VANGL2,Major susceptibility factor in,Assessed
823,GARD:0007673,Spina bifida,268397,Cervicothoracic spina bifida aperta,HGNC:15511,VANGL2,Major susceptibility factor in,Assessed
213,GARD:0006236,Cystinosis,411634,Juvenile nephropathic cystinosis,HGNC:2518,CTNS,Disease-causing germline mutation(s) in,Assessed
93969,GARD:0003475,Myelomeningocele,268752,Thoracolumbosacral spina bifida cystica,HGNC:7432,MTHFD1,Major susceptibility factor in,Assessed
26791,GARD:0006523,Glutaric acidemia type II,394532,"Multiple acyl-CoA dehydrogenase deficiency, mild type",HGNC:29683,SLC25A32,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,101001,Autosomal recessive spastic paraplegia type 21,HGNC:20373,SPG21,Disease-causing germline mutation(s) in,Assessed
182058,GARD:0012959,Primary orthostatic hypotension,2828,Young-onset Parkinson disease,HGNC:11503,SYNJ1,Disease-causing germline mutation(s) in,Assessed
69077,GARD:0007572,Rhabdoid tumor,231108,Familial rhabdoid tumor,HGNC:11103,SMARCB1,Disease-causing germline mutation(s) (loss of function) in,Assessed
408,GARD:0002807,Hyperglycerolemia,284411,"Glycerol kinase deficiency, juvenile form",HGNC:4289,GK,Disease-causing germline mutation(s) in,Assessed
220460,GARD:0008532,Attenuated familial adenomatous polyposis,480536,MSH3-related attenuated familial adenomatous polyposis,HGNC:7326,MSH3,Disease-causing germline mutation(s) (loss of function) in,Assessed
828,GARD:0010782,Stickler syndrome,250984,Autosomal recessive Stickler syndrome,HGNC:2186,COL11A1,Disease-causing germline mutation(s) in,Assessed
85458,GARD:0010266,Hereditary cerebral hemorrhage with amyloidosis,100006,"ABeta amyloidosis, Dutch type",HGNC:620,APP,Disease-causing germline mutation(s) in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",96266,Leydig cell hypoplasia due to partial LH resistance,HGNC:6585,LHCGR,Disease-causing germline mutation(s) (loss of function) in,Assessed
2162,GARD:0006665,Holoprosencephaly,220386,Semilobar holoprosencephaly,HGNC:4318,GLI2,Disease-causing germline mutation(s) in,Assessed
1531,GARD:0006209,Craniosynostosis,3366,Isolated trigonocephaly,HGNC:23399,FREM1,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268752,Thoracolumbosacral spina bifida cystica,HGNC:15511,VANGL2,Major susceptibility factor in,Assessed
710,GARD:0007380,Pfeiffer syndrome,93258,Pfeiffer syndrome type 1,HGNC:3688,FGFR1,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:11896,TNFAIP3,Major susceptibility factor in,Assessed
2671,GARD:0000102,Neu Laxova syndrome,583607,Neu-laxova syndrome due to 3-phosphoglycerate dehydrogenase deficiency,HGNC:8923,PHGDH,Disease-causing germline mutation(s) (loss of function) in,Assessed
253,GARD:0007687,Spondyloepiphyseal dysplasia,250984,Autosomal recessive Stickler syndrome,HGNC:2219,COL9A3,Disease-causing germline mutation(s) (loss of function) in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:16266,SLC19A3,Disease-causing germline mutation(s) in,Assessed
253,GARD:0007687,Spondyloepiphyseal dysplasia,459051,"Spondyloepiphyseal dysplasia, Stanescu type",HGNC:2200,COL2A1,Disease-causing germline mutation(s) in,Assessed
98277,GARD:0012758,Acute myeloid leukemia with recurrent genetic anomaly,402017,Acute myeloid leukemia with t(9;11)(p22;q23),HGNC:7132,KMT2A,Part of a fusion gene in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293910,"Familial isolated arrhythmogenic ventricular dysplasia, right dominant form",HGNC:2511,CTNNA3,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,401849,Autosomal spastic paraplegia type 72,HGNC:17975,REEP2,Disease-causing germline mutation(s) (loss of function) in,Assessed
98634,GARD:0002978,Iridogoniodysgenesis type 1,488197,Familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome,HGNC:31582,MIR204,Disease-causing germline mutation(s) (gain of function) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93925,Alobar holoprosencephaly,HGNC:11701,TDGF1,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:5041,HNRNPH1,Part of a fusion gene in,Assessed
68356,GARD:0006895,Leukodystrophy,280234,Null syndrome,HGNC:9086,PLP1,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,220386,Semilobar holoprosencephaly,HGNC:9585,PTCH1,Disease-causing germline mutation(s) in,Assessed
280886,GARD:0010941,Anterior uveitis,797,Sarcoidosis,HGNC:4948,HLA-DRB1,Major susceptibility factor in,Assessed
443909,GARD:0008533,Familial colorectal cancer,144,Lynch syndrome,HGNC:7329,MSH6,Disease-causing germline mutation(s) in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,589595,Mixed phenotype acute leukemia with t(v;11q23.3),HGNC:3765,FLT3,Disease-causing somatic mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268748,Total spina bifida cystica,HGNC:15511,VANGL2,Major susceptibility factor in,Assessed
399786,GARD:0012513,Male infertility with spermatogenesis disorder due to single gene mutation ,399808,Male infertility with teratozoospermia due to single gene mutation,HGNC:23044,NANOS1,Disease-causing germline mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,370924,STT3B-CDG,HGNC:30611,STT3B,Disease-causing germline mutation(s) in,Assessed
304,GARD:0010752,Epidermolysis bullosa simplex,412189,Epidermolysis bullosa simplex due to exophilin 5 deficiency,HGNC:30578,EXPH5,Disease-causing germline mutation(s) in,Assessed
253,GARD:0007687,Spondyloepiphyseal dysplasia,163649,"Spondyloepiphyseal dysplasia, Nishimura type",HGNC:31527,MIR140,Disease-causing germline mutation(s) in,Assessed
443909,GARD:0008533,Familial colorectal cancer,144,Lynch syndrome,HGNC:11773,TGFBR2,Candidate gene tested in,Not yet assessed
823,GARD:0007673,Spina bifida,268770,Upper thoracic spina bifida cystica,HGNC:7432,MTHFD1,Major susceptibility factor in,Assessed
813,GARD:0004870,Russell-Silver syndrome,231144,Silver-Russell syndrome due to 11p15 microduplication,HGNC:5466,IGF2,Role in the phenotype of,Assessed
68356,GARD:0006895,Leukodystrophy,314918,Mild Canavan disease,HGNC:756,ASPA,Disease-causing germline mutation(s) (loss of function) in,Assessed
3394,GARD:0004898,Soft tissue sarcoma,99966,Atypical teratoid rhabdoid tumor,HGNC:11103,SMARCB1,Disease-causing somatic mutation(s) in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",168563,"46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome",HGNC:2865,DHH,Disease-causing germline mutation(s) in,Assessed
79225,GARD:0007672,Sphingolipidosis,206448,Adult Krabbe disease,HGNC:4115,GALC,Disease-causing germline mutation(s) in,Assessed
289899,GARD:0009433,Organic acidemias,391428,"HSD10 disease, infantile type",HGNC:4800,HSD17B10,Disease-causing germline mutation(s) in,Assessed
263440,GARD:0010902,Neuroacanthocytosis,216873,Atypical pantothenate kinase-associated neurodegeneration,HGNC:15894,PANK2,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:4172,GATA3,Major susceptibility factor in,Assessed
280892,GARD:0006062,Choroiditis,797,Sarcoidosis,HGNC:4948,HLA-DRB1,Major susceptibility factor in,Assessed
182067,GARD:0006513,Glioma,251615,Pilomyxoid astrocytoma,HGNC:6407,KRAS,Disease-causing somatic mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:29666,MTFMT,Disease-causing germline mutation(s) (loss of function) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,401835,Autosomal recessive spastic paraplegia type 70,HGNC:6898,MARS1,Disease-causing germline mutation(s) in,Assessed
448,GARD:0010418,Hemophilia,169793,Severe hemophilia B,HGNC:3551,F9,Disease-causing germline mutation(s) in,Assessed
391417,GARD:0010716,HSD10 disease,391428,"HSD10 disease, infantile type",HGNC:4800,HSD17B10,Disease-causing germline mutation(s) in,Assessed
748,GARD:0012977,Mendelian susceptibility to mycobacterial diseases,319574,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency,HGNC:5440,IFNGR2,Disease-causing germline mutation(s) in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,329469,Acute megakaryoblastic leukemia without Down syndrome,HGNC:29450,GLIS2,Part of a fusion gene in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,309263,"Metachromatic leukodystrophy, juvenile form",HGNC:713,ARSA,Disease-causing germline mutation(s) (loss of function) in,Assessed
655,GARD:0000206,Nephronophthisis,93589,Late-onset nephronophthisis,HGNC:28052,XPNPEP3,Disease-causing germline mutation(s) in,Assessed
209,GARD:0006227,Cutis laxa,357074,"Autosomal recessive cutis laxa type 2, classic type",HGNC:857,ATP6V1E1,Disease-causing germline mutation(s) in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:7711,NDUFS4,Disease-causing germline mutation(s) in,Assessed
305,GARD:0002152,Junctional epidermolysis bullosa,306504,Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome,HGNC:6139,ITGA3,Disease-causing germline mutation(s) (loss of function) in,Assessed
1531,GARD:0006209,Craniosynostosis,457193,Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome,HGNC:13013,KAT6A,Disease-causing germline mutation(s) in,Assessed
79264,GARD:0005897,Neuronal ceroid lipofuscinosis 3,228346,CLN3 disease,HGNC:2074,CLN3,Disease-causing germline mutation(s) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,157713,Congenital or early infantile CACH syndrome,HGNC:3259,EIF2B3,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,280195,Septopreoptic holoprosencephaly,HGNC:11701,TDGF1,Disease-causing germline mutation(s) in,Assessed
3394,GARD:0004898,Soft tissue sarcoma,370334,Extraskeletal Ewing sarcoma,HGNC:11101,SMARCA5,Part of a fusion gene in,Assessed
98277,GARD:0012758,Acute myeloid leukemia with recurrent genetic anomaly,402017,Acute myeloid leukemia with t(9;11)(p22;q23),HGNC:7136,MLLT3,Part of a fusion gene in,Assessed
98261,GARD:0007140,Progressive myoclonic epilepsy,402082,Progressive myoclonic epilepsy type 5,HGNC:9179,POLG,Candidate gene tested in,Assessed
2162,GARD:0006665,Holoprosencephaly,220386,Semilobar holoprosencephaly,HGNC:11701,TDGF1,Disease-causing germline mutation(s) in,Assessed
93969,GARD:0003475,Myelomeningocele,268766,Cervicothoracic spina bifida cystica,HGNC:7432,MTHFD1,Major susceptibility factor in,Assessed
217071,GARD:0008417,Renal cell carcinoma 4,404511,Clear cell papillary renal cell carcinoma,HGNC:11621,HNF1A,Biomarker tested in,Not yet assessed
97245,GARD:0005898,Myopathy congenital,97240,Zebra body myopathy,HGNC:129,ACTA1,Disease-causing germline mutation(s) in,Assessed
88632,GARD:0010025,Anterior segment dysgenesis,98978,Axenfeld anomaly,HGNC:9005,PITX2,Disease-causing germline mutation(s) in,Assessed
702,GARD:0004265,Pelizaeus-Merzbacher disease,280224,"Pelizaeus-Merzbacher disease, transitional form",HGNC:9086,PLP1,Disease-causing germline mutation(s) in,Assessed
79264,GARD:0005897,Neuronal ceroid lipofuscinosis 3,228354,CLN8 disease,HGNC:2079,CLN8,Disease-causing germline mutation(s) in,Assessed
86851,GARD:0008638,Acute leukemia of ambiguous lineage,589534,Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2),HGNC:7132,KMT2A,Part of a fusion gene in,Assessed
280886,GARD:0010941,Anterior uveitis,85408,Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis,HGNC:1677,CD247,Major susceptibility factor in,Assessed
238468,GARD:0000076,Hypohidrotic ectodermal dysplasia,1810,Autosomal dominant hypohidrotic ectodermal dysplasia,HGNC:12036,TRAF6,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93924,Lobar holoprosencephaly,HGNC:11701,TDGF1,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268397,Cervicothoracic spina bifida aperta,HGNC:7432,MTHFD1,Major susceptibility factor in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,435819,Autosomal dominant Charcot-Marie-Tooth disease type 2 due to TFG mutation,HGNC:11758,TFG,Disease-causing germline mutation(s) (gain of function) in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293910,"Familial isolated arrhythmogenic ventricular dysplasia, right dominant form",HGNC:3036,DSC2,Disease-causing germline mutation(s) in,Assessed
309144,GARD:0012510,Gangliosidosis,309246,"GM2 gangliosidosis, AB variant",HGNC:4367,GM2A,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,280195,Septopreoptic holoprosencephaly,HGNC:2908,DLL1,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,320406,Spastic paraplegia-optic atrophy-neuropathy syndrome,HGNC:3760,FLRT1,Disease-causing germline mutation(s) in,Assessed
268337,GARD:0012452,Autosomal recessive intermediate Charcot-Marie-Tooth disease ,435998,Autosomal recessive intermediate Charcot-Marie-Tooth disease type D,HGNC:2277,COX6A1,Disease-causing germline mutation(s) (loss of function) in,Assessed
2162,GARD:0006665,Holoprosencephaly,280195,Septopreoptic holoprosencephaly,HGNC:3686,FGF8,Disease-causing germline mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,370959,Congenital muscular dystrophy with cerebellar involvement,HGNC:26267,POMK,Disease-causing germline mutation(s) (loss of function) in,Assessed
304,GARD:0010752,Epidermolysis bullosa simplex,508529,Intermediate epidermolysis bullosa simplex with cardiomyopathy,HGNC:25947,KLHL24,Disease-causing germline mutation(s) in,Assessed
35656,GARD:0010423,Coenzyme Q10 deficiency,319678,Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome,HGNC:25302,COQ9,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,352723,Attenuated Chédiak-Higashi syndrome,HGNC:1968,LYST,Disease-causing germline mutation(s) in,Assessed
64746,GARD:0012431,Charcot-Marie-Tooth disease type 2,447964,Autosomal dominant Charcot-Marie-Tooth disease type 2V,HGNC:7632,NAGLU,Disease-causing germline mutation(s) in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",494433,MIRAGE syndrome,HGNC:1348,SAMD9,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,163746,Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease,HGNC:11190,SOX10,Disease-causing germline mutation(s) in,Assessed
790,GARD:0007563,Retinoblastoma,357027,Hereditary retinoblastoma,HGNC:7559,MYCN,Candidate gene tested in,Not yet assessed
217071,GARD:0008417,Renal cell carcinoma 4,319308,MiT family translocation renal cell carcinoma,HGNC:11753,TFEB,Part of a fusion gene in,Assessed
182090,GARD:0007501,Pulmonary arterial hypertension,275777,Heritable pulmonary arterial hypertension,HGNC:6278,KCNK3,Disease-causing germline mutation(s) (loss of function) in,Assessed
437,GARD:0006735,Hypophosphatemic rickets,289176,Autosomal recessive hypophosphatemic rickets,HGNC:2932,DMP1,Disease-causing germline mutation(s) in,Assessed
437,GARD:0006735,Hypophosphatemic rickets,89937,Autosomal dominant hypophosphatemic rickets,HGNC:3680,FGF23,Disease-causing germline mutation(s) (gain of function) in,Assessed
98722,GARD:0000802,Atrioventricular septal defect,99068,Complete atrioventricular septal defect-tetralogy of Fallot,HGNC:4173,GATA4,Disease-causing germline mutation(s) in,Assessed
27,GARD:0003586,Methylmalonyl-Coenzyme A mutase deficiency,79312,Vitamin B12-unresponsive methylmalonic acidemia type mut-,HGNC:7526,MMUT,Disease-causing germline mutation(s) (loss of function) in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:28625,NDUFAF6,Disease-causing germline mutation(s) in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:23987,NDUFA12,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,70474,Leigh syndrome with cardiomyopathy,HGNC:7703,NDUFB8,Disease-causing germline mutation(s) in,Assessed
157,GARD:0001121,Carnitine palmitoyltransferase 2 deficiency,228308,"Carnitine palmitoyl transferase II deficiency, neonatal form",HGNC:2330,CPT2,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255182,Pyruvate dehydrogenase E3-binding protein deficiency,HGNC:21350,PDHX,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268770,Upper thoracic spina bifida cystica,HGNC:15511,VANGL2,Major susceptibility factor in,Assessed
68356,GARD:0006895,Leukodystrophy,206448,Adult Krabbe disease,HGNC:4115,GALC,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:6120,IRF5,Major susceptibility factor in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:11998,TP53,Major susceptibility factor in,Assessed
93969,GARD:0003475,Myelomeningocele,268752,Thoracolumbosacral spina bifida cystica,HGNC:26219,FUZ,Disease-causing germline mutation(s) in,Assessed
250,GARD:0002392,Frontonasal dysplasia,488437,SIX2-related frontonasal dysplasia,HGNC:10888,SIX2,Role in the phenotype of,Assessed
157850,GARD:0006564,Pantothenate kinase-associated neurodegeneration,216873,Atypical pantothenate kinase-associated neurodegeneration,HGNC:15894,PANK2,Disease-causing germline mutation(s) in,Assessed
93442,GARD:0008542,Chondrodysplasia punctata syndrome,468717,Rhizomelic chondrodysplasia punctata type 5,HGNC:9719,PEX5,Disease-causing germline mutation(s) (loss of function) in,Assessed
68356,GARD:0006895,Leukodystrophy,280224,"Pelizaeus-Merzbacher disease, transitional form",HGNC:9086,PLP1,Disease-causing germline mutation(s) in,Assessed
512,GARD:0003230,Metachromatic leukodystrophy,309256,"Metachromatic leukodystrophy, late infantile form",HGNC:713,ARSA,Disease-causing germline mutation(s) (loss of function) in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:16903,TNIP1,Major susceptibility factor in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,495274,Charcot-Marie-Tooth disease type 2T,HGNC:7154,MME,Disease-causing germline mutation(s) (loss of function) in,Assessed
98634,GARD:0002978,Iridogoniodysgenesis type 1,91483,Rieger anomaly,HGNC:9005,PITX2,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:3765,FLT3,Disease-causing somatic mutation(s) in,Assessed
231692,GARD:0003921,Isolated growth hormone deficiency type 3,67045,X-linked intellectual disability with isolated growth hormone deficiency,HGNC:11199,SOX3,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268392,Cervical spina bifida aperta,HGNC:15511,VANGL2,Major susceptibility factor in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,263463,CHST3-related skeletal dysplasia,HGNC:1971,CHST3,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268740,Upper thoracic spina bifida aperta,HGNC:7432,MTHFD1,Major susceptibility factor in,Assessed
88632,GARD:0010025,Anterior segment dysgenesis,782,Axenfeld-Rieger syndrome,HGNC:9005,PITX2,Disease-causing germline mutation(s) (loss of function) in,Assessed
93969,GARD:0003475,Myelomeningocele,268770,Upper thoracic spina bifida cystica,HGNC:15511,VANGL2,Major susceptibility factor in,Assessed
263,GARD:0006907,Limb-girdle muscular dystrophy,476084,BVES-related limb-girdle muscular dystrophy,HGNC:1152,BVES,Disease-causing germline mutation(s) in,Assessed
97242,GARD:0009138,Congenital muscular dystrophy,370959,Congenital muscular dystrophy with cerebellar involvement,HGNC:19743,POMT2,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,363412,Hypomyelination with brain stem and spinal cord involvement and leg spasticity,HGNC:2678,DARS1,Disease-causing germline mutation(s) in,Assessed
443909,GARD:0008533,Familial colorectal cancer,440437,Familial colorectal cancer Type X,HGNC:10729,SEMA4A,Disease-causing germline mutation(s) in,Assessed
85450,GARD:0008282,Amyloidosis familial visceral,93562,AFib amyloidosis,HGNC:3661,FGA,Disease-causing germline mutation(s) in,Assessed
251612,GARD:0009808,Pilocytic astrocytoma,251615,Pilomyxoid astrocytoma,HGNC:6407,KRAS,Disease-causing somatic mutation(s) in,Assessed
309279,GARD:0010670,Glycoproteinosis,93400,Congenital sialidosis type 2,HGNC:7758,NEU1,Disease-causing germline mutation(s) in,Assessed
442,GARD:0001487,Congenital hypothyroidism,95716,Familial thyroid dyshormonogenesis,HGNC:32698,DUOXA2,Disease-causing germline mutation(s) in,Assessed
182090,GARD:0007501,Pulmonary arterial hypertension,275777,Heritable pulmonary arterial hypertension,HGNC:1527,CAV1,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268758,Lumbosacral spina bifida cystica,HGNC:26219,FUZ,Disease-causing germline mutation(s) in,Assessed
282,GARD:0008436,Frontotemporal dementia,275864,Behavioral variant of frontotemporal dementia,HGNC:22407,TMEM106B,Major susceptibility factor in,Assessed
2162,GARD:0006665,Holoprosencephaly,93924,Lobar holoprosencephaly,HGNC:3688,FGFR1,Candidate gene tested in,Not yet assessed
3033,GARD:0000379,Renal tubular dysgenesis,97369,Renal tubular dysgenesis of genetic origin,HGNC:2707,ACE,Disease-causing germline mutation(s) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,369867,Autosomal recessive intermediate Charcot-Marie-Tooth disease type C,HGNC:29105,PLEKHG5,Disease-causing germline mutation(s) in,Assessed
655,GARD:0000206,Nephronophthisis,93592,Juvenile nephronophthisis,HGNC:29450,GLIS2,Disease-causing germline mutation(s) (loss of function) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,536467,B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome,HGNC:17978,B3GALT6,Disease-causing germline mutation(s) (loss of function) in,Assessed
52,GARD:0000804,Alagille syndrome,261629,Alagille syndrome due to a NOTCH2 point mutation,HGNC:7882,NOTCH2,Disease-causing germline mutation(s) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,320406,Spastic paraplegia-optic atrophy-neuropathy syndrome,HGNC:20716,KLC2,Disease-causing germline mutation(s) (gain of function) in,Assessed
68356,GARD:0006895,Leukodystrophy,502444,Alkaline ceramidase 3 deficiency,HGNC:16066,ACER3,Disease-causing germline mutation(s) in,Assessed
97245,GARD:0005898,Myopathy congenital,210163,"Congenital lethal myopathy, Compton-North type",HGNC:2171,CNTN1,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,401795,Autosomal recessive spastic paraplegia type 59,HGNC:12631,USP8,Disease-causing germline mutation(s) in,Assessed
1041,GARD:0002783,Hydrops fetalis,363999,Non-immune hydrops fetalis,HGNC:485,ANGPT2,Disease-causing germline mutation(s) (loss of function) in,Assessed
391417,GARD:0010716,HSD10 disease,85295,"HSD10 disease, atypical type",HGNC:4800,HSD17B10,Disease-causing germline mutation(s) in,Assessed
93969,GARD:0003475,Myelomeningocele,268770,Upper thoracic spina bifida cystica,HGNC:7432,MTHFD1,Major susceptibility factor in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:5056,TLX1,Part of a fusion gene in,Assessed
97242,GARD:0009138,Congenital muscular dystrophy,536516,Myopathic Ehlers-Danlos syndrome,HGNC:2188,COL12A1,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:23987,NDUFA12,Disease-causing germline mutation(s) in,Assessed
932,GARD:0002882,Achondrogenesis,93297,Hypochondrogenesis,HGNC:2200,COL2A1,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:8803,PDGFRA,Part of a fusion gene in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,357074,"Autosomal recessive cutis laxa type 2, classic type",HGNC:857,ATP6V1E1,Disease-causing germline mutation(s) in,Assessed
443909,GARD:0008533,Familial colorectal cancer,144,Lynch syndrome,HGNC:9121,PMS1,Candidate gene tested in,Not yet assessed
595,GARD:0000101,Centronuclear myopathy,456328,X-linked myotubular myopathy-abnormal genitalia syndrome,HGNC:2568,MAMLD1,Role in the phenotype of,Assessed
511,GARD:0003228,Maple syrup urine disease,268145,Classic maple syrup urine disease,HGNC:986,BCKDHA,Disease-causing germline mutation(s) in,Assessed
360,GARD:0002491,Glioblastoma,251579,Giant cell glioblastoma,HGNC:3236,EGFR,Part of a fusion gene in,Assessed
512,GARD:0003230,Metachromatic leukodystrophy,309263,"Metachromatic leukodystrophy, juvenile form",HGNC:713,ARSA,Disease-causing germline mutation(s) (loss of function) in,Assessed
2962,GARD:0000049,De Barsy syndrome,293633,PYCR1-related De Barsy syndrome,HGNC:9721,PYCR1,Disease-causing germline mutation(s) in,Assessed
88632,GARD:0010025,Anterior segment dysgenesis,488197,Familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome,HGNC:31582,MIR204,Disease-causing germline mutation(s) (gain of function) in,Assessed
303,GARD:0002150,Dystrophic epidermolysis bullosa,89843,Dystrophic epidermolysis bullosa pruriginosa,HGNC:2214,COL7A1,Disease-causing germline mutation(s) (loss of function) in,Assessed
2134,GARD:0008702,Atypical hemolytic uremic syndrome,93581,Atypical hemolytic uremic syndrome with anti-factor H antibodies,HGNC:24668,CFHR5,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,513436,Autosomal recessive spastic paraplegia type 78,HGNC:30213,ATP13A2,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,401800,Autosomal recessive spastic paraplegia type 60,HGNC:30914,WDR48,Disease-causing germline mutation(s) in,Assessed
98879,GARD:0008732,Hemophilia B,177929,Bleeding disorder in hemophilia B carriers,HGNC:3551,F9,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268766,Cervicothoracic spina bifida cystica,HGNC:7432,MTHFD1,Major susceptibility factor in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:3495,ETV6,Part of a fusion gene in,Assessed
739,GARD:0005575,Prader-Willi syndrome,177901,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1,HGNC:32781,SNORD116@,Role in the phenotype of,Assessed
739,GARD:0005575,Prader-Willi syndrome,177904,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2,HGNC:32781,SNORD116@,Role in the phenotype of,Assessed
360,GARD:0002491,Glioblastoma,251579,Giant cell glioblastoma,HGNC:11524,TACC3,Part of a fusion gene in,Assessed
765,GARD:0007513,Pyruvate dehydrogenase complex deficiency,255182,Pyruvate dehydrogenase E3-binding protein deficiency,HGNC:21350,PDHX,Disease-causing germline mutation(s) in,Assessed
2978,GARD:0012744,Chronic intestinal pseudoobstruction,99811,Neuronal intestinal pseudoobstruction,HGNC:3754,FLNA,Disease-causing germline mutation(s) in,Assessed
3394,GARD:0004898,Soft tissue sarcoma,209916,Extraskeletal myxoid chondrosarcoma,HGNC:7982,NR4A3,Part of a fusion gene in,Assessed
34526,GARD:0002906,Familial primary hypomagnesemia,30924,Primary hypomagnesemia with secondary hypocalcemia,HGNC:17995,TRPM6,Disease-causing germline mutation(s) in,Assessed
98306,GARD:0011962,Familial partial lipodystrophy,435651,CIDEC-related familial partial lipodystrophy,HGNC:24229,CIDEC,Disease-causing germline mutation(s) (loss of function) in,Assessed
3242,GARD:0009509,Renpenning syndrome,93945,"X-linked intellectual disability, Porteous type",HGNC:9330,PQBP1,Disease-causing germline mutation(s) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,99853,Ovarioleukodystrophy,HGNC:3257,EIF2B1,Disease-causing germline mutation(s) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,99853,Ovarioleukodystrophy,HGNC:3258,EIF2B2,Disease-causing germline mutation(s) in,Assessed
444116,GARD:0006611,Hereditary amyloidosis,324723,"ABeta amyloidosis, Arctic type",HGNC:620,APP,Disease-causing germline mutation(s) in,Assessed
444116,GARD:0006611,Hereditary amyloidosis,93562,AFib amyloidosis,HGNC:3661,FGA,Disease-causing germline mutation(s) in,Assessed
98292,GARD:0006987,Mastocytosis,98849,Systemic mastocytosis with associated hematologic neoplasm,HGNC:18318,ASXL1,Disease-causing somatic mutation(s) in,Assessed
55,GARD:0010958,Oculocutaneous albinism,370097,Oculocutaneous albinism type 6,HGNC:20611,SLC24A5,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268758,Lumbosacral spina bifida cystica,HGNC:7432,MTHFD1,Major susceptibility factor in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:15899,NDUFAF5,Disease-causing germline mutation(s) in,Assessed
280886,GARD:0010941,Anterior uveitis,85408,Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis,HGNC:6009,IL2RB,Major susceptibility factor in,Not yet assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:5041,HNRNPH1,Part of a fusion gene in,Assessed
98274,GARD:0009319,Chronic myeloproliferative disorders,480851,Hereditary thrombocytopenia with early-onset myelofibrosis,HGNC:11283,SRC,Disease-causing germline mutation(s) (gain of function) in,Assessed
53739,GARD:0012683,Distal hereditary motor neuropathy,139536,Distal hereditary motor neuropathy type 5,HGNC:15832,BSCL2,Disease-causing germline mutation(s) in,Assessed
535,GARD:0006225,Cutaneous lupus erythematosus,481662,Familial Chilblain lupus,HGNC:12269,TREX1,Disease-causing germline mutation(s) (loss of function) in,Assessed
98292,GARD:0006987,Mastocytosis,98849,Systemic mastocytosis with associated hematologic neoplasm,HGNC:10783,SRSF2,Disease-causing somatic mutation(s) in,Assessed
739,GARD:0005575,Prader-Willi syndrome,177904,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2,HGNC:32780,SNORD115@,Role in the phenotype of,Assessed
79225,GARD:0007672,Sphingolipidosis,309271,"Metachromatic leukodystrophy, adult form",HGNC:713,ARSA,Disease-causing germline mutation(s) (loss of function) in,Assessed
98274,GARD:0009319,Chronic myeloproliferative disorders,314950,Primary hypereosinophilic syndrome,HGNC:8803,PDGFRA,Part of a fusion gene in,Assessed
282,GARD:0008436,Frontotemporal dementia,275864,Behavioral variant of frontotemporal dementia,HGNC:11280,SQSTM1,Disease-causing germline mutation(s) in,Assessed
217071,GARD:0008417,Renal cell carcinoma 4,319308,MiT family translocation renal cell carcinoma,HGNC:10774,SFPQ,Part of a fusion gene in,Assessed
443909,GARD:0008533,Familial colorectal cancer,144,Lynch syndrome,HGNC:7128,MLH3,Modifying germline mutation in,Assessed
716,GARD:0007383,Phenylketonuria,293284,Tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria,HGNC:8582,PAH,Disease-causing germline mutation(s) in,Assessed
2467,GARD:0008616,Systemic mastocytosis,98850,Aggressive systemic mastocytosis,HGNC:1541,CBL,Disease-causing somatic mutation(s) in,Assessed
220460,GARD:0008532,Attenuated familial adenomatous polyposis,454840,NTHL1-related attenuated familial adenomatous polyposis,HGNC:8028,NTHL1,Disease-causing germline mutation(s) (loss of function) in,Assessed
156005,GARD:0002490,Glaucoma 3 primary infantile B,98976,Congenital glaucoma,HGNC:2597,CYP1B1,Disease-causing germline mutation(s) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,99853,Ovarioleukodystrophy,HGNC:3261,EIF2B5,Disease-causing germline mutation(s) in,Assessed
36388,GARD:0007326,Paraneoplastic cerebellar degeneration,163908,Limbic encephalitis with LGI1 antibodies,HGNC:4948,HLA-DRB1,Major susceptibility factor in,Assessed
93383,GARD:0000985,Brachydactyly type B,140908,Brachydactyly type B2,HGNC:7866,NOG,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:11255,SPP1,Major susceptibility factor in,Assessed
156005,GARD:0002490,Glaucoma 3 primary infantile B,98977,Juvenile glaucoma,HGNC:7610,MYOC,Disease-causing germline mutation(s) in,Assessed
88632,GARD:0010025,Anterior segment dysgenesis,261629,Alagille syndrome due to a NOTCH2 point mutation,HGNC:7882,NOTCH2,Disease-causing germline mutation(s) in,Assessed
2467,GARD:0008616,Systemic mastocytosis,98849,Systemic mastocytosis with associated hematologic neoplasm,HGNC:25941,TET2,Disease-causing somatic mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,370997,Muscle-eye-brain disease with bilateral multicystic leucodystrophy,HGNC:2666,DAG1,Disease-causing germline mutation(s) in,Assessed
183660,GARD:0007628,Severe combined immunodeficiency,357237,Severe combined immunodeficiency due to CARD11 deficiency,HGNC:16393,CARD11,Disease-causing germline mutation(s) (loss of function) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,443811,PGM3-CDG,HGNC:8907,PGM3,Disease-causing germline mutation(s) in,Assessed
3148,GARD:0010872,Malignant peripheral nerve sheath tumor,252212,Malignant triton tumor,HGNC:23664,SH3PXD2A,Part of a fusion gene in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,431329,Autosomal recessive spastic paraplegia type 57,HGNC:11758,TFG,Disease-causing germline mutation(s) in,Assessed
167714,GARD:0012760,Unclassified acute myeloid leukemia ,98832,Acute myeloid leukemia with minimal differentiation,HGNC:3765,FLT3,Disease-causing somatic mutation(s) in,Assessed
213500,GARD:0007295,Ovarian cancer,213504,Adenocarcinoma of ovary,HGNC:6066,INHBA,Disease-causing germline mutation(s) in,Assessed
450,GARD:0008591,X-linked visceral heterotaxy 1,157769,Situs ambiguus,HGNC:18053,PKD1L1,Disease-causing germline mutation(s) in,Assessed
370953,GARD:0012584,Congenital muscular dystrophy due to dystroglycanopathy ,370968,Congenital muscular dystrophy with intellectual disability,HGNC:19743,POMT2,Disease-causing germline mutation(s) in,Assessed
589,GARD:0007122,Myasthenia gravis,391490,Adult-onset myasthenia gravis,HGNC:11908,TNFRSF11A,Major susceptibility factor in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,98835,Acute undifferentiated leukemia,HGNC:7132,KMT2A,Part of a fusion gene in,Assessed
87876,GARD:0007183,"Sialidosis, type II",93400,Congenital sialidosis type 2,HGNC:7758,NEU1,Disease-causing germline mutation(s) in,Assessed
168956,GARD:0002804,Hypereosinophilic syndrome,314950,Primary hypereosinophilic syndrome,HGNC:8804,PDGFRB,Part of a fusion gene in,Assessed
69078,GARD:0006913,Liposarcoma,99971,Well-differentiated liposarcoma,HGNC:6973,MDM2,Role in the phenotype of,Assessed
511,GARD:0003228,Maple syrup urine disease,268162,Intermediate maple syrup urine disease,HGNC:2698,DBT,Disease-causing germline mutation(s) (loss of function) in,Assessed
748,GARD:0012977,Mendelian susceptibility to mycobacterial diseases,319547,Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency,HGNC:5440,IFNGR2,Disease-causing germline mutation(s) in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:26927,FOXRED1,Disease-causing germline mutation(s) in,Assessed
309279,GARD:0010670,Glycoproteinosis,93399,Juvenile sialidosis type 2,HGNC:7758,NEU1,Disease-causing germline mutation(s) in,Assessed
93969,GARD:0003475,Myelomeningocele,268766,Cervicothoracic spina bifida cystica,HGNC:15511,VANGL2,Major susceptibility factor in,Assessed
253,GARD:0007687,Spondyloepiphyseal dysplasia,250984,Autosomal recessive Stickler syndrome,HGNC:2217,COL9A1,Disease-causing germline mutation(s) in,Assessed
544,GARD:0003178,Diffuse Large B-Cell Lymphoma,98838,Primary mediastinal large B-cell lymphoma,HGNC:1001,BCL6,Disease-causing somatic mutation(s) in,Assessed
411709,GARD:0009228,Renal agenesis,1848,"Renal agenesis, bilateral",HGNC:12779,WNT9B,Disease-causing germline mutation(s) (loss of function) in,Assessed
306498,GARD:0012800,PTEN hamartoma tumor syndrome,137608,Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome,HGNC:9588,PTEN,Disease-causing germline mutation(s) in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",251510,"46,XY partial gonadal dysgenesis",HGNC:11204,SOX9,Disease-causing germline mutation(s) in,Assessed
331223,GARD:0010956,Hyper IgE syndrome,369992,Severe dermatitis-multiple allergies-metabolic wasting syndrome,HGNC:3048,DSG1,Disease-causing germline mutation(s) (loss of function) in,Assessed
401854,GARD:0012679,Lipoic acid biosynthesis defects,363424,Multiple mitochondrial dysfunctions syndrome type 3,HGNC:27302,IBA57,Disease-causing germline mutation(s) in,Assessed
450,GARD:0008591,X-linked visceral heterotaxy 1,157769,Situs ambiguus,HGNC:2953,DNAH9,Disease-causing germline mutation(s) (loss of function) in,Assessed
182058,GARD:0012959,Primary orthostatic hypotension,2828,Young-onset Parkinson disease,HGNC:12513,UCHL1,Candidate gene tested in,Not yet assessed
91024,GARD:0012449,Autosomal recessive axonal Charcot-Marie-Tooth disease type 2,90120,Hereditary motor and sensory neuropathy type 6,HGNC:25198,SLC25A46,Disease-causing germline mutation(s) (loss of function) in,Assessed
253,GARD:0007687,Spondyloepiphyseal dysplasia,90654,Stickler syndrome type 2,HGNC:2186,COL11A1,Disease-causing germline mutation(s) in,Assessed
1531,GARD:0006209,Craniosynostosis,3366,Isolated trigonocephaly,HGNC:3688,FGFR1,Disease-causing germline mutation(s) in,Assessed
98275,GARD:0009351,Myelodysplastic/myeloproliferative disease,98824,Atypical chronic myeloid leukemia,HGNC:2439,CSF3R,Disease-causing somatic mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:10760,SET,Part of a fusion gene in,Assessed
1531,GARD:0006209,Craniosynostosis,35093,Isolated scaphocephaly,HGNC:450,ALX4,Major susceptibility factor in,Assessed
593,GARD:0010529,Myofibrillar myopathy,199340,"Muscular dystrophy, Selcen type",HGNC:939,BAG3,Disease-causing germline mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,536516,Myopathic Ehlers-Danlos syndrome,HGNC:2188,COL12A1,Disease-causing germline mutation(s) in,Assessed
3394,GARD:0004898,Soft tissue sarcoma,252128,Malignant peripheral nerve sheath tumor with perineurial differentiation,HGNC:23664,SH3PXD2A,Part of a fusion gene in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,228179,Autosomal dominant Charcot-Marie-Tooth disease type 2M,HGNC:2974,DNM2,Disease-causing germline mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,98863,X-linked Emery-Dreifuss muscular dystrophy,HGNC:3331,EMD,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:15899,NDUFAF5,Disease-causing germline mutation(s) in,Assessed
19,GARD:0010761,2-Hydroxyglutaric aciduria,356978,"D,L-2-hydroxyglutaric aciduria",HGNC:10979,SLC25A1,Disease-causing germline mutation(s) in,Assessed
716,GARD:0007383,Phenylketonuria,79254,Classic phenylketonuria,HGNC:8582,PAH,Disease-causing germline mutation(s) (loss of function) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,370980,Congenital muscular dystrophy without intellectual disability,HGNC:3622,FKTN,Disease-causing germline mutation(s) in,Assessed
209,GARD:0006227,Cutis laxa,221145,"Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies",HGNC:6717,LTBP4,Disease-causing germline mutation(s) (gain of function) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,357074,"Autosomal recessive cutis laxa type 2, classic type",HGNC:851,ATP6V1A,Disease-causing germline mutation(s) in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,319465,Inherited acute myeloid leukemia,HGNC:1833,CEBPA,Disease-causing germline mutation(s) in,Assessed
2134,GARD:0008702,Atypical hemolytic uremic syndrome,544472,Atypical hemolytic uremic syndrome with complement gene abnormality,HGNC:1037,CFB,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93926,Midline interhemispheric variant of holoprosencephaly,HGNC:10848,SHH,Disease-causing germline mutation(s) in,Assessed
370953,GARD:0012584,Congenital muscular dystrophy due to dystroglycanopathy ,370959,Congenital muscular dystrophy with cerebellar involvement,HGNC:9202,POMT1,Disease-causing germline mutation(s) in,Assessed
739,GARD:0005575,Prader-Willi syndrome,177904,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2,HGNC:11164,SNRPN,Role in the phenotype of,Assessed
3394,GARD:0004898,Soft tissue sarcoma,79105,Myxofibrosarcoma,HGNC:18856,CREB3L1,Part of a fusion gene in,Assessed
1576,GARD:0005040,Striatonigral degeneration infantile,225154,Familial infantile bilateral striatal necrosis,HGNC:7414,MT-ATP6,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:15514,PICALM,Part of a fusion gene in,Assessed
182067,GARD:0006513,Glioma,251598,Protoplasmic astrocytoma,HGNC:5383,IDH2,Biomarker tested in,Assessed
2162,GARD:0006665,Holoprosencephaly,220386,Semilobar holoprosencephaly,HGNC:17104,CDON,Disease-causing germline mutation(s) in,Assessed
616,GARD:0007005,Medulloblastoma,251863,Desmoplastic/nodular medulloblastoma,HGNC:16466,SUFU,Major susceptibility factor in,Assessed
593,GARD:0010529,Myofibrillar myopathy,476093,Autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome,HGNC:30171,HSPB8,Disease-causing germline mutation(s) in,Assessed
231692,GARD:0003921,Isolated growth hormone deficiency type 3,632,Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia,HGNC:3319,ELF4,Disease-causing germline mutation(s) in,Assessed
217071,GARD:0008417,Renal cell carcinoma 4,319308,MiT family translocation renal cell carcinoma,HGNC:11752,TFE3,Part of a fusion gene in,Assessed
683,GARD:0007471,Progressive supranuclear palsy,240085,Progressive supranuclear palsy-parkinsonism syndrome,HGNC:6893,MAPT,Major susceptibility factor in,Assessed
823,GARD:0007673,Spina bifida,268392,Cervical spina bifida aperta,HGNC:7436,MTHFR,Major susceptibility factor in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,319465,Inherited acute myeloid leukemia,HGNC:16255,TGM6,Disease-causing germline mutation(s) in,Assessed
64749,GARD:0012440,Charcot-Marie-Tooth disease type 4,363981,Charcot-Marie-Tooth disease type 4B3,HGNC:10542,SBF1,Disease-causing germline mutation(s) in,Assessed
738,GARD:0010353,Porphyria,443062,Familial porphyria cutanea tarda,HGNC:12591,UROD,Disease-causing germline mutation(s) (loss of function) in,Assessed
98722,GARD:0000802,Atrioventricular septal defect,576235,Partial atrioventricular septal defect without ventricular hypoplasia,HGNC:14630,CRELD1,Disease-causing germline mutation(s) (loss of function) in,Assessed
79225,GARD:0007672,Sphingolipidosis,216981,"Niemann-Pick disease type C, juvenile neurologic onset",HGNC:7897,NPC1,Disease-causing germline mutation(s) in,Assessed
1037,GARD:0000777,Arthrogryposis multiplex congenita,319332,Autosomal recessive myogenic arthrogryposis multiplex congenita,HGNC:17089,SYNE1,Disease-causing germline mutation(s) in,Assessed
91024,GARD:0012449,Autosomal recessive axonal Charcot-Marie-Tooth disease type 2,90118,Severe early-onset axonal neuropathy due to MFN2 deficiency,HGNC:16877,MFN2,Disease-causing germline mutation(s) in,Assessed
3394,GARD:0004898,Soft tissue sarcoma,79105,Myxofibrosarcoma,HGNC:23720,CREB3L2,Part of a fusion gene in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:3488,ETS1,Major susceptibility factor in,Assessed
308166,GARD:0010923,Erythrokeratodermia variabilis et progressiva,316,Progressive symmetric erythrokeratodermia,HGNC:4021,KDSR,Disease-causing germline mutation(s) (loss of function) in,Assessed
442,GARD:0001487,Congenital hypothyroidism,226307,Hypothyroidism due to deficient transcription factors involved in pituitary development or function,HGNC:4877,HESX1,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,309192,"Tay-Sachs disease, B variant, adult form",HGNC:4878,HEXA,Disease-causing germline mutation(s) in,Assessed
93403,GARD:0005087,Syndactyly type 2,295195,Synpolydactyly type 1,HGNC:5136,HOXD13,Disease-causing germline mutation(s) in,Assessed
813,GARD:0004870,Russell-Silver syndrome,397590,Silver-Russell syndrome due to a point mutation,HGNC:5009,HMGA2,Disease-causing germline mutation(s) in,Assessed
98249,GARD:0006322,Ehlers-Danlos syndromes,300179,Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency,HGNC:18625,FKBP14,Disease-causing germline mutation(s) in,Assessed
98277,GARD:0012758,Acute myeloid leukemia with recurrent genetic anomaly,402023,Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13),HGNC:14334,MRTFA,Part of a fusion gene in,Assessed
264665,GARD:0010559,Children's interstitial lung disease,217563,Neonatal acute respiratory distress due to SP-B deficiency,HGNC:10801,SFTPB,Disease-causing germline mutation(s) (loss of function) in,Assessed
79430,GARD:0006643,Hermansky-Pudlak syndrome,231500,Hermansky-Pudlak syndrome due to BLOC-3 deficiency,HGNC:15844,HPS4,Disease-causing germline mutation(s) in,Assessed
261494,GARD:0008672,Kleefstra syndrome,261652,Kleefstra syndrome due to a point mutation,HGNC:13726,KMT2C,Disease-causing germline mutation(s) (loss of function) in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293910,"Familial isolated arrhythmogenic ventricular dysplasia, right dominant form",HGNC:11769,TGFB3,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,306511,Autosomal recessive spastic paraplegia type 48,HGNC:22197,AP5Z1,Disease-causing germline mutation(s) (loss of function) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:13532,TLX3,Part of a fusion gene in,Assessed
98473,GARD:0007922,Muscular dystrophy,370968,Congenital muscular dystrophy with intellectual disability,HGNC:9202,POMT1,Disease-causing germline mutation(s) in,Assessed
1531,GARD:0006209,Craniosynostosis,178377,Osteosclerosis-developmental delay-craniosynostosis syndrome,HGNC:6697,LRP5,Disease-causing germline mutation(s) (gain of function) in,Assessed
506,GARD:0006877,Leigh syndrome,70474,Leigh syndrome with cardiomyopathy,HGNC:29918,NDUFAF3,Disease-causing germline mutation(s) in,Assessed
98277,GARD:0012758,Acute myeloid leukemia with recurrent genetic anomaly,402014,Acute myeloid leukemia with t(6;9)(p23;q34),HGNC:8064,NUP214,Part of a fusion gene in,Assessed
442,GARD:0001487,Congenital hypothyroidism,589856,Choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome,HGNC:7133,KMT2D,Disease-causing germline mutation(s) in,Assessed
104008,GARD:0001502,Short bowel syndrome,2301,Congenital short bowel syndrome,HGNC:24039,CLMP,Disease-causing germline mutation(s) (loss of function) in,Assessed
823,GARD:0007673,Spina bifida,268397,Cervicothoracic spina bifida aperta,HGNC:7436,MTHFR,Major susceptibility factor in,Assessed
823,GARD:0007673,Spina bifida,268392,Cervical spina bifida aperta,HGNC:11515,TBXT,Major susceptibility factor in,Assessed
69078,GARD:0006913,Liposarcoma,99971,Well-differentiated liposarcoma,HGNC:5009,HMGA2,Role in the phenotype of,Assessed
63454,GARD:0009821,Pattern dystrophy,99001,Butterfly-shaped pigment dystrophy,HGNC:9942,PRPH2,Disease-causing germline mutation(s) in,Assessed
97229,GARD:0009993,Riboflavin transporter deficiency,572543,RFVT2-related riboflavin transporter deficiency,HGNC:30224,SLC52A2,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:10526,SALL2,Part of a fusion gene in,Assessed
79225,GARD:0007672,Sphingolipidosis,206436,Infantile Krabbe disease,HGNC:9498,PSAP,Disease-causing germline mutation(s) in,Assessed
97245,GARD:0005898,Myopathy congenital,324604,Classic multiminicore myopathy,HGNC:15999,SELENON,Disease-causing germline mutation(s) in,Assessed
437,GARD:0006735,Hypophosphatemic rickets,157215,Hereditary hypophosphatemic rickets with hypercalciuria,HGNC:20305,SLC34A3,Disease-causing germline mutation(s) (loss of function) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93926,Midline interhemispheric variant of holoprosencephaly,HGNC:12873,ZIC2,Disease-causing germline mutation(s) in,Assessed
35656,GARD:0010423,Coenzyme Q10 deficiency,255249,Leigh syndrome with nephrotic syndrome,HGNC:25223,COQ2,Disease-causing germline mutation(s) in,Assessed
79213,GARD:0007065,Mucopolysaccharidosis,276212,"Mucopolysaccharidosis type 6, rapidly progressing",HGNC:714,ARSB,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,280288,Pelizaeus-Merzbacher-like disease due to HSPD1 mutation,HGNC:5261,HSPD1,Disease-causing germline mutation(s) in,Assessed
53739,GARD:0012683,Distal hereditary motor neuropathy,397744,Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome,HGNC:23212,MYH14,Disease-causing germline mutation(s) in,Assessed
251355,GARD:0012459,Sickle cell disease associated with an other hemoglobin anomaly,251380,Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome,HGNC:13221,BCL11A,Candidate gene tested in,Not yet assessed
450,GARD:0008591,X-linked visceral heterotaxy 1,157769,Situs ambiguus,HGNC:26530,CFAP53,Disease-causing germline mutation(s) in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,102724,Acute myeloid leukemia with t(8;21)(q22;q22) translocation,HGNC:10471,RUNX1,Part of a fusion gene in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293888,"Familial isolated arrhythmogenic ventricular dysplasia, left dominant form",HGNC:10484,RYR2,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268388,Lumbosacral spina bifida aperta,HGNC:11515,TBXT,Major susceptibility factor in,Assessed
91378,GARD:0005979,Hereditary angioedema,599418,Hereditary angioedema with normal C1Inh not related to F12 or PLG variant,HGNC:484,ANGPT1,Disease-causing germline mutation(s) in,Assessed
88632,GARD:0010025,Anterior segment dysgenesis,519388,Autosomal recessive anterior segment dysgenesis,HGNC:23228,CPAMD8,Disease-causing germline mutation(s) in,Assessed
442,GARD:0001487,Congenital hypothyroidism,226307,Hypothyroidism due to deficient transcription factors involved in pituitary development or function,HGNC:9455,PROP1,Disease-causing germline mutation(s) in,Assessed
444116,GARD:0006611,Hereditary amyloidosis,93561,ALys amyloidosis,HGNC:6740,LYZ,Disease-causing germline mutation(s) in,Assessed
646,GARD:0007207,Niemann-Pick disease type C1,216981,"Niemann-Pick disease type C, juvenile neurologic onset",HGNC:14537,NPC2,Disease-causing germline mutation(s) in,Assessed
655,GARD:0000206,Nephronophthisis,93591,Infantile nephronophthisis,HGNC:7907,NPHP3,Disease-causing germline mutation(s) (loss of function) in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:7684,NDUFA10,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93925,Alobar holoprosencephaly,HGNC:17104,CDON,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,401815,Autosomal recessive spastic paraplegia type 66,HGNC:32521,ARSI,Disease-causing germline mutation(s) in,Assessed
512,GARD:0003230,Metachromatic leukodystrophy,309256,"Metachromatic leukodystrophy, late infantile form",HGNC:9498,PSAP,Disease-causing germline mutation(s) in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,370026,Acute myeloid leukemia with t(8;16)(p11;p13) translocation,HGNC:2348,CREBBP,Part of a fusion gene in,Assessed
845,GARD:0007737,Tay-Sachs disease,309192,"Tay-Sachs disease, B variant, adult form",HGNC:4878,HEXA,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:7135,AFF1,Part of a fusion gene in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,101007,Autosomal recessive spastic paraplegia type 27,HGNC:26071,SPG27,Disease-causing germline mutation(s) in,Assessed
261,GARD:0006329,Emery-Dreifuss muscular dystrophy,98853,Autosomal dominant Emery-Dreifuss muscular dystrophy,HGNC:17084,SYNE2,Disease-causing germline mutation(s) in,Not yet assessed
98473,GARD:0007922,Muscular dystrophy,480682,POGLUT1-related  limb-girdle muscular dystrophy R21,HGNC:22954,POGLUT1,Disease-causing germline mutation(s) in,Assessed
2929,GARD:0003065,Juvenile polyposis syndrome,79076,Juvenile polyposis of infancy,HGNC:1076,BMPR1A,Role in the phenotype of,Assessed
506,GARD:0006877,Leigh syndrome,255249,Leigh syndrome with nephrotic syndrome,HGNC:25223,COQ2,Disease-causing germline mutation(s) in,Assessed
213500,GARD:0007295,Ovarian cancer,99915,Maligant granulosa cell tumor of the ovary,HGNC:17098,DICER1,Major susceptibility factor in,Assessed
156207,GARD:0003342,Macroglossia,231120,Beckwith-Wiedemann syndrome due to CDKN1C mutation,HGNC:1786,CDKN1C,Disease-causing germline mutation(s) (loss of function) in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,402026,Acute myeloid leukemia with NPM1 somatic mutations,HGNC:7910,NPM1,Disease-causing somatic mutation(s) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,488333,Autosomal dominant Charcot-Marie-Tooth disease type 2W,HGNC:4816,HARS1,Disease-causing germline mutation(s) (loss of function) in,Assessed
577,GARD:0003806,Mucolipidosis III alpha/beta,423461,Mucolipidosis type III alpha/beta,HGNC:29670,GNPTAB,Disease-causing germline mutation(s) (loss of function) in,Assessed
98473,GARD:0007922,Muscular dystrophy,370968,Congenital muscular dystrophy with intellectual disability,HGNC:6511,LARGE1,Disease-causing germline mutation(s) in,Assessed
442,GARD:0001487,Congenital hypothyroidism,226307,Hypothyroidism due to deficient transcription factors involved in pituitary development or function,HGNC:9210,POU1F1,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,477673,Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome,HGNC:18062,GPT2,Disease-causing germline mutation(s) in,Assessed
238468,GARD:0000076,Hypohidrotic ectodermal dysplasia,1810,Autosomal dominant hypohidrotic ectodermal dysplasia,HGNC:2895,EDAR,Disease-causing germline mutation(s) in,Assessed
79373,GARD:0006317,Ectodermal dysplasia,1997,Blepharo-cheilo-odontic syndrome,HGNC:2515,CTNND1,Disease-causing germline mutation(s) (loss of function) in,Assessed
65283,GARD:0009294,Timothy syndrome,595098,Timothy syndrome type 1,HGNC:1390,CACNA1C,Disease-causing germline mutation(s) in,Assessed
309279,GARD:0010670,Glycoproteinosis,309282,"Alpha-mannosidosis, infantile form",HGNC:6826,MAN2B1,Disease-causing germline mutation(s) in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:7707,NDUFS1,Disease-causing germline mutation(s) in,Assessed
63454,GARD:0009821,Pattern dystrophy,99001,Butterfly-shaped pigment dystrophy,HGNC:2509,CTNNA1,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,220386,Semilobar holoprosencephaly,HGNC:12873,ZIC2,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,436174,Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome,HGNC:29685,IARS2,Disease-causing germline mutation(s) (loss of function) in,Assessed
442,GARD:0001487,Congenital hypothyroidism,95713,Athyreosis,HGNC:12373,TSHR,Disease-causing germline mutation(s) (loss of function) in,Assessed
739,GARD:0005575,Prader-Willi syndrome,177901,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1,HGNC:7675,NDN,Role in the phenotype of,Assessed
2162,GARD:0006665,Holoprosencephaly,93925,Alobar holoprosencephaly,HGNC:10889,SIX3,Disease-causing germline mutation(s) in,Assessed
171901,GARD:0006226,Cutaneous T-cell lymphoma,300865,Primary cutaneous anaplastic large cell lymphoma,HGNC:7910,NPM1,Part of a fusion gene in,Assessed
3394,GARD:0004898,Soft tissue sarcoma,231108,Familial rhabdoid tumor,HGNC:11100,SMARCA4,Disease-causing germline mutation(s) in,Assessed
631,GARD:0012556,Isolated growth hormone deficiency,632,Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia,HGNC:3319,ELF4,Disease-causing germline mutation(s) in,Assessed
264665,GARD:0010559,Children's interstitial lung disease,70587,Infant acute respiratory distress syndrome,HGNC:10801,SFTPB,Major susceptibility factor in,Assessed
253,GARD:0007687,Spondyloepiphyseal dysplasia,250984,Autosomal recessive Stickler syndrome,HGNC:2218,COL9A2,Disease-causing germline mutation(s) (loss of function) in,Assessed
636,GARD:0007866,Neurofibromatosis type 1,363700,Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion,HGNC:7765,NF1,Disease-causing germline mutation(s) (loss of function) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,353327,Congenital myasthenic syndromes with glycosylation defect,HGNC:4241,GFPT1,Disease-causing germline mutation(s) in,Assessed
2875,GARD:0004312,Phacomatosis pigmentovascularis,79484,Phakomatosis cesiomarmorata,HGNC:4379,GNA11,Disease-causing somatic mutation(s) in,Assessed
98292,GARD:0006987,Mastocytosis,98850,Aggressive systemic mastocytosis,HGNC:10471,RUNX1,Disease-causing somatic mutation(s) in,Assessed
657,GARD:0003947,Congenital hyperinsulinism,276598,Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency,HGNC:59,ABCC8,Disease-causing germline mutation(s) in,Assessed
53739,GARD:0012683,Distal hereditary motor neuropathy,139557,X-linked distal spinal muscular atrophy type 3,HGNC:869,ATP7A,Disease-causing germline mutation(s) in,Assessed
209,GARD:0006227,Cutis laxa,314718,Lethal arteriopathy syndrome due to fibulin-4 deficiency,HGNC:3219,EFEMP2,Disease-causing germline mutation(s) in,Assessed
52,GARD:0000804,Alagille syndrome,261600,Alagille syndrome due to 20p12 microdeletion,HGNC:6188,JAG1,Role in the phenotype of,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:7135,AFF1,Part of a fusion gene in,Assessed
2442,GARD:0010915,X-linked lymphoproliferative syndrome,538931,X-linked lymphoproliferative disease due to SH2D1A deficiency,HGNC:10820,SH2D1A,Disease-causing germline mutation(s) in,Assessed
593,GARD:0010529,Myofibrillar myopathy,399058,Alpha-B crystallin-related late-onset myopathy,HGNC:2389,CRYAB,Disease-causing germline mutation(s) in,Assessed
93969,GARD:0003475,Myelomeningocele,268752,Thoracolumbosacral spina bifida cystica,HGNC:15512,VANGL1,Major susceptibility factor in,Assessed
98757,GARD:0006801,Spinocerebellar ataxia 3,276238,Machado-Joseph disease type 1,HGNC:7106,ATXN3,Disease-causing germline mutation(s) in,Assessed
444116,GARD:0006611,Hereditary amyloidosis,93560,AApoAI amyloidosis,HGNC:600,APOA1,Disease-causing germline mutation(s) in,Assessed
799,GARD:0000166,Schizencephaly,485275,Acquired schizencephaly,HGNC:3341,EMX2,Major susceptibility factor in,Assessed
580,GARD:0006675,Mucopolysaccharidosis type II,217093,"Mucopolysaccharidosis type 2, attenuated form",HGNC:5389,IDS,Disease-causing germline mutation(s) in,Assessed
217071,GARD:0008417,Renal cell carcinoma 4,404511,Clear cell papillary renal cell carcinoma,HGNC:30064,PBRM1,Major susceptibility factor in,Assessed
98277,GARD:0012758,Acute myeloid leukemia with recurrent genetic anomaly,102724,Acute myeloid leukemia with t(8;21)(q22;q22) translocation,HGNC:10471,RUNX1,Part of a fusion gene in,Assessed
213500,GARD:0007295,Ovarian cancer,370396,Small cell carcinoma of the ovary,HGNC:11100,SMARCA4,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93924,Lobar holoprosencephaly,HGNC:12873,ZIC2,Disease-causing germline mutation(s) in,Assessed
98878,GARD:0006591,Hemophilia A,177926,Bleeding disorder in hemophilia A carriers,HGNC:3546,F8,Disease-causing germline mutation(s) in,Assessed
748,GARD:0012977,Mendelian susceptibility to mycobacterial diseases,319581,Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency,HGNC:5439,IFNGR1,Disease-causing germline mutation(s) in,Assessed
182058,GARD:0012959,Primary orthostatic hypotension,2828,Young-onset Parkinson disease,HGNC:16369,PARK7,Disease-causing germline mutation(s) in,Assessed
94075,GARD:0008689,Autoimmune enteropathy,397959,TCR-alpha-beta-positive T-cell deficiency,HGNC:12029,TRAC,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93924,Lobar holoprosencephaly,HGNC:10879,STIL,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:8619,PAX5,Part of a fusion gene in,Assessed
34526,GARD:0002906,Familial primary hypomagnesemia,31043,Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular involvement,HGNC:2037,CLDN16,Disease-causing germline mutation(s) (loss of function) in,Assessed
64746,GARD:0012431,Charcot-Marie-Tooth disease type 2,466768,Autosomal dominant Charcot-Marie-Tooth disease type 2Z,HGNC:23573,MORC2,Disease-causing germline mutation(s) in,Assessed
94075,GARD:0008689,Autoimmune enteropathy,220465,Laron syndrome with immunodeficiency,HGNC:11367,STAT5B,Disease-causing germline mutation(s) in,Assessed
261,GARD:0006329,Emery-Dreifuss muscular dystrophy,98855,Autosomal recessive Emery-Dreifuss muscular dystrophy,HGNC:6636,LMNA,Disease-causing germline mutation(s) in,Assessed
595,GARD:0000101,Centronuclear myopathy,319160,Congenital myopathy with internal nuclei and atypical cores,HGNC:14153,CCDC78,Disease-causing germline mutation(s) in,Assessed
399786,GARD:0012513,Male infertility with spermatogenesis disorder due to single gene mutation ,529970,Male infertility due to acephalic spermatozoa,HGNC:17728,PMFBP1,Disease-causing germline mutation(s) in,Assessed
94075,GARD:0008689,Autoimmune enteropathy,438159,STAT3-related early-onset multisystem autoimmune disease,HGNC:11364,STAT3,Disease-causing germline mutation(s) (gain of function) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:3151,ECHS1,Disease-causing germline mutation(s) in,Assessed
442,GARD:0001487,Congenital hypothyroidism,226316,Genetic transient congenital hypothyroidism,HGNC:13273,DUOX2,Disease-causing germline mutation(s) (loss of function) in,Assessed
280270,GARD:0012300,Pelizaeus-Merzbacher-like disease,280288,Pelizaeus-Merzbacher-like disease due to HSPD1 mutation,HGNC:5261,HSPD1,Disease-causing germline mutation(s) in,Assessed
261,GARD:0006329,Emery-Dreifuss muscular dystrophy,98853,Autosomal dominant Emery-Dreifuss muscular dystrophy,HGNC:6636,LMNA,Disease-causing germline mutation(s) in,Assessed
79225,GARD:0007672,Sphingolipidosis,309271,"Metachromatic leukodystrophy, adult form",HGNC:9498,PSAP,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:10471,RUNX1,Part of a fusion gene in,Assessed
90794,GARD:0012665,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,315311,"Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form",HGNC:2600,CYP21A2,Disease-causing germline mutation(s) in,Assessed
1037,GARD:0000777,Arthrogryposis multiplex congenita,439897,Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome,HGNC:19181,KIF14,Disease-causing germline mutation(s) (loss of function) in,Assessed
66646,GARD:0007842,Cutaneous mastocytosis,158772,Nodular urticaria pigmentosa,HGNC:6342,KIT,Disease-causing germline mutation(s) in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:7710,NDUFS3,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:12027,TRA,Part of a fusion gene in,Assessed
79430,GARD:0006643,Hermansky-Pudlak syndrome,231531,Hermansky-Pudlak syndrome due to BLOC-1 deficiency,HGNC:18561,BLOC1S5,Disease-causing germline mutation(s) in,Assessed
101330,GARD:0007433,Porphyria cutanea tarda,443057,Sporadic porphyria cutanea tarda,HGNC:4886,HFE,Major susceptibility factor in,Assessed
93969,GARD:0003475,Myelomeningocele,268766,Cervicothoracic spina bifida cystica,HGNC:7436,MTHFR,Major susceptibility factor in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,247262,Hyperphosphatasia-intellectual disability syndrome,HGNC:26031,PIGV,Disease-causing germline mutation(s) in,Assessed
79238,GARD:0005392,Galactose epimerase deficiency,308473,Erythrocyte galactose epimerase deficiency,HGNC:4116,GALE,Disease-causing germline mutation(s) in,Assessed
443909,GARD:0008533,Familial colorectal cancer,144,Lynch syndrome,HGNC:9122,PMS2,Disease-causing germline mutation(s) in,Assessed
2909,GARD:0004392,Rothmund-Thomson syndrome,221016,Rothmund-Thomson syndrome type 2,HGNC:9949,RECQL4,Disease-causing germline mutation(s) in,Assessed
511,GARD:0003228,Maple syrup urine disease,268184,Thiamine-responsive maple syrup urine disease,HGNC:987,BCKDHB,Disease-causing germline mutation(s) (loss of function) in,Assessed
68356,GARD:0006895,Leukodystrophy,447893,Hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome,HGNC:30074,POLR3A,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,309256,"Metachromatic leukodystrophy, late infantile form",HGNC:9498,PSAP,Disease-causing germline mutation(s) in,Assessed
1531,GARD:0006209,Craniosynostosis,93258,Pfeiffer syndrome type 1,HGNC:3689,FGFR2,Disease-causing germline mutation(s) (gain of function) in,Assessed
360,GARD:0002491,Glioblastoma,251579,Giant cell glioblastoma,HGNC:11522,TACC1,Part of a fusion gene in,Assessed
877,GARD:0009316,Carcinoid tumor,100093,Carcinoid syndrome,HGNC:10683,SDHD,Candidate gene tested in,Not yet assessed
3394,GARD:0004898,Soft tissue sarcoma,99970,Dedifferentiated liposarcoma,HGNC:1773,CDK4,Role in the phenotype of,Assessed
487,GARD:0006844,Krabbe disease,206436,Infantile Krabbe disease,HGNC:9498,PSAP,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,35664,ALDH18A1-related De Barsy syndrome,HGNC:9722,ALDH18A1,Disease-causing germline mutation(s) in,Assessed
97242,GARD:0009138,Congenital muscular dystrophy,370968,Congenital muscular dystrophy with intellectual disability,HGNC:17997,FKRP,Disease-causing germline mutation(s) in,Assessed
261494,GARD:0008672,Kleefstra syndrome,96147,Kleefstra syndrome due to 9q34 microdeletion,HGNC:24650,EHMT1,Role in the phenotype of,Assessed
2152,GARD:0009673,Mowat-Wilson syndrome,261552,Mowat-Wilson syndrome due to a ZEB2 point mutation,HGNC:14881,ZEB2,Disease-causing germline mutation(s) in,Assessed
26791,GARD:0006523,Glutaric acidemia type II,394532,"Multiple acyl-CoA dehydrogenase deficiency, mild type",HGNC:3482,ETFB,Disease-causing germline mutation(s) in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:8806,PDHA1,Disease-causing germline mutation(s) in,Assessed
813,GARD:0004870,Russell-Silver syndrome,397590,Silver-Russell syndrome due to a point mutation,HGNC:1786,CDKN1C,Disease-causing germline mutation(s) (gain of function) in,Assessed
848,GARD:0000871,Beta-thalassemia,231214,Beta-thalassemia major,HGNC:4827,HBB,Disease-causing germline mutation(s) in,Assessed
97242,GARD:0009138,Congenital muscular dystrophy,319332,Autosomal recessive myogenic arthrogryposis multiplex congenita,HGNC:17089,SYNE1,Disease-causing germline mutation(s) in,Assessed
748,GARD:0012977,Mendelian susceptibility to mycobacterial diseases,99898,Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency,HGNC:5439,IFNGR1,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268762,Cervical spina bifida cystica,HGNC:7436,MTHFR,Major susceptibility factor in,Assessed
79262,GARD:0010973,Adult neuronal ceroid lipofuscinosis,314629,CLN11 disease,HGNC:4601,GRN,Disease-causing germline mutation(s) in,Assessed
97245,GARD:0005898,Myopathy congenital,319160,Congenital myopathy with internal nuclei and atypical cores,HGNC:14153,CCDC78,Disease-causing germline mutation(s) in,Assessed
263,GARD:0006907,Limb-girdle muscular dystrophy,424261,TOR1AIP1-related limb-girdle muscular dystrophy,HGNC:29456,TOR1AIP1,Disease-causing germline mutation(s) (loss of function) in,Assessed
85110,GARD:0010037,Familial encephalopathy with neuroserpin inclusion bodies,530303,Progressive dementia with neuroserpin inclusion bodies,HGNC:8943,SERPINI1,Disease-causing germline mutation(s) in,Assessed
79373,GARD:0006317,Ectodermal dysplasia,447961,Pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome,HGNC:19182,SASH1,Disease-causing germline mutation(s) in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293888,"Familial isolated arrhythmogenic ventricular dysplasia, left dominant form",HGNC:11769,TGFB3,Disease-causing germline mutation(s) in,Assessed
52,GARD:0000804,Alagille syndrome,261619,Alagille syndrome due to a JAG1 point mutation,HGNC:6188,JAG1,Disease-causing germline mutation(s) in,Assessed
252057,GARD:0012697,Tumor of cranial and spinal nerves,252212,Malignant triton tumor,HGNC:9476,HTRA1,Part of a fusion gene in,Assessed
182067,GARD:0006513,Glioma,251601,Fibrillary astrocytoma,HGNC:5383,IDH2,Biomarker tested in,Assessed
304,GARD:0010752,Epidermolysis bullosa simplex,158681,Epidermolysis bullosa simplex with circinate migratory erythema,HGNC:6442,KRT5,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:11633,TCF3,Part of a fusion gene in,Assessed
137807,GARD:0000132,Primary cutaneous amyloidosis,319635,Amyloidosis cutis dyschromia,HGNC:4462,GPNMB,Disease-causing germline mutation(s) (loss of function) in,Assessed
93548,GARD:0012736,Glomerular disease,93560,AApoAI amyloidosis,HGNC:600,APOA1,Disease-causing germline mutation(s) in,Assessed
411709,GARD:0009228,Renal agenesis,93100,"Renal agenesis, unilateral",HGNC:31042,GREB1L,Disease-causing germline mutation(s) (loss of function) in,Assessed
360,GARD:0002491,Glioblastoma,251579,Giant cell glioblastoma,HGNC:9236,PPARG,Biomarker tested in,Assessed
448,GARD:0010418,Hemophilia,169808,Mild hemophilia A,HGNC:3546,F8,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,447896,Tremor-ataxia-central hypomyelination syndrome,HGNC:30074,POLR3A,Disease-causing germline mutation(s) in,Assessed
26791,GARD:0006523,Glutaric acidemia type II,394532,"Multiple acyl-CoA dehydrogenase deficiency, mild type",HGNC:24671,FLAD1,Disease-causing germline mutation(s) (loss of function) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99860,Precursor B-cell acute lymphoblastic leukemia,HGNC:2621,CYP2C19,Candidate gene tested in,Not yet assessed
253,GARD:0007687,Spondyloepiphyseal dysplasia,496751,EVEN-plus syndrome,HGNC:5244,HSPA9,Disease-causing germline mutation(s) in,Assessed
1531,GARD:0006209,Craniosynostosis,63440,Isolated oxycephaly,HGNC:12872,ZIC1,Disease-causing germline mutation(s) (gain of function) in,Assessed
319276,GARD:0009574,Clear cell renal cell carcinoma,404511,Clear cell papillary renal cell carcinoma,HGNC:30064,PBRM1,Major susceptibility factor in,Assessed
112,GARD:0005893,Bartter syndrome,93604,Antenatal Bartter syndrome,HGNC:6255,KCNJ1,Disease-causing germline mutation(s) (loss of function) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:8064,NUP214,Part of a fusion gene in,Assessed
2875,GARD:0004312,Phacomatosis pigmentovascularis,79483,Phakomatosis cesioflammea,HGNC:4390,GNAQ,Disease-causing somatic mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,485418,EMILIN-1-related connective tissue disease,HGNC:19880,EMILIN1,Disease-causing germline mutation(s) in,Assessed
26791,GARD:0006523,Glutaric acidemia type II,394532,"Multiple acyl-CoA dehydrogenase deficiency, mild type",HGNC:3481,ETFA,Disease-causing germline mutation(s) in,Assessed
657,GARD:0003947,Congenital hyperinsulinism,276603,Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency,HGNC:6257,KCNJ11,Disease-causing germline mutation(s) in,Assessed
98292,GARD:0006987,Mastocytosis,158775,Smoldering systemic mastocytosis,HGNC:6342,KIT,Disease-causing somatic mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,220386,Semilobar holoprosencephaly,HGNC:10879,STIL,Disease-causing germline mutation(s) in,Assessed
97229,GARD:0009993,Riboflavin transporter deficiency,572550,RFVT3-related riboflavin transporter deficiency,HGNC:16187,SLC52A3,Disease-causing germline mutation(s) in,Assessed
511,GARD:0003228,Maple syrup urine disease,268162,Intermediate maple syrup urine disease,HGNC:25415,PPM1K,Disease-causing germline mutation(s) in,Assessed
655,GARD:0000206,Nephronophthisis,93592,Juvenile nephronophthisis,HGNC:29536,MAPKBP1,Disease-causing germline mutation(s) (loss of function) in,Assessed
68356,GARD:0006895,Leukodystrophy,309271,"Metachromatic leukodystrophy, adult form",HGNC:9498,PSAP,Disease-causing germline mutation(s) in,Assessed
1531,GARD:0006209,Craniosynostosis,35099,Isolated brachycephaly,HGNC:12428,TWIST1,Disease-causing germline mutation(s) in,Assessed
1531,GARD:0006209,Craniosynostosis,168624,"Familial scaphocephaly syndrome, McGillivray type",HGNC:3689,FGFR2,Disease-causing germline mutation(s) in,Assessed
35656,GARD:0010423,Coenzyme Q10 deficiency,280406,Familial steroid-resistant nephrotic syndrome with sensorineural deafness,HGNC:20233,COQ6,Disease-causing germline mutation(s) in,Assessed
182067,GARD:0006513,Glioma,251579,Giant cell glioblastoma,HGNC:7059,MGMT,Biomarker tested in,Assessed
88661,GARD:0005791,Amelogenesis imperfecta,100032,Hypocalcified amelogenesis imperfecta,HGNC:6161,ITGB6,Disease-causing germline mutation(s) in,Assessed
3394,GARD:0004898,Soft tissue sarcoma,370334,Extraskeletal Ewing sarcoma,HGNC:3446,ERG,Part of a fusion gene in,Assessed
91378,GARD:0005979,Hereditary angioedema,599418,Hereditary angioedema with normal C1Inh not related to F12 or PLG variant,HGNC:6383,KNG1,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,171629,Autosomal recessive spastic paraplegia type 35,HGNC:21197,FA2H,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268770,Upper thoracic spina bifida cystica,HGNC:11515,TBXT,Major susceptibility factor in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293910,"Familial isolated arrhythmogenic ventricular dysplasia, right dominant form",HGNC:3049,DSG2,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,309185,"Tay-Sachs disease, B variant, juvenile form",HGNC:4878,HEXA,Disease-causing germline mutation(s) in,Assessed
64746,GARD:0012431,Charcot-Marie-Tooth disease type 2,521414,Autosomal dominant Charcot-Marie-Tooth disease type 2DD,HGNC:799,ATP1A1,Disease-causing germline mutation(s) in,Assessed
360,GARD:0002491,Glioblastoma,251579,Giant cell glioblastoma,HGNC:33280,SEPTIN14,Part of a fusion gene in,Assessed
238468,GARD:0000076,Hypohidrotic ectodermal dysplasia,1810,Autosomal dominant hypohidrotic ectodermal dysplasia,HGNC:26624,KDF1,Disease-causing germline mutation(s) in,Assessed
79430,GARD:0006643,Hermansky-Pudlak syndrome,231512,Hermansky-Pudlak syndrome due to BLOC-2 deficiency,HGNC:17022,HPS5,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93926,Midline interhemispheric variant of holoprosencephaly,HGNC:19711,DISP1,Disease-causing germline mutation(s) in,Assessed
738,GARD:0010353,Porphyria,100924,Porphyria due to ALA dehydratase deficiency,HGNC:395,ALAD,Disease-causing germline mutation(s) in,Assessed
99732,GARD:0003705,Molybdenum cofactor deficiency,308386,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A,HGNC:7190,MOCS1,Disease-causing germline mutation(s) (loss of function) in,Assessed
79225,GARD:0007672,Sphingolipidosis,216975,"Niemann-Pick disease type C, severe early infantile neurologic onset",HGNC:14537,NPC2,Disease-causing germline mutation(s) in,Assessed
253,GARD:0007687,Spondyloepiphyseal dysplasia,83629,Leukoencephalopathy-spondyloepimetaphyseal dysplasia syndrome,HGNC:8768,AIFM1,Disease-causing germline mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,370959,Congenital muscular dystrophy with cerebellar involvement,HGNC:19139,POMGNT1,Disease-causing germline mutation(s) in,Assessed
93293,GARD:0009182,Duane-radial ray syndrome,261647,Okihiro syndrome due to a point mutation,HGNC:15924,SALL4,Disease-causing germline mutation(s) in,Assessed
331223,GARD:0010956,Hyper IgE syndrome,369992,Severe dermatitis-multiple allergies-metabolic wasting syndrome,HGNC:3052,DSP,Disease-causing germline mutation(s) in,Assessed
217071,GARD:0008417,Renal cell carcinoma 4,319308,MiT family translocation renal cell carcinoma,HGNC:13825,ASPSCR1,Part of a fusion gene in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,480682,POGLUT1-related  limb-girdle muscular dystrophy R21,HGNC:22954,POGLUT1,Disease-causing germline mutation(s) in,Assessed
116,GARD:0003343,Beckwith-Wiedemann syndrome,231127,Beckwith-Wiedemann syndrome due to 11p15 microdeletion,HGNC:4713,H19,Role in the phenotype of,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,538574,Palmoplantar keratoderma-hereditary motor and sensory neuropathy syndrome,HGNC:7225,MPZ,Modifying germline mutation in,Assessed
182067,GARD:0006513,Glioma,251671,Angiocentric glioma,HGNC:21100,QKI,Part of a fusion gene in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99860,Precursor B-cell acute lymphoblastic leukemia,HGNC:25547,CEP72,Candidate gene tested in,Not yet assessed
513,GARD:0000522,Acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:1014,BCR,Part of a fusion gene in,Assessed
783,GARD:0007593,Rubinstein-Taybi syndrome,353277,Rubinstein-Taybi syndrome due to CREBBP mutations,HGNC:2348,CREBBP,Disease-causing germline mutation(s) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,99854,Cree leukoencephalopathy,HGNC:3260,EIF2B4,Disease-causing germline mutation(s) in,Assessed
217071,GARD:0008417,Renal cell carcinoma 4,319298,Papillary renal cell carcinoma,HGNC:7105,MITF,Major susceptibility factor in,Assessed
97245,GARD:0005898,Myopathy congenital,467176,Severe hypotonia-psychomotor developmental delay-strabismus-cardiac septal defect syndrome,HGNC:28033,CCDC174,Disease-causing germline mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,589821,Congenital-onset Steinert myotonic dystrophy,HGNC:2933,DMPK,Disease-causing germline mutation(s) in,Assessed
739,GARD:0005575,Prader-Willi syndrome,177910,Prader-Willi syndrome due to imprinting mutation,HGNC:6814,MAGEL2,Role in the phenotype of,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:23326,PXK,Major susceptibility factor in,Assessed
97242,GARD:0009138,Congenital muscular dystrophy,370959,Congenital muscular dystrophy with cerebellar involvement,HGNC:9202,POMT1,Disease-causing germline mutation(s) in,Assessed
26791,GARD:0006523,Glutaric acidemia type II,394529,"Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type",HGNC:3483,ETFDH,Disease-causing germline mutation(s) in,Assessed
444116,GARD:0006611,Hereditary amyloidosis,238269,AApoAII amyloidosis,HGNC:601,APOA2,Disease-causing germline mutation(s) in,Assessed
280886,GARD:0010941,Anterior uveitis,85408,Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis,HGNC:9650,PTPN2,Major susceptibility factor in,Assessed
140997,GARD:0010692,Orofaciodigital syndromes,508501,Oral-facial-digital syndrome with short stature and brachymesophalangy,HGNC:17367,IFT57,Disease-causing germline mutation(s) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,99853,Ovarioleukodystrophy,HGNC:3260,EIF2B4,Disease-causing germline mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,370959,Congenital muscular dystrophy with cerebellar involvement,HGNC:17997,FKRP,Disease-causing germline mutation(s) in,Assessed
255,GARD:0012144,GTPCH1-deficient DRD,98808,Autosomal dominant dopa-responsive dystonia,HGNC:4193,GCH1,Disease-causing germline mutation(s) in,Assessed
53739,GARD:0012683,Distal hereditary motor neuropathy,476093,Autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome,HGNC:30171,HSPB8,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,556985,Early-onset calcifying leukoencephalopathy-skeletal dysplasia,HGNC:2433,CSF1R,Disease-causing germline mutation(s) in,Assessed
3394,GARD:0004898,Soft tissue sarcoma,209916,Extraskeletal myxoid chondrosarcoma,HGNC:11547,TAF15,Part of a fusion gene in,Assessed
436,GARD:0006734,Hypophosphatasia,247676,Adult hypophosphatasia,HGNC:438,ALPL,Disease-causing germline mutation(s) (loss of function) in,Assessed
156207,GARD:0003342,Macroglossia,231117,Beckwith-Wiedemann syndrome due to imprinting defect of 11p15,HGNC:4713,H19,Role in the phenotype of,Assessed
251595,GARD:0005907,Diffuse astrocytoma,251598,Protoplasmic astrocytoma,HGNC:5383,IDH2,Biomarker tested in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,370959,Congenital muscular dystrophy with cerebellar involvement,HGNC:19139,POMGNT1,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:10471,RUNX1,Part of a fusion gene in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293910,"Familial isolated arrhythmogenic ventricular dysplasia, right dominant form",HGNC:10484,RYR2,Disease-causing germline mutation(s) in,Assessed
1329,GARD:0001454,Complete atrioventricular canal,99068,Complete atrioventricular septal defect-tetralogy of Fallot,HGNC:14630,CRELD1,Major susceptibility factor in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:76,ABL1,Part of a fusion gene in,Assessed
93969,GARD:0003475,Myelomeningocele,268762,Cervical spina bifida cystica,HGNC:11515,TBXT,Major susceptibility factor in,Assessed
79238,GARD:0005392,Galactose epimerase deficiency,308487,Generalized galactose epimerase deficiency,HGNC:4116,GALE,Disease-causing germline mutation(s) in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293899,"Familial isolated arrhythmogenic ventricular dysplasia, biventricular form",HGNC:15710,LDB3,Disease-causing germline mutation(s) in,Assessed
79373,GARD:0006317,Ectodermal dysplasia,247820,Ectodermal dysplasia-syndactyly syndrome,HGNC:19688,NECTIN4,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:8997,PIP4K2A,Major susceptibility factor in,Assessed
683,GARD:0007471,Progressive supranuclear palsy,240094,Progressive supranuclear palsy-pure akinesia with gait freezing syndrome,HGNC:6893,MAPT,Major susceptibility factor in,Assessed
97242,GARD:0009138,Congenital muscular dystrophy,370980,Congenital muscular dystrophy without intellectual disability,HGNC:37276,CRPPA,Disease-causing germline mutation(s) (loss of function) in,Assessed
3394,GARD:0004898,Soft tissue sarcoma,209916,Extraskeletal myxoid chondrosarcoma,HGNC:11623,TCF12,Part of a fusion gene in,Assessed
401854,GARD:0012679,Lipoic acid biosynthesis defects,569274,Multiple mitochondrial dysfunctions syndrome type 5,HGNC:28660,ISCA1,Disease-causing germline mutation(s) in,Assessed
612,GARD:0004459,Potassium aggravated myotonia,99735,Myotonia permanens,HGNC:10591,SCN4A,Disease-causing germline mutation(s) in,Assessed
98634,GARD:0003026,Iridogoniodysgenesis type 2,519388,Autosomal recessive anterior segment dysgenesis,HGNC:23228,CPAMD8,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,280195,Septopreoptic holoprosencephaly,HGNC:12873,ZIC2,Disease-causing germline mutation(s) in,Assessed
182058,GARD:0012959,Primary orthostatic hypotension,2828,Young-onset Parkinson disease,HGNC:14348,HTRA2,Candidate gene tested in,Not yet assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293910,"Familial isolated arrhythmogenic ventricular dysplasia, right dominant form",HGNC:6207,JUP,Disease-causing germline mutation(s) in,Assessed
90114,GARD:0012436,Autosomal dominant intermediate Charcot-Marie-Tooth,324585,Autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic pain,HGNC:7225,MPZ,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,171617,Autosomal dominant spastic paraplegia type 38,HGNC:33485,SPG38,Disease-causing germline mutation(s) in,Assessed
91378,GARD:0005979,Hereditary angioedema,599418,Hereditary angioedema with normal C1Inh not related to F12 or PLG variant,HGNC:14178,HS3ST6,Disease-causing germline mutation(s) in,Assessed
217071,GARD:0008417,Renal cell carcinoma 4,319308,MiT family translocation renal cell carcinoma,HGNC:9343,PRCC,Part of a fusion gene in,Assessed
616,GARD:0007005,Medulloblastoma,251858,Medulloblastoma with extensive nodularity,HGNC:16466,SUFU,Major susceptibility factor in,Assessed
79225,GARD:0007672,Sphingolipidosis,309178,"Tay-Sachs disease, B variant, infantile form",HGNC:4878,HEXA,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:6990,MECP2,Major susceptibility factor in,Assessed
226298,GARD:0012280,Central congenital hypothyroidism,226307,Hypothyroidism due to deficient transcription factors involved in pituitary development or function,HGNC:21734,LHX4,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99860,Precursor B-cell acute lymphoblastic leukemia,HGNC:23063,NUDT15,Candidate gene tested in,Not yet assessed
98634,GARD:0003026,Iridogoniodysgenesis type 2,91483,Rieger anomaly,HGNC:9005,PITX2,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,101010,Autosomal spastic paraplegia type 30,HGNC:888,KIF1A,Disease-causing germline mutation(s) in,Assessed
97242,GARD:0009138,Congenital muscular dystrophy,370997,Muscle-eye-brain disease with bilateral multicystic leucodystrophy,HGNC:2666,DAG1,Disease-causing germline mutation(s) in,Assessed
79373,GARD:0006317,Ectodermal dysplasia,1810,Autosomal dominant hypohidrotic ectodermal dysplasia,HGNC:12036,TRAF6,Disease-causing germline mutation(s) in,Assessed
2467,GARD:0008616,Systemic mastocytosis,98850,Aggressive systemic mastocytosis,HGNC:10783,SRSF2,Disease-causing somatic mutation(s) in,Assessed
1329,GARD:0001454,Complete atrioventricular canal,99068,Complete atrioventricular septal defect-tetralogy of Fallot,HGNC:4173,GATA4,Disease-causing germline mutation(s) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,447964,Autosomal dominant Charcot-Marie-Tooth disease type 2V,HGNC:7632,NAGLU,Disease-causing germline mutation(s) in,Assessed
755,GARD:0003244,Leydig cell hypoplasia,96265,Leydig cell hypoplasia due to complete LH resistance,HGNC:6585,LHCGR,Disease-causing germline mutation(s) (loss of function) in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,589595,Mixed phenotype acute leukemia with t(v;11q23.3),HGNC:7132,KMT2A,Part of a fusion gene in,Assessed
2162,GARD:0006665,Holoprosencephaly,93926,Midline interhemispheric variant of holoprosencephaly,HGNC:4165,GAS1,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,157719,Juvenile or adult CACH syndrome,HGNC:3259,EIF2B3,Disease-causing germline mutation(s) in,Assessed
733,GARD:0006408,Familial adenomatous polyposis,261584,Familial adenomatous polyposis due to 5q22.2 microdeletion,HGNC:583,APC,Role in the phenotype of,Assessed
544,GARD:0003178,Diffuse Large B-Cell Lymphoma,364043,ALK-positive large B-cell lymphoma,HGNC:427,ALK,Part of a fusion gene in,Not yet assessed
398934,GARD:0009362,Ovarian epithelial cancer,213504,Adenocarcinoma of ovary,HGNC:6066,INHBA,Disease-causing germline mutation(s) in,Assessed
2415,GARD:0009789,Lymphatic malformations,99141,Lymphedema-posterior choanal atresia syndrome,HGNC:9647,PTPN14,Disease-causing germline mutation(s) (loss of function) in,Assessed
2346,GARD:0003122,Klippel-Trenaunay syndrome,90308,Klippel-Trénaunay syndrome,HGNC:24684,AGGF1,Major susceptibility factor in,Assessed
68356,GARD:0006895,Leukodystrophy,99853,Ovarioleukodystrophy,HGNC:3257,EIF2B1,Disease-causing germline mutation(s) in,Assessed
182067,GARD:0006513,Glioma,251579,Giant cell glioblastoma,HGNC:7797,NFKBIA,Biomarker tested in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:12271,TRG,Candidate gene tested in,Not yet assessed
519,GARD:0012757,Acute myeloid leukemia ,370026,Acute myeloid leukemia with t(8;16)(p11;p13) translocation,HGNC:13013,KAT6A,Part of a fusion gene in,Assessed
97245,GARD:0005898,Myopathy congenital,447974,Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome,HGNC:18150,MYO18B,Disease-causing germline mutation(s) (loss of function) in,Assessed
3242,GARD:0009509,Renpenning syndrome,93947,"X-linked intellectual disability, Golabi-Ito-Hall type",HGNC:9330,PQBP1,Disease-causing germline mutation(s) in,Assessed
355,GARD:0008233,Gaucher disease,2072,Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,HGNC:4177,GBA,Disease-causing germline mutation(s) in,Assessed
2134,GARD:0008702,Atypical hemolytic uremic syndrome,544472,Atypical hemolytic uremic syndrome with complement gene abnormality,HGNC:6953,CD46,Disease-causing germline mutation(s) in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,102724,Acute myeloid leukemia with t(8;21)(q22;q22) translocation,HGNC:3765,FLT3,Biomarker tested in,Assessed
94075,GARD:0008689,Autoimmune enteropathy,445018,Combined immunodeficiency due to LRBA deficiency,HGNC:1742,LRBA,Disease-causing germline mutation(s) (loss of function) in,Assessed
813,GARD:0004870,Russell-Silver syndrome,397590,Silver-Russell syndrome due to a point mutation,HGNC:5466,IGF2,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:11998,TP53,Major susceptibility factor in,Assessed
828,GARD:0010782,Stickler syndrome,90654,Stickler syndrome type 2,HGNC:2186,COL11A1,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,171863,Autosomal dominant spastic paraplegia type 42,HGNC:95,SLC33A1,Disease-causing germline mutation(s) in,Assessed
442,GARD:0001487,Congenital hypothyroidism,238670,Isolated thyrotropin-releasing hormone deficiency,HGNC:12298,TRH,Candidate gene tested in,Not yet assessed
407,GARD:0007219,Glycine encephalopathy,289857,Neonatal glycine encephalopathy,HGNC:473,AMT,Disease-causing germline mutation(s) (loss of function) in,Assessed
53739,GARD:0012683,Distal hereditary motor neuropathy,139525,Distal hereditary motor neuropathy type 2,HGNC:5246,HSPB1,Disease-causing germline mutation(s) in,Assessed
98292,GARD:0006987,Mastocytosis,98850,Aggressive systemic mastocytosis,HGNC:25941,TET2,Disease-causing somatic mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:7879,CNOT3,Disease-causing somatic mutation(s) in,Not yet assessed
157,GARD:0001121,Carnitine palmitoyltransferase 2 deficiency,228305,"Carnitine palmitoyl transferase II deficiency, severe infantile form",HGNC:2330,CPT2,Disease-causing germline mutation(s) in,Assessed
799,GARD:0000166,Schizencephaly,481986,Familial schizencephaly,HGNC:2202,COL4A1,Disease-causing germline mutation(s) in,Assessed
289573,GARD:0012632,Multiple mitochondrial dysfunctions syndrome,457406,Multiple mitochondrial dysfunctions syndrome type 4,HGNC:19857,ISCA2,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,597874,MTHFS-related developmental delay-microcephaly-short stature-epilepsy syndrome,HGNC:7437,MTHFS,Disease-causing germline mutation(s) in,Assessed
182067,GARD:0006513,Glioma,251615,Pilomyxoid astrocytoma,HGNC:3688,FGFR1,Disease-causing somatic mutation(s) in,Assessed
437,GARD:0006735,Hypophosphatemic rickets,93623,Dent disease type 2,HGNC:8108,OCRL,Disease-causing germline mutation(s) (loss of function) in,Assessed
182067,GARD:0006513,Glioma,251671,Angiocentric glioma,HGNC:7545,MYB,Part of a fusion gene in,Assessed
823,GARD:0007673,Spina bifida,268762,Cervical spina bifida cystica,HGNC:15511,VANGL2,Major susceptibility factor in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,401785,Autosomal recessive spastic paraplegia type 62,HGNC:16947,ERLIN1,Disease-causing germline mutation(s) in,Assessed
331223,GARD:0010956,Hyper IgE syndrome,443811,PGM3-CDG,HGNC:8907,PGM3,Disease-causing germline mutation(s) in,Assessed
757,GARD:0004553,Pseudohypoaldosteronism type 2,88939,Pseudohypoaldosteronism type 2B,HGNC:14544,WNK4,Disease-causing germline mutation(s) in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293888,"Familial isolated arrhythmogenic ventricular dysplasia, left dominant form",HGNC:9024,PKP2,Disease-causing germline mutation(s) in,Assessed
79373,GARD:0006317,Ectodermal dysplasia,423454,Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome,HGNC:2799,GRHL2,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,447753,Autosomal dominant spastic paraplegia type 9A,HGNC:26222,FAR1,Disease-causing germline mutation(s) in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,402017,Acute myeloid leukemia with t(9;11)(p22;q23),HGNC:7132,KMT2A,Part of a fusion gene in,Assessed
209,GARD:0006227,Cutis laxa,221145,"Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies",HGNC:6717,LTBP4,Disease-causing germline mutation(s) (loss of function) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93926,Midline interhemispheric variant of holoprosencephaly,HGNC:2908,DLL1,Disease-causing germline mutation(s) in,Assessed
748,GARD:0012977,Mendelian susceptibility to mycobacterial diseases,319600,Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency,HGNC:5358,IRF8,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:10760,SET,Part of a fusion gene in,Assessed
79225,GARD:0007672,Sphingolipidosis,206436,Infantile Krabbe disease,HGNC:4115,GALC,Disease-causing germline mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,445110,Limb-girdle muscular dystrophy due to POMK deficiency,HGNC:26267,POMK,Disease-causing germline mutation(s) (loss of function) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,247262,Hyperphosphatasia-intellectual disability syndrome,HGNC:28213,PIGY,Disease-causing germline mutation(s) (loss of function) in,Assessed
3148,GARD:0008211,Neurofibrosarcoma,252212,Malignant triton tumor,HGNC:23664,SH3PXD2A,Part of a fusion gene in,Assessed
112,GARD:0005893,Bartter syndrome,93604,Antenatal Bartter syndrome,HGNC:10910,SLC12A1,Disease-causing germline mutation(s) (loss of function) in,Assessed
444116,GARD:0006611,Hereditary amyloidosis,324718,ABetaA21G amyloidosis,HGNC:620,APP,Disease-causing germline mutation(s) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,320406,Spastic paraplegia-optic atrophy-neuropathy syndrome,HGNC:3760,FLRT1,Disease-causing germline mutation(s) in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",168558,"46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency",HGNC:2590,CYP11A1,Disease-causing germline mutation(s) (loss of function) in,Assessed
364,GARD:0007864,Glycogen storage disease type 1A,79258,Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia,HGNC:4056,G6PC1,Disease-causing germline mutation(s) in,Assessed
846,GARD:0000621,Alpha-thalassemia,163596,Hb Bart's hydrops fetalis,HGNC:4823,HBA1,Disease-causing germline mutation(s) in,Assessed
702,GARD:0004265,Pelizaeus-Merzbacher disease,280229,Pelizaeus-Merzbacher disease in female carriers,HGNC:9086,PLP1,Disease-causing germline mutation(s) in,Assessed
97242,GARD:0009138,Congenital muscular dystrophy,370980,Congenital muscular dystrophy without intellectual disability,HGNC:3622,FKTN,Disease-causing germline mutation(s) in,Assessed
367,GARD:0002520,Glycogen storage disease type 4,308698,"Glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form",HGNC:4180,GBE1,Disease-causing germline mutation(s) in,Assessed
98879,GARD:0008732,Hemophilia B,169799,Mild hemophilia B,HGNC:3551,F9,Disease-causing germline mutation(s) in,Assessed
88632,GARD:0010025,Anterior segment dysgenesis,91483,Rieger anomaly,HGNC:3800,FOXC1,Disease-causing germline mutation(s) in,Assessed
97245,GARD:0005898,Myopathy congenital,456328,X-linked myotubular myopathy-abnormal genitalia syndrome,HGNC:2568,MAMLD1,Role in the phenotype of,Assessed
3148,GARD:0008211,Neurofibrosarcoma,252128,Malignant peripheral nerve sheath tumor with perineurial differentiation,HGNC:23664,SH3PXD2A,Part of a fusion gene in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,466926,Seizures-scoliosis-macrocephaly syndrome,HGNC:3513,EXT2,Disease-causing germline mutation(s) (loss of function) in,Assessed
367,GARD:0002520,Glycogen storage disease type 4,308655,"Glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form",HGNC:4180,GBE1,Disease-causing germline mutation(s) in,Assessed
657,GARD:0003947,Congenital hyperinsulinism,324575,Hyperinsulinism due to HNF1A deficiency,HGNC:11621,HNF1A,Disease-causing germline mutation(s) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,90120,Hereditary motor and sensory neuropathy type 6,HGNC:25198,SLC25A46,Disease-causing germline mutation(s) (loss of function) in,Assessed
216,GARD:0010739,Neuronal ceroid lipofuscinosis,228354,CLN8 disease,HGNC:2079,CLN8,Disease-causing germline mutation(s) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,157719,Juvenile or adult CACH syndrome,HGNC:3261,EIF2B5,Disease-causing germline mutation(s) in,Assessed
352687,GARD:0012588,Congenital muscular alpha-dystroglycanopathy with brain and eye anomalies,370997,Muscle-eye-brain disease with bilateral multicystic leucodystrophy,HGNC:2666,DAG1,Disease-causing germline mutation(s) in,Assessed
450,GARD:0008591,X-linked visceral heterotaxy 1,157769,Situs ambiguus,HGNC:18292,CFC1,Candidate gene tested in,Not yet assessed
98634,GARD:0002978,Iridogoniodysgenesis type 1,91483,Rieger anomaly,HGNC:3800,FOXC1,Disease-causing germline mutation(s) in,Assessed
64746,GARD:0012431,Charcot-Marie-Tooth disease type 2,497757,MME-related autosomal dominant Charcot Marie Tooth disease type 2,HGNC:7154,MME,Disease-causing germline mutation(s) (loss of function) in,Assessed
98473,GARD:0007922,Muscular dystrophy,447977,Progressive scapulohumeroperoneal distal myopathy,HGNC:129,ACTA1,Disease-causing germline mutation(s) in,Assessed
182067,GARD:0006513,Glioma,251579,Giant cell glioblastoma,HGNC:11998,TP53,Biomarker tested in,Assessed
2134,GARD:0008702,Atypical hemolytic uremic syndrome,544472,Atypical hemolytic uremic syndrome with complement gene abnormality,HGNC:1318,C3,Disease-causing germline mutation(s) in,Assessed
385,GARD:0011899,Neurodegeneration with brain iron accumulation,496756,Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome,HGNC:11582,TBCE,Disease-causing germline mutation(s) in,Assessed
590,GARD:0011902,Congenital myasthenic syndromes,353327,Congenital myasthenic syndromes with glycosylation defect,HGNC:2995,DPAGT1,Disease-causing germline mutation(s) in,Assessed
216675,GARD:0007795,Transposition of the great arteries,216718,Isolated congenitally uncorrected transposition of the great arteries,HGNC:4214,GDF1,Major susceptibility factor in,Not yet assessed
216,GARD:0010739,Neuronal ceroid lipofuscinosis,228346,CLN3 disease,HGNC:2074,CLN3,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,157713,Congenital or early infantile CACH syndrome,HGNC:3259,EIF2B3,Disease-causing germline mutation(s) in,Assessed
3008,GARD:0007512,Pyruvate carboxylase deficiency,353314,"Pyruvate carboxylase deficiency, severe neonatal type",HGNC:8636,PC,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268752,Thoracolumbosacral spina bifida cystica,HGNC:7432,MTHFD1,Major susceptibility factor in,Assessed
444116,GARD:0006611,Hereditary amyloidosis,85447,ATTRV30M amyloidosis,HGNC:12405,TTR,Disease-causing germline mutation(s) in,Assessed
331223,GARD:0002816,Autosomal recessive hyper IgE syndrome,369992,Severe dermatitis-multiple allergies-metabolic wasting syndrome,HGNC:3048,DSG1,Disease-causing germline mutation(s) (loss of function) in,Assessed
85458,GARD:0010266,Hereditary cerebral hemorrhage with amyloidosis,324713,"ABeta amyloidosis, Italian type",HGNC:620,APP,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,309271,"Metachromatic leukodystrophy, adult form",HGNC:713,ARSA,Disease-causing germline mutation(s) (loss of function) in,Assessed
183660,GARD:0007628,Severe combined immunodeficiency,420573,Severe combined immunodeficiency due to CTPS1 deficiency,HGNC:2519,CTPS1,Disease-causing germline mutation(s) (loss of function) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93924,Lobar holoprosencephaly,HGNC:11776,TGIF1,Disease-causing germline mutation(s) in,Assessed
55,GARD:0010958,Oculocutaneous albinism,352737,Temperature-sensitive oculocutaneous albinism type 1,HGNC:12442,TYR,Disease-causing germline mutation(s) (loss of function) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,101008,Autosomal recessive spastic paraplegia type 28,HGNC:19714,DDHD1,Disease-causing germline mutation(s) in,Assessed
280892,GARD:0004457,Posterior uveitis,797,Sarcoidosis,HGNC:1142,BTNL2,Major susceptibility factor in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,453533,Polyendocrine-polyneuropathy syndrome,HGNC:2938,DMXL2,Disease-causing germline mutation(s) in,Assessed
511,GARD:0003228,Maple syrup urine disease,268173,Intermittent maple syrup urine disease,HGNC:986,BCKDHA,Disease-causing germline mutation(s) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,157719,Juvenile or adult CACH syndrome,HGNC:3258,EIF2B2,Disease-causing germline mutation(s) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,99854,Cree leukoencephalopathy,HGNC:3261,EIF2B5,Disease-causing germline mutation(s) in,Assessed
34526,GARD:0002906,Familial primary hypomagnesemia,199326,"Isolated autosomal dominant hypomagnesemia, Glaudemans type",HGNC:6218,KCNA1,Disease-causing germline mutation(s) in,Assessed
309279,GARD:0010670,Glycoproteinosis,423470,Mucolipidosis type III gamma,HGNC:23026,GNPTG,Disease-causing germline mutation(s) (loss of function) in,Assessed
289573,GARD:0012632,Multiple mitochondrial dysfunctions syndrome,569290,Multiple mitochondrial dysfunctions syndrome type 6,HGNC:9119,PMPCB,Disease-causing germline mutation(s) in,Assessed
370953,GARD:0012584,Congenital muscular dystrophy due to dystroglycanopathy ,370959,Congenital muscular dystrophy with cerebellar involvement,HGNC:19743,POMT2,Disease-causing germline mutation(s) in,Assessed
140471,GARD:0012688,Hereditary sensory and autonomic neuropathy,397606,PrP systemic amyloidosis,HGNC:9449,PRNP,Disease-causing germline mutation(s) in,Assessed
511,GARD:0003228,Maple syrup urine disease,268162,Intermediate maple syrup urine disease,HGNC:986,BCKDHA,Disease-causing germline mutation(s) in,Assessed
98274,GARD:0009319,Chronic myeloproliferative disorders,168940,Chronic eosinophilic leukemia,HGNC:8803,PDGFRA,Part of a fusion gene in,Assessed
165,GARD:0003262,Lipidosis with triglycerid storage disease,565612,Triglyceride deposit cardiomyovasculopathy,HGNC:30802,PNPLA2,Disease-causing germline mutation(s) in,Assessed
3394,GARD:0004898,Soft tissue sarcoma,99970,Dedifferentiated liposarcoma,HGNC:6973,MDM2,Role in the phenotype of,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,353327,Congenital myasthenic syndromes with glycosylation defect,HGNC:23159,ALG2,Disease-causing germline mutation(s) in,Assessed
85458,GARD:0010266,Hereditary cerebral hemorrhage with amyloidosis,324718,ABetaA21G amyloidosis,HGNC:620,APP,Disease-causing germline mutation(s) in,Assessed
877,GARD:0009316,Carcinoid tumor,100075,Neuroendocrine tumor of stomach,HGNC:2681,DAXX,Candidate gene tested in,Not yet assessed
2542,GARD:0012085,Microphthalmia,35612,Nanophthalmos,HGNC:2343,CRB1,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,797,Sarcoidosis,HGNC:1142,BTNL2,Major susceptibility factor in,Assessed
63,GARD:0005785,Alport syndrome,88917,X-linked Alport syndrome,HGNC:2207,COL4A5,Disease-causing germline mutation(s) in,Assessed
367,GARD:0002520,Glycogen storage disease type 4,308638,"Glycogen storage disease due to glycogen branching enzyme deficiency, non progressive hepatic form",HGNC:4180,GBE1,Disease-causing germline mutation(s) in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,589534,Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2),HGNC:3765,FLT3,Disease-causing somatic mutation(s) in,Assessed
535,GARD:0006225,Cutaneous lupus erythematosus,481662,Familial Chilblain lupus,HGNC:15925,SAMHD1,Disease-causing germline mutation(s) (loss of function) in,Assessed
1329,GARD:0001454,Complete atrioventricular canal,99067,Complete atrioventricular septal defect with ventricular hypoplasia,HGNC:7976,NR2F2,Major susceptibility factor in,Assessed
253,GARD:0007687,Spondyloepiphyseal dysplasia,457395,Progressive spondyloepimetaphyseal dysplasia-short stature-short fourth metatarsals-intellectual disability syndrome,HGNC:29420,RSPRY1,Disease-causing germline mutation(s) (loss of function) in,Assessed
1330,GARD:0004229,Partial atrioventricular canal,576232,Partial atrioventricular septal defect with ventricular hypoplasia,HGNC:4173,GATA4,Disease-causing germline mutation(s) (loss of function) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,538574,Palmoplantar keratoderma-hereditary motor and sensory neuropathy syndrome,HGNC:6412,KRT1,Modifying germline mutation in,Assessed
401854,GARD:0012679,Lipoic acid biosynthesis defects,457406,Multiple mitochondrial dysfunctions syndrome type 4,HGNC:19857,ISCA2,Disease-causing germline mutation(s) in,Assessed
2913,GARD:0004410,Polydactyly,93334,Postaxial polydactyly type A,HGNC:29171,IQCE,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,51,Aicardi-Goutières syndrome,HGNC:24116,RNASEH2C,Disease-causing germline mutation(s) in,Assessed
64746,GARD:0012431,Charcot-Marie-Tooth disease type 2,435387,Autosomal dominant Charcot-Marie-Tooth disease type 2Y,HGNC:12666,VCP,Disease-causing germline mutation(s) in,Assessed
182067,GARD:0006513,Glioma,251579,Giant cell glioblastoma,HGNC:3236,EGFR,Part of a fusion gene in,Assessed
391384,GARD:0012684,Familial episodic pain syndrome,391389,Familial episodic pain syndrome with predominantly upper body involvement,HGNC:497,TRPA1,Disease-causing germline mutation(s) (gain of function) in,Assessed
399786,GARD:0012513,Male infertility with spermatogenesis disorder due to single gene mutation ,529970,Male infertility due to acephalic spermatozoa,HGNC:16252,SUN5,Disease-causing germline mutation(s) in,Assessed
182058,GARD:0012959,Primary orthostatic hypotension,411602,Hereditary late-onset Parkinson disease,HGNC:4177,GBA,Major susceptibility factor in,Assessed
68356,GARD:0006895,Leukodystrophy,88637,Hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome,HGNC:20194,POLR1C,Disease-causing germline mutation(s) in,Assessed
2542,GARD:0012085,Microphthalmia,35612,Nanophthalmos,HGNC:39433,PRSS56,Disease-causing germline mutation(s) in,Assessed
401854,GARD:0012679,Lipoic acid biosynthesis defects,401869,Multiple mitochondrial dysfunctions syndrome type 1,HGNC:16287,NFU1,Disease-causing germline mutation(s) in,Assessed
2207,GARD:0002837,Familial isolated hyperparathyroidism,99879,Familial isolated hyperparathyroidism,HGNC:16783,CDC73,Disease-causing germline mutation(s) in,Assessed
209,GARD:0006227,Cutis laxa,293633,PYCR1-related De Barsy syndrome,HGNC:9721,PYCR1,Disease-causing germline mutation(s) in,Assessed
2134,GARD:0008702,Atypical hemolytic uremic syndrome,93581,Atypical hemolytic uremic syndrome with anti-factor H antibodies,HGNC:16979,CFHR4,Disease-causing germline mutation(s) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,423894,Microcephaly-complex motor and sensory axonal neuropathy syndrome,HGNC:12718,VRK1,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:26927,FOXRED1,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:28917,JAZF1,Major susceptibility factor in,Assessed
68356,GARD:0006895,Leukodystrophy,436271,Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy,HGNC:20492,COA8,Disease-causing germline mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,486815,Congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome,HGNC:12310,TRIP4,Disease-causing germline mutation(s) in,Assessed
401854,GARD:0012679,Lipoic acid biosynthesis defects,508093,MEPAN syndrome,HGNC:19691,MECR,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,70474,Leigh syndrome with cardiomyopathy,HGNC:10604,SCO2,Candidate gene tested in,Not yet assessed
407,GARD:0007219,Glycine encephalopathy,289863,Atypical glycine encephalopathy,HGNC:473,AMT,Disease-causing germline mutation(s) (loss of function) in,Assessed
442,GARD:0001487,Congenital hypothyroidism,453533,Polyendocrine-polyneuropathy syndrome,HGNC:2938,DMXL2,Disease-causing germline mutation(s) in,Assessed
2929,GARD:0003065,Juvenile polyposis syndrome,79076,Juvenile polyposis of infancy,HGNC:9588,PTEN,Role in the phenotype of,Assessed
53739,GARD:0012683,Distal hereditary motor neuropathy,139536,Distal hereditary motor neuropathy type 5,HGNC:25786,REEP1,Disease-causing germline mutation(s) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,157713,Congenital or early infantile CACH syndrome,HGNC:3258,EIF2B2,Disease-causing germline mutation(s) in,Assessed
407,GARD:0007219,Glycine encephalopathy,289863,Atypical glycine encephalopathy,HGNC:4313,GLDC,Disease-causing germline mutation(s) in,Assessed
3033,GARD:0000379,Renal tubular dysgenesis,97369,Renal tubular dysgenesis of genetic origin,HGNC:336,AGTR1,Disease-causing germline mutation(s) in,Assessed
183660,GARD:0007628,Severe combined immunodeficiency,169160,T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta,HGNC:1673,CD3D,Disease-causing germline mutation(s) in,Assessed
99927,GARD:0010263,Hydatidiform mole,254693,Partial hydatidiform mole,HGNC:33699,KHDC3L,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:8760,PDCD1,Major susceptibility factor in,Assessed
95708,GARD:0007446,Precocious puberty,169615,Idiopathic central precocious puberty,HGNC:7114,MKRN3,Disease-causing germline mutation(s) (loss of function) in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",251510,"46,XY partial gonadal dysgenesis",HGNC:13909,DMRT3,Candidate gene tested in,Not yet assessed
98261,GARD:0007140,Progressive myoclonic epilepsy,352709,CLN13 disease,HGNC:2531,CTSF,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,309263,"Metachromatic leukodystrophy, juvenile form",HGNC:713,ARSA,Disease-causing germline mutation(s) (loss of function) in,Assessed
280898,GARD:0008577,Panuveitis,797,Sarcoidosis,HGNC:4948,HLA-DRB1,Major susceptibility factor in,Assessed
823,GARD:0007673,Spina bifida,268392,Cervical spina bifida aperta,HGNC:26219,FUZ,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:3495,ETV6,Part of a fusion gene in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:1057,BLK,Major susceptibility factor in,Assessed
280898,GARD:0008577,Panuveitis,797,Sarcoidosis,HGNC:1142,BTNL2,Major susceptibility factor in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,247262,Hyperphosphatasia-intellectual disability syndrome,HGNC:8966,PIGL,Disease-causing germline mutation(s) in,Assessed
55,GARD:0010958,Oculocutaneous albinism,79431,Oculocutaneous albinism type 1A,HGNC:12442,TYR,Disease-causing germline mutation(s) (loss of function) in,Assessed
98634,GARD:0002978,Iridogoniodysgenesis type 1,98978,Axenfeld anomaly,HGNC:3800,FOXC1,Disease-causing germline mutation(s) in,Assessed
308166,GARD:0010923,Erythrokeratodermia variabilis et progressiva,316,Progressive symmetric erythrokeratodermia,HGNC:6460,KRT83,Disease-causing germline mutation(s) (loss of function) in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:7717,NDUFV2,Disease-causing germline mutation(s) in,Assessed
303,GARD:0002150,Dystrophic epidermolysis bullosa,158673,"Localized dystrophic epidermolysis bullosa, acral form",HGNC:2214,COL7A1,Disease-causing germline mutation(s) (loss of function) in,Assessed
739,GARD:0005575,Prader-Willi syndrome,177901,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1,HGNC:32780,SNORD115@,Role in the phenotype of,Assessed
289899,GARD:0009433,Organic acidemias,505216,3-methylglutaconic aciduria type 9,HGNC:23656,TIMM50,Disease-causing germline mutation(s) in,Assessed
249,GARD:0006444,Fibrous dysplasia,93277,Monostotic fibrous dysplasia,HGNC:4392,GNAS,Disease-causing somatic mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,466921,Childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome,HGNC:12403,TTN,Disease-causing germline mutation(s) (loss of function) in,Assessed
207073,GARD:0002003,Dysferlinopathy,199329,"Congenital myopathy, Paradas type",HGNC:3097,DYSF,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,157719,Juvenile or adult CACH syndrome,HGNC:3258,EIF2B2,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,51,Aicardi-Goutières syndrome,HGNC:15925,SAMHD1,Disease-causing germline mutation(s) in,Assessed
93969,GARD:0003475,Myelomeningocele,268762,Cervical spina bifida cystica,HGNC:15511,VANGL2,Major susceptibility factor in,Assessed
823,GARD:0007673,Spina bifida,268762,Cervical spina bifida cystica,HGNC:26219,FUZ,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,280195,Septopreoptic holoprosencephaly,HGNC:4165,GAS1,Disease-causing germline mutation(s) in,Assessed
64746,GARD:0012431,Charcot-Marie-Tooth disease type 2,99946,Autosomal dominant Charcot-Marie-Tooth disease type 2A1,HGNC:16636,KIF1B,Disease-causing germline mutation(s) (loss of function) in,Assessed
140471,GARD:0012688,Hereditary sensory and autonomic neuropathy,157820,Cold-induced sweating syndrome,HGNC:2364,CRLF1,Disease-causing germline mutation(s) in,Assessed
93437,GARD:0000006,Acromesomelic dysplasia,2639,Fibular aplasia-complex brachydactyly syndrome,HGNC:4220,GDF5,Disease-causing germline mutation(s) (loss of function) in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,86849,Acute basophilic leukemia,HGNC:7545,MYB,Part of a fusion gene in,Assessed
418,GARD:0001467,Congenital adrenal hyperplasia,325524,Classic congenital lipoid adrenal hyperplasia due to STAR deficency,HGNC:11359,STAR,Disease-causing germline mutation(s) (loss of function) in,Assessed
94075,GARD:0008689,Autoimmune enteropathy,391487,Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome,HGNC:11362,STAT1,Disease-causing germline mutation(s) (gain of function) in,Assessed
93437,GARD:0000006,Acromesomelic dysplasia,2639,Fibular aplasia-complex brachydactyly syndrome,HGNC:1077,BMPR1B,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:1787,CDKN2A,Disease-causing somatic mutation(s) in,Assessed
216,GARD:0010739,Neuronal ceroid lipofuscinosis,314632,ATP13A2-related juvenile neuronal ceroid lipofuscinosis,HGNC:30213,ATP13A2,Disease-causing germline mutation(s) in,Assessed
98274,GARD:0009319,Chronic myeloproliferative disorders,314950,Primary hypereosinophilic syndrome,HGNC:8804,PDGFRB,Part of a fusion gene in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,320375,Autosomal recessive spastic paraplegia type 55,HGNC:26784,MTRFR,Disease-causing germline mutation(s) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,397735,Autosomal dominant Charcot-Marie-Tooth disease type 2U,HGNC:6898,MARS1,Disease-causing germline mutation(s) (loss of function) in,Assessed
98277,GARD:0012758,Acute myeloid leukemia with recurrent genetic anomaly,402014,Acute myeloid leukemia with t(6;9)(p23;q34),HGNC:2768,DEK,Part of a fusion gene in,Assessed
823,GARD:0007673,Spina bifida,268766,Cervicothoracic spina bifida cystica,HGNC:15511,VANGL2,Major susceptibility factor in,Assessed
220460,GARD:0008532,Attenuated familial adenomatous polyposis,447877,Polymerase proofreading-related adenomatous polyposis,HGNC:9177,POLE,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,157713,Congenital or early infantile CACH syndrome,HGNC:3257,EIF2B1,Disease-causing germline mutation(s) in,Assessed
98879,GARD:0008732,Hemophilia B,169796,Moderate hemophilia B,HGNC:3551,F9,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:7711,NDUFS4,Disease-causing germline mutation(s) in,Assessed
357058,GARD:0001638,"Cutis laxa, autosomal recessive type 2A",357074,"Autosomal recessive cutis laxa type 2, classic type",HGNC:851,ATP6V1A,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:40038,PET100,Disease-causing germline mutation(s) (loss of function) in,Assessed
3242,GARD:0009509,Renpenning syndrome,93946,Hamel cerebro-palato-cardiac syndrome,HGNC:9330,PQBP1,Disease-causing germline mutation(s) in,Assessed
213500,GARD:0007295,Ovarian cancer,99915,Maligant granulosa cell tumor of the ovary,HGNC:1092,FOXL2,Disease-causing somatic mutation(s) in,Assessed
214,GARD:0006237,Cystinuria,93612,Cystinuria type A,HGNC:11025,SLC3A1,Disease-causing germline mutation(s) in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:7714,NDUFS7,Disease-causing germline mutation(s) in,Assessed
97242,GARD:0009138,Congenital muscular dystrophy,199329,"Congenital myopathy, Paradas type",HGNC:3097,DYSF,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,220386,Semilobar holoprosencephaly,HGNC:2908,DLL1,Disease-causing germline mutation(s) in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293888,"Familial isolated arrhythmogenic ventricular dysplasia, left dominant form",HGNC:2511,CTNNA3,Disease-causing germline mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,468684,CCDC115-CDG,HGNC:28178,CCDC115,Disease-causing germline mutation(s) (loss of function) in,Assessed
748,GARD:0012977,Mendelian susceptibility to mycobacterial diseases,319589,Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency,HGNC:5440,IFNGR2,Disease-causing germline mutation(s) in,Assessed
168956,GARD:0002804,Hypereosinophilic syndrome,314950,Primary hypereosinophilic syndrome,HGNC:3495,ETV6,Part of a fusion gene in,Assessed
411709,GARD:0009228,Renal agenesis,1848,"Renal agenesis, bilateral",HGNC:6144,ITGA8,Disease-causing germline mutation(s) in,Assessed
331223,GARD:0002816,Autosomal recessive hyper IgE syndrome,443811,PGM3-CDG,HGNC:8907,PGM3,Disease-causing germline mutation(s) in,Assessed
55,GARD:0010958,Oculocutaneous albinism,352734,Minimal pigment oculocutaneous albinism type 1,HGNC:12442,TYR,Disease-causing germline mutation(s) (loss of function) in,Assessed
411709,GARD:0009228,Renal agenesis,93100,"Renal agenesis, unilateral",HGNC:25396,FREM2,Disease-causing germline mutation(s) in,Assessed
733,GARD:0006408,Familial adenomatous polyposis,99818,Turcot syndrome with polyposis,HGNC:583,APC,Disease-causing germline mutation(s) in,Assessed
98249,GARD:0006322,Ehlers-Danlos syndromes,536516,Myopathic Ehlers-Danlos syndrome,HGNC:2188,COL12A1,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,401830,Autosomal recessive spastic paraplegia type 69,HGNC:17168,RAB3GAP2,Disease-causing germline mutation(s) in,Assessed
182067,GARD:0006513,Glioma,251579,Giant cell glioblastoma,HGNC:3688,FGFR1,Part of a fusion gene in,Assessed
367,GARD:0002520,Glycogen storage disease type 4,308670,"Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form",HGNC:4180,GBE1,Disease-causing germline mutation(s) in,Assessed
304,GARD:0010752,Epidermolysis bullosa simplex,300333,Nephrotic syndrome-epidermolysis bullosa-sensorineural deafness syndrome,HGNC:1630,CD151,Disease-causing germline mutation(s) in,Assessed
98274,GARD:0009319,Chronic myeloproliferative disorders,86830,"Chronic myeloproliferative disease, unclassifiable",HGNC:8804,PDGFRB,Part of a fusion gene in,Assessed
2929,GARD:0003065,Juvenile polyposis syndrome,329971,Generalized juvenile polyposis/juvenile polyposis coli,HGNC:6770,SMAD4,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:6149,ITGAM,Major susceptibility factor in,Assessed
823,GARD:0007673,Spina bifida,268748,Total spina bifida cystica,HGNC:26219,FUZ,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268384,Thoracolumbosacral spina bifida aperta,HGNC:26219,FUZ,Disease-causing germline mutation(s) in,Assessed
140471,GARD:0012688,Hereditary sensory and autonomic neuropathy,314381,Hereditary sensory and autonomic neuropathy type 6,HGNC:1090,DST,Disease-causing germline mutation(s) in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",63269,Antley-Bixler syndrome with genital anomaly and disorder of steroidogenesis,HGNC:9208,POR,Disease-causing germline mutation(s) (loss of function) in,Assessed
97245,GARD:0005898,Myopathy congenital,456328,X-linked myotubular myopathy-abnormal genitalia syndrome,HGNC:7448,MTM1,Role in the phenotype of,Assessed
289899,GARD:0009433,Organic acidemias,79312,Vitamin B12-unresponsive methylmalonic acidemia type mut-,HGNC:7526,MMUT,Disease-causing germline mutation(s) (loss of function) in,Assessed
216,GARD:0010739,Neuronal ceroid lipofuscinosis,352709,CLN13 disease,HGNC:2531,CTSF,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:5477,IGH,Disease-causing somatic mutation(s) in,Assessed
98274,GARD:0009319,Chronic myeloproliferative disorders,168940,Chronic eosinophilic leukemia,HGNC:19124,FIP1L1,Part of a fusion gene in,Assessed
757,GARD:0004553,Pseudohypoaldosteronism type 2,88940,Pseudohypoaldosteronism type 2C,HGNC:14540,WNK1,Disease-causing germline mutation(s) in,Assessed
444116,GARD:0006611,Hereditary amyloidosis,100006,"ABeta amyloidosis, Dutch type",HGNC:620,APP,Disease-causing germline mutation(s) in,Assessed
1531,GARD:0006209,Craniosynostosis,93258,Pfeiffer syndrome type 1,HGNC:3688,FGFR1,Disease-causing germline mutation(s) in,Assessed
308166,GARD:0010923,Erythrokeratodermia variabilis et progressiva,316,Progressive symmetric erythrokeratodermia,HGNC:17993,TRPM4,Disease-causing germline mutation(s) (gain of function) in,Assessed
93548,GARD:0012736,Glomerular disease,444092,Autoimmune interstitial lung disease-arthritis syndrome,HGNC:2230,COPA,Disease-causing germline mutation(s) in,Assessed
303,GARD:0002150,Dystrophic epidermolysis bullosa,79409,Recessive dystrophic epidermolysis bullosa inversa,HGNC:2214,COL7A1,Disease-causing germline mutation(s) (loss of function) in,Assessed
32,GARD:0010047,Glutathione synthetase deficiency,289849,Glutathione synthetase deficiency without 5-oxoprolinuria,HGNC:4624,GSS,Disease-causing germline mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,98863,X-linked Emery-Dreifuss muscular dystrophy,HGNC:3702,FHL1,Disease-causing germline mutation(s) in,Assessed
360,GARD:0002491,Glioblastoma,251579,Giant cell glioblastoma,HGNC:3688,FGFR1,Part of a fusion gene in,Assessed
167714,GARD:0012760,Unclassified acute myeloid leukemia ,86849,Acute basophilic leukemia,HGNC:7545,MYB,Part of a fusion gene in,Assessed
295047,GARD:0006951,Macrodactyly of toes,295243,"Macrodactyly of toes, unilateral",HGNC:8975,PIK3CA,Disease-causing somatic mutation(s) in,Assessed
280892,GARD:0006062,Choroiditis,797,Sarcoidosis,HGNC:1142,BTNL2,Major susceptibility factor in,Assessed
98473,GARD:0007922,Muscular dystrophy,199329,"Congenital myopathy, Paradas type",HGNC:3097,DYSF,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:4948,HLA-DRB1,Major susceptibility factor in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,330050,DNM1L-related encephalopathy due to mitochondrial and peroxisomal fission defect,HGNC:2973,DNM1L,Disease-causing germline mutation(s) (gain of function) in,Assessed
251612,GARD:0009808,Pilocytic astrocytoma,251615,Pilomyxoid astrocytoma,HGNC:1097,BRAF,Disease-causing somatic mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,247262,Hyperphosphatasia-intellectual disability syndrome,HGNC:23215,PIGO,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,93552,Pediatric systemic lupus erythematosus,HGNC:11365,STAT4,Major susceptibility factor in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",1422,Chondrodysplasia-disorder of sex development syndrome,HGNC:18270,HHAT,Disease-causing germline mutation(s) (loss of function) in,Assessed
444116,GARD:0006611,Hereditary amyloidosis,324713,"ABeta amyloidosis, Italian type",HGNC:620,APP,Disease-causing germline mutation(s) in,Assessed
3394,GARD:0004898,Soft tissue sarcoma,99971,Well-differentiated liposarcoma,HGNC:6973,MDM2,Role in the phenotype of,Assessed
98634,GARD:0003026,Iridogoniodysgenesis type 2,91483,Rieger anomaly,HGNC:3800,FOXC1,Disease-causing germline mutation(s) in,Assessed
88632,GARD:0010025,Anterior segment dysgenesis,98978,Axenfeld anomaly,HGNC:3800,FOXC1,Disease-causing germline mutation(s) in,Assessed
58,GARD:0005774,Alexander disease,363717,Alexander disease type I,HGNC:4235,GFAP,Disease-causing germline mutation(s) (gain of function) in,Assessed
289899,GARD:0009433,Organic acidemias,85295,"HSD10 disease, atypical type",HGNC:4800,HSD17B10,Disease-causing germline mutation(s) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,99946,Autosomal dominant Charcot-Marie-Tooth disease type 2A1,HGNC:16636,KIF1B,Disease-causing germline mutation(s) (loss of function) in,Assessed
589,GARD:0007122,Myasthenia gravis,391490,Adult-onset myasthenia gravis,HGNC:4942,HLA-DQA1,Major susceptibility factor in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,293633,PYCR1-related De Barsy syndrome,HGNC:9721,PYCR1,Disease-causing germline mutation(s) in,Assessed
251,GARD:0010756,Multiple epiphyseal dysplasia,166024,"Multiple epiphyseal dysplasia, Al-Gazali type",HGNC:30497,KIF7,Disease-causing germline mutation(s) in,Assessed
757,GARD:0004553,Pseudohypoaldosteronism type 2,300525,Pseudohypoaldosteronism type 2D,HGNC:6354,KLHL3,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,280195,Septopreoptic holoprosencephaly,HGNC:10848,SHH,Disease-causing germline mutation(s) in,Assessed
799,GARD:0000166,Schizencephaly,485275,Acquired schizencephaly,HGNC:10848,SHH,Major susceptibility factor in,Assessed
657,GARD:0003947,Congenital hyperinsulinism,263455,Hyperinsulinism due to HNF4A deficiency,HGNC:5024,HNF4A,Disease-causing germline mutation(s) in,Assessed
98277,GARD:0012758,Acute myeloid leukemia with recurrent genetic anomaly,319480,Acute myeloid leukemia with CEBPA somatic mutations,HGNC:1833,CEBPA,Disease-causing somatic mutation(s) in,Assessed
72,GARD:0005810,Angelman syndrome,98794,Angelman syndrome due to maternal 15q11q13 deletion,HGNC:8101,OCA2,Role in the phenotype of,Assessed
739,GARD:0005575,Prader-Willi syndrome,177901,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1,HGNC:8101,OCA2,Role in the phenotype of,Assessed
519,GARD:0012757,Acute myeloid leukemia ,102724,Acute myeloid leukemia with t(8;21)(q22;q22) translocation,HGNC:1833,CEBPA,Biomarker tested in,Assessed
55,GARD:0010958,Oculocutaneous albinism,79435,Oculocutaneous albinism type 4,HGNC:16472,SLC45A2,Disease-causing germline mutation(s) in,Assessed
209,GARD:0006227,Cutis laxa,217335,RIN2 syndrome,HGNC:18750,RIN2,Disease-causing germline mutation(s) (loss of function) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,100924,Porphyria due to ALA dehydratase deficiency,HGNC:395,ALAD,Disease-causing germline mutation(s) in,Assessed
167714,GARD:0012760,Unclassified acute myeloid leukemia ,86849,Acute basophilic leukemia,HGNC:4170,GATA1,Part of a fusion gene in,Assessed
657,GARD:0003947,Congenital hyperinsulinism,276580,Autosomal dominant hyperinsulinism due to Kir6.2 deficiency,HGNC:6257,KCNJ11,Disease-causing germline mutation(s) in,Assessed
98292,GARD:0006987,Mastocytosis,280785,Bullous diffuse cutaneous mastocytosis,HGNC:6342,KIT,Disease-causing germline mutation(s) in,Assessed
683,GARD:0007471,Progressive supranuclear palsy,240112,Progressive supranuclear palsy-progressive non-fluent aphasia syndrome,HGNC:6893,MAPT,Major susceptibility factor in,Assessed
739,GARD:0005575,Prader-Willi syndrome,98754,Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15,HGNC:6814,MAGEL2,Role in the phenotype of,Assessed
1037,GARD:0000777,Arthrogryposis multiplex congenita,53696,Arthrogryposis-anterior horn cell disease syndrome,HGNC:4315,GLE1,Disease-causing germline mutation(s) in,Assessed
3394,GARD:0004898,Soft tissue sarcoma,370334,Extraskeletal Ewing sarcoma,HGNC:3749,FLI1,Part of a fusion gene in,Assessed
289573,GARD:0012632,Multiple mitochondrial dysfunctions syndrome,569274,Multiple mitochondrial dysfunctions syndrome type 5,HGNC:28660,ISCA1,Disease-causing germline mutation(s) in,Assessed
817,GARD:0007347,Peeling skin syndrome,263548,Peeling skin syndrome type A,HGNC:33276,FLG2,Disease-causing germline mutation(s) (loss of function) in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",251510,"46,XY partial gonadal dysgenesis",HGNC:6848,MAP3K1,Disease-causing germline mutation(s) in,Assessed
757,GARD:0004553,Pseudohypoaldosteronism type 2,300530,Pseudohypoaldosteronism type 2E,HGNC:2553,CUL3,Disease-causing germline mutation(s) in,Assessed
182090,GARD:0007501,Pulmonary arterial hypertension,275777,Heritable pulmonary arterial hypertension,HGNC:175,ACVRL1,Candidate gene tested in,Not yet assessed
102,GARD:0007079,Multiple system atrophy,98933,"Multiple system atrophy, parkinsonian type",HGNC:25223,COQ2,Major susceptibility factor in,Assessed
448,GARD:0010418,Hemophilia,177926,Bleeding disorder in hemophilia A carriers,HGNC:3546,F8,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:7710,NDUFS3,Disease-causing germline mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,424261,TOR1AIP1-related limb-girdle muscular dystrophy,HGNC:29456,TOR1AIP1,Disease-causing germline mutation(s) (loss of function) in,Assessed
231692,GARD:0003921,Isolated growth hormone deficiency type 3,632,Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia,HGNC:1133,BTK,Disease-causing germline mutation(s) in,Assessed
3394,GARD:0004898,Soft tissue sarcoma,99971,Well-differentiated liposarcoma,HGNC:5009,HMGA2,Role in the phenotype of,Assessed
293642,GARD:0010892,Blepharophimosis intellectual disability syndromes,3047,"Blepharophimosis-intellectual disability syndrome, SBBYS type",HGNC:17582,KAT6B,Disease-causing germline mutation(s) in,Assessed
182067,GARD:0006513,Glioma,251579,Giant cell glioblastoma,HGNC:6742,LZTR1,Disease-causing somatic mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:23063,NUDT15,Candidate gene tested in,Not yet assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,485421,MFF-related encephalopathy due to mitochondrial and peroxisomal fission defect,HGNC:24858,MFF,Disease-causing germline mutation(s) (loss of function) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93925,Alobar holoprosencephaly,HGNC:11355,STAG2,Disease-causing germline mutation(s) (loss of function) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:25547,CEP72,Candidate gene tested in,Not yet assessed
544,GARD:0003178,Diffuse Large B-Cell Lymphoma,98839,Intravascular large B-cell lymphoma,HGNC:990,BCL2,Biomarker tested in,Assessed
182090,GARD:0007501,Pulmonary arterial hypertension,275777,Heritable pulmonary arterial hypertension,HGNC:1078,BMPR2,Disease-causing germline mutation(s) (loss of function) in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293888,"Familial isolated arrhythmogenic ventricular dysplasia, left dominant form",HGNC:3049,DSG2,Disease-causing germline mutation(s) in,Assessed
182058,GARD:0012959,Primary orthostatic hypotension,411602,Hereditary late-onset Parkinson disease,HGNC:30343,DNAJC13,Disease-causing germline mutation(s) (gain of function) in,Assessed
411709,GARD:0009228,Renal agenesis,1848,"Renal agenesis, bilateral",HGNC:31042,GREB1L,Disease-causing germline mutation(s) (loss of function) in,Assessed
2467,GARD:0008616,Systemic mastocytosis,566396,Chronic mast cell leukemia,HGNC:6342,KIT,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93926,Midline interhemispheric variant of holoprosencephaly,HGNC:17104,CDON,Disease-causing germline mutation(s) in,Assessed
365,GARD:0005714,Glycogen storage disease type 2,420429,"Glycogen storage disease due to acid maltase deficiency, late-onset",HGNC:4065,GAA,Disease-causing germline mutation(s) in,Assessed
796,GARD:0002521,"GM2 gangliosidosis, 0 variant",309162,"Sandhoff disease, juvenile form",HGNC:4879,HEXB,Disease-causing germline mutation(s) (loss of function) in,Assessed
79225,GARD:0007672,Sphingolipidosis,216972,"Niemann-Pick disease type C, severe perinatal form",HGNC:7897,NPC1,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:3823,FOXP1,Part of a fusion gene in,Assessed
93548,GARD:0012736,Glomerular disease,280406,Familial steroid-resistant nephrotic syndrome with sensorineural deafness,HGNC:20233,COQ6,Disease-causing germline mutation(s) in,Assessed
226298,GARD:0012280,Central congenital hypothyroidism,329235,X-linked central congenital hypothyroidism with late-onset testicular enlargement,HGNC:5948,IGSF1,Disease-causing germline mutation(s) (loss of function) in,Assessed
280886,GARD:0010941,Anterior uveitis,85408,Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis,HGNC:25681,ANKRD55,Major susceptibility factor in,Not yet assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:23063,NUDT15,Candidate gene tested in,Not yet assessed
66646,GARD:0007842,Cutaneous mastocytosis,90389,Telangiectasia macularis eruptiva perstans,HGNC:6342,KIT,Disease-causing germline mutation(s) in,Assessed
182058,GARD:0012959,Primary orthostatic hypotension,2828,Young-onset Parkinson disease,HGNC:18618,LRRK2,Candidate gene tested in,Not yet assessed
91378,GARD:0005979,Hereditary angioedema,100051,Hereditary angioedema type 2,HGNC:1228,SERPING1,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268748,Total spina bifida cystica,HGNC:11515,TBXT,Major susceptibility factor in,Assessed
68356,GARD:0006895,Leukodystrophy,99853,Ovarioleukodystrophy,HGNC:3260,EIF2B4,Disease-causing germline mutation(s) in,Assessed
88632,GARD:0010025,Anterior segment dysgenesis,261600,Alagille syndrome due to 20p12 microdeletion,HGNC:6188,JAG1,Role in the phenotype of,Assessed
183660,GARD:0007628,Severe combined immunodeficiency,35078,T-B+ severe combined immunodeficiency due to JAK3 deficiency,HGNC:6193,JAK3,Disease-causing germline mutation(s) in,Assessed
442,GARD:0001487,Congenital hypothyroidism,99832,Resistance to thyrotropin-releasing hormone syndrome,HGNC:12299,TRHR,Disease-causing germline mutation(s) (loss of function) in,Assessed
93548,GARD:0012736,Glomerular disease,238269,AApoAII amyloidosis,HGNC:601,APOA2,Disease-causing germline mutation(s) in,Assessed
69077,GARD:0007572,Rhabdoid tumor,231108,Familial rhabdoid tumor,HGNC:11100,SMARCA4,Disease-causing germline mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,370968,Congenital muscular dystrophy with intellectual disability,HGNC:9202,POMT1,Disease-causing germline mutation(s) in,Assessed
69078,GARD:0006913,Liposarcoma,99971,Well-differentiated liposarcoma,HGNC:1773,CDK4,Role in the phenotype of,Assessed
68356,GARD:0006895,Leukodystrophy,157716,Late infantile CACH syndrome,HGNC:3260,EIF2B4,Disease-causing germline mutation(s) in,Assessed
98292,GARD:0006987,Mastocytosis,280794,Pseudoxanthomatous diffuse cutaneous mastocytosis,HGNC:6342,KIT,Disease-causing germline mutation(s) in,Assessed
282,GARD:0008436,Frontotemporal dementia,275864,Behavioral variant of frontotemporal dementia,HGNC:6893,MAPT,Major susceptibility factor in,Assessed
85450,GARD:0008282,Amyloidosis familial visceral,93561,ALys amyloidosis,HGNC:6740,LYZ,Disease-causing germline mutation(s) in,Assessed
450,GARD:0008591,X-linked visceral heterotaxy 1,157769,Situs ambiguus,HGNC:7865,NODAL,Candidate gene tested in,Not yet assessed
53739,GARD:0012683,Distal hereditary motor neuropathy,139525,Distal hereditary motor neuropathy type 2,HGNC:28844,FBXO38,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99860,Precursor B-cell acute lymphoblastic leukemia,HGNC:25547,CEP72,Candidate gene tested in,Not yet assessed
98085,GARD:0008538,"46, XY disorders of sexual development",90796,"46,XY disorder of sex development due to isolated 17,20-lyase deficiency",HGNC:2570,CYB5A,Disease-causing germline mutation(s) in,Assessed
783,GARD:0007593,Rubinstein-Taybi syndrome,353284,Rubinstein-Taybi syndrome due to EP300 haploinsufficiency,HGNC:3373,EP300,Disease-causing germline mutation(s) (loss of function) in,Assessed
79225,GARD:0007672,Sphingolipidosis,309192,"Tay-Sachs disease, B variant, adult form",HGNC:4878,HEXA,Disease-causing germline mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,370959,Congenital muscular dystrophy with cerebellar involvement,HGNC:9202,POMT1,Disease-causing germline mutation(s) in,Assessed
163892,GARD:0008742,Limbic encephalitis,163908,Limbic encephalitis with LGI1 antibodies,HGNC:4944,HLA-DQB1,Major susceptibility factor in,Assessed
182090,GARD:0007501,Pulmonary arterial hypertension,275777,Heritable pulmonary arterial hypertension,HGNC:19687,EIF2AK4,Disease-causing germline mutation(s) (loss of function) in,Assessed
1531,GARD:0006209,Craniosynostosis,293925,Lethal occipital encephalocele-skeletal dysplasia syndrome,HGNC:20581,CYP26B1,Disease-causing germline mutation(s) (loss of function) in,Assessed
88661,GARD:0005791,Amelogenesis imperfecta,100032,Hypocalcified amelogenesis imperfecta,HGNC:33188,AMTN,Disease-causing germline mutation(s) in,Assessed
264665,GARD:0010559,Children's interstitial lung disease,70587,Infant acute respiratory distress syndrome,HGNC:33,ABCA3,Candidate gene tested in,Not yet assessed
2978,GARD:0012744,Chronic intestinal pseudoobstruction,104077,Myopathic intestinal pseudoobstruction,HGNC:145,ACTG2,Disease-causing germline mutation(s) in,Assessed
213500,GARD:0007295,Ovarian cancer,213524,Hereditary site-specific ovarian cancer syndrome,HGNC:1101,BRCA2,Major susceptibility factor in,Assessed
813,GARD:0004870,Russell-Silver syndrome,231140,Silver-Russell syndrome due to an imprinting defect of 11p15,HGNC:4713,H19,Role in the phenotype of,Assessed
282,GARD:0008436,Frontotemporal dementia,275864,Behavioral variant of frontotemporal dementia,HGNC:24537,CHMP2B,Major susceptibility factor in,Assessed
360,GARD:0002491,Glioblastoma,251579,Giant cell glioblastoma,HGNC:3690,FGFR3,Part of a fusion gene in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:1014,BCR,Part of a fusion gene in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,319646,PGM1-CDG,HGNC:8905,PGM1,Disease-causing germline mutation(s) in,Assessed
877,GARD:0009316,Carcinoid tumor,100075,Neuroendocrine tumor of stomach,HGNC:886,ATRX,Candidate gene tested in,Not yet assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,99947,Autosomal dominant Charcot-Marie-Tooth disease type 2A2,HGNC:16877,MFN2,Disease-causing germline mutation(s) in,Assessed
96169,GARD:0010727,Koolen de Vries syndrome,363958,17q21.31 microdeletion syndrome,HGNC:24565,KANSL1,Role in the phenotype of,Assessed
442,GARD:0001487,Congenital hypothyroidism,3047,"Blepharophimosis-intellectual disability syndrome, SBBYS type",HGNC:17582,KAT6B,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,401805,Autosomal recessive spastic paraplegia type 63,HGNC:469,AMPD2,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268752,Thoracolumbosacral spina bifida cystica,HGNC:15512,VANGL1,Major susceptibility factor in,Assessed
98261,GARD:0007140,Progressive myoclonic epilepsy,530303,Progressive dementia with neuroserpin inclusion bodies,HGNC:8943,SERPINI1,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268384,Thoracolumbosacral spina bifida aperta,HGNC:11515,TBXT,Major susceptibility factor in,Assessed
846,GARD:0000621,Alpha-thalassemia,163596,Hb Bart's hydrops fetalis,HGNC:4824,HBA2,Disease-causing germline mutation(s) in,Assessed
739,GARD:0005575,Prader-Willi syndrome,177910,Prader-Willi syndrome due to imprinting mutation,HGNC:11164,SNRPN,Role in the phenotype of,Assessed
97242,GARD:0009138,Congenital muscular dystrophy,370980,Congenital muscular dystrophy without intellectual disability,HGNC:17997,FKRP,Disease-causing germline mutation(s) in,Assessed
3394,GARD:0004898,Soft tissue sarcoma,209916,Extraskeletal myxoid chondrosarcoma,HGNC:3508,EWSR1,Part of a fusion gene in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",251510,"46,XY partial gonadal dysgenesis",HGNC:7983,NR5A1,Disease-causing germline mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,353327,Congenital myasthenic syndromes with glycosylation defect,HGNC:28287,ALG14,Disease-causing germline mutation(s) in,Assessed
36204,GARD:0012331,Intestinal lymphangiectasia,566175,Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome,HGNC:2665,CD55,Disease-causing germline mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,98855,Autosomal recessive Emery-Dreifuss muscular dystrophy,HGNC:6636,LMNA,Disease-causing germline mutation(s) in,Assessed
442,GARD:0001487,Congenital hypothyroidism,95712,Thyroid ectopia,HGNC:8622,PAX8,Disease-causing germline mutation(s) (loss of function) in,Assessed
53739,GARD:0012683,Distal hereditary motor neuropathy,139525,Distal hereditary motor neuropathy type 2,HGNC:30171,HSPB8,Disease-causing germline mutation(s) in,Assessed
98722,GARD:0000802,Atrioventricular septal defect,99067,Complete atrioventricular septal defect with ventricular hypoplasia,HGNC:4174,GATA6,Disease-causing germline mutation(s) in,Not yet assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:13532,TLX3,Part of a fusion gene in,Assessed
79430,GARD:0006643,Hermansky-Pudlak syndrome,231512,Hermansky-Pudlak syndrome due to BLOC-2 deficiency,HGNC:15597,HPS3,Disease-causing germline mutation(s) in,Assessed
93969,GARD:0003475,Myelomeningocele,268752,Thoracolumbosacral spina bifida cystica,HGNC:7436,MTHFR,Major susceptibility factor in,Assessed
140471,GARD:0012688,Hereditary sensory and autonomic neuropathy,157820,Cold-induced sweating syndrome,HGNC:15646,KLHL7,Disease-causing germline mutation(s) (loss of function) in,Assessed
443909,GARD:0008533,Familial colorectal cancer,440437,Familial colorectal cancer Type X,HGNC:10405,RPS20,Disease-causing germline mutation(s) in,Assessed
182090,GARD:0007501,Pulmonary arterial hypertension,275777,Heritable pulmonary arterial hypertension,HGNC:6774,SMAD9,Disease-causing germline mutation(s) in,Assessed
2238,GARD:0002910,Familial isolated hypoparathyroidism,2239,Familial isolated hypoparathyroidism due to agenesis of parathyroid gland,HGNC:4198,GCM2,Disease-causing germline mutation(s) (loss of function) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,466722,Autosomal recessive spastic paraplegia type 77,HGNC:21062,FARS2,Disease-causing germline mutation(s) (loss of function) in,Assessed
93969,GARD:0003475,Myelomeningocele,268766,Cervicothoracic spina bifida cystica,HGNC:11515,TBXT,Major susceptibility factor in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:2263,COX15,Disease-causing germline mutation(s) in,Assessed
845,GARD:0007737,Tay-Sachs disease,309239,"Tay-Sachs disease, B1 variant",HGNC:4878,HEXA,Disease-causing germline mutation(s) in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",983,Testicular regression syndrome,HGNC:17210,DHX37,Disease-causing germline mutation(s) in,Assessed
2207,GARD:0002837,Familial isolated hyperparathyroidism,99879,Familial isolated hyperparathyroidism,HGNC:4198,GCM2,Disease-causing germline mutation(s) in,Assessed
506,GARD:0006877,Leigh syndrome,70474,Leigh syndrome with cardiomyopathy,HGNC:11474,SURF1,Disease-causing germline mutation(s) (loss of function) in,Assessed
97242,GARD:0009138,Congenital muscular dystrophy,370968,Congenital muscular dystrophy with intellectual disability,HGNC:22932,GMPPB,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:30071,KIAA0319L,Major susceptibility factor in,Assessed
748,GARD:0012977,Mendelian susceptibility to mycobacterial diseases,574957,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial JAK1 deficiency,HGNC:6190,JAK1,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93926,Midline interhemispheric variant of holoprosencephaly,HGNC:10889,SIX3,Disease-causing germline mutation(s) in,Assessed
511,GARD:0003228,Maple syrup urine disease,268145,Classic maple syrup urine disease,HGNC:987,BCKDHB,Disease-causing germline mutation(s) (loss of function) in,Assessed
655,GARD:0000206,Nephronophthisis,93591,Infantile nephronophthisis,HGNC:16762,ZNF423,Disease-causing germline mutation(s) in,Assessed
506,GARD:0006877,Leigh syndrome,70474,Leigh syndrome with cardiomyopathy,HGNC:7708,NDUFS2,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:76,ABL1,Part of a fusion gene in,Assessed
116,GARD:0003343,Beckwith-Wiedemann syndrome,231120,Beckwith-Wiedemann syndrome due to CDKN1C mutation,HGNC:1786,CDKN1C,Disease-causing germline mutation(s) (loss of function) in,Assessed
171901,GARD:0006226,Cutaneous T-cell lymphoma,300865,Primary cutaneous anaplastic large cell lymphoma,HGNC:12440,TYK2,Part of a fusion gene in,Assessed
657,GARD:0003947,Congenital hyperinsulinism,79643,Autosomal recessive hyperinsulinism due to SUR1 deficiency,HGNC:59,ABCC8,Disease-causing germline mutation(s) in,Assessed
79373,GARD:0006317,Ectodermal dysplasia,33364,Trichothiodystrophy,HGNC:3434,ERCC2,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,88637,Hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome,HGNC:30074,POLR3A,Disease-causing germline mutation(s) in,Assessed
1531,GARD:0006209,Craniosynostosis,35099,Isolated brachycephaly,HGNC:3690,FGFR3,Disease-causing germline mutation(s) in,Assessed
79225,GARD:0007672,Sphingolipidosis,309169,"Sandhoff disease, adult form",HGNC:4879,HEXB,Disease-causing germline mutation(s) (loss of function) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,70474,Leigh syndrome with cardiomyopathy,HGNC:7708,NDUFS2,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93924,Lobar holoprosencephaly,HGNC:3814,FOXH1,Disease-causing germline mutation(s) in,Assessed
370953,GARD:0012584,Congenital muscular dystrophy due to dystroglycanopathy ,370959,Congenital muscular dystrophy with cerebellar involvement,HGNC:17997,FKRP,Disease-causing germline mutation(s) in,Assessed
443909,GARD:0008533,Familial colorectal cancer,144,Lynch syndrome,HGNC:7325,MSH2,Disease-causing germline mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,370980,Congenital muscular dystrophy without intellectual disability,HGNC:37276,CRPPA,Disease-causing germline mutation(s) (loss of function) in,Assessed
79225,GARD:0007672,Sphingolipidosis,309256,"Metachromatic leukodystrophy, late infantile form",HGNC:9498,PSAP,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,320360,MT-ATP6-related mitochondrial spastic paraplegia,HGNC:7414,MT-ATP6,Disease-causing germline mutation(s) in,Assessed
646,GARD:0007207,Niemann-Pick disease type C1,216978,"Niemann-Pick disease type C, late infantile neurologic onset",HGNC:14537,NPC2,Disease-causing germline mutation(s) in,Assessed
391384,GARD:0012684,Familial episodic pain syndrome,391392,Familial episodic pain syndrome with predominantly lower limb involvement,HGNC:10583,SCN11A,Disease-causing germline mutation(s) (gain of function) in,Assessed
253,GARD:0007687,Spondyloepiphyseal dysplasia,93282,"Spondyloepimetaphyseal dysplasia, PAPSS2 type",HGNC:8604,PAPSS2,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:15514,PICALM,Part of a fusion gene in,Assessed
79167,GARD:0007837,Urea cycle disorders,247546,Acute neonatal citrullinemia type I,HGNC:758,ASS1,Disease-causing germline mutation(s) (loss of function) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:8632,PBX1,Part of a fusion gene in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,324585,Autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic pain,HGNC:7225,MPZ,Disease-causing germline mutation(s) in,Assessed
97360,GARD:0000312,Robinow syndrome,3107,Autosomal dominant Robinow syndrome,HGNC:4040,FZD2,Disease-causing germline mutation(s) in,Assessed
182058,GARD:0012959,Primary orthostatic hypotension,2828,Young-onset Parkinson disease,HGNC:14581,PINK1,Disease-causing germline mutation(s) in,Assessed
72,GARD:0005810,Angelman syndrome,98795,Angelman syndrome due to paternal uniparental disomy of chromosome 15,HGNC:12496,UBE3A,Role in the phenotype of,Assessed
79213,GARD:0007065,Mucopolysaccharidosis,217085,"Mucopolysaccharidosis type 2, severe form",HGNC:5389,IDS,Disease-causing germline mutation(s) in,Assessed
518,GARD:0000524,Acute megakaryoblastic leukemia,329469,Acute megakaryoblastic leukemia without Down syndrome,HGNC:1537,CBFA2T3,Part of a fusion gene in,Assessed
2238,GARD:0002910,Familial isolated hypoparathyroidism,189466,Familial isolated hypoparathyroidism due to impaired PTH secretion,HGNC:9606,PTH,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268752,Thoracolumbosacral spina bifida cystica,HGNC:11515,TBXT,Major susceptibility factor in,Assessed
1531,GARD:0006209,Craniosynostosis,35098,Isolated plagiocephaly,HGNC:12428,TWIST1,Disease-causing germline mutation(s) in,Assessed
79373,GARD:0006317,Ectodermal dysplasia,1810,Autosomal dominant hypohidrotic ectodermal dysplasia,HGNC:14341,EDARADD,Disease-causing germline mutation(s) in,Assessed
352,GARD:0002424,Galactosemia,308487,Generalized galactose epimerase deficiency,HGNC:4116,GALE,Disease-causing germline mutation(s) in,Assessed
79167,GARD:0007837,Urea cycle disorders,401948,Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency,HGNC:1377,CA5A,Disease-causing germline mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,370980,Congenital muscular dystrophy without intellectual disability,HGNC:9202,POMT1,Disease-causing germline mutation(s) in,Assessed
2467,GARD:0008616,Systemic mastocytosis,158778,Isolated bone marrow mastocytosis,HGNC:6342,KIT,Disease-causing somatic mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,320391,Autosomal recessive spastic paraplegia type 46,HGNC:18986,GBA2,Disease-causing germline mutation(s) (loss of function) in,Assessed
2781,GARD:0004155,Osteopetrosis,556985,Early-onset calcifying leukoencephalopathy-skeletal dysplasia,HGNC:2433,CSF1R,Disease-causing germline mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,247262,Hyperphosphatasia-intellectual disability syndrome,HGNC:23719,PGAP3,Disease-causing germline mutation(s) (loss of function) in,Assessed
217,GARD:0006242,Dandy-Walker complex,269215,Isolated Dandy-Walker malformation without hydrocephalus,HGNC:12872,ZIC1,Role in the phenotype of,Assessed
631,GARD:0012556,Isolated growth hormone deficiency,632,Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia,HGNC:1133,BTK,Disease-causing germline mutation(s) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,391351,SURF1-related Charcot-Marie-Tooth disease type 4,HGNC:11474,SURF1,Disease-causing germline mutation(s) in,Assessed
655,GARD:0000206,Nephronophthisis,93591,Infantile nephronophthisis,HGNC:17870,INVS,Disease-causing germline mutation(s) in,Assessed
97360,GARD:0000312,Robinow syndrome,3107,Autosomal dominant Robinow syndrome,HGNC:3084,DVL1,Disease-causing germline mutation(s) in,Assessed
72,GARD:0005810,Angelman syndrome,411515,Angelman syndrome due to imprinting defect in 15q11-q13,HGNC:11164,SNRPN,Role in the phenotype of,Assessed
68356,GARD:0006895,Leukodystrophy,83629,Leukoencephalopathy-spondyloepimetaphyseal dysplasia syndrome,HGNC:8768,AIFM1,Disease-causing germline mutation(s) in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293888,"Familial isolated arrhythmogenic ventricular dysplasia, left dominant form",HGNC:15710,LDB3,Disease-causing germline mutation(s) in,Assessed
442,GARD:0001487,Congenital hypothyroidism,226307,Hypothyroidism due to deficient transcription factors involved in pituitary development or function,HGNC:21734,LHX4,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:11648,TCL1A,Part of a fusion gene in,Assessed
253,GARD:0007687,Spondyloepiphyseal dysplasia,166100,Autosomal dominant otospondylomegaepiphyseal dysplasia,HGNC:2187,COL11A2,Disease-causing germline mutation(s) in,Assessed
2467,GARD:0008616,Systemic mastocytosis,566393,Acute mast cell leukemia,HGNC:6342,KIT,Disease-causing germline mutation(s) in,Assessed
140471,GARD:0012688,Hereditary sensory and autonomic neuropathy,139578,Mutilating hereditary sensory neuropathy with spastic paraplegia,HGNC:1618,CCT5,Disease-causing germline mutation(s) in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",251510,"46,XY partial gonadal dysgenesis",HGNC:12799,WWOX,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93925,Alobar holoprosencephaly,HGNC:3814,FOXH1,Disease-causing germline mutation(s) in,Assessed
436,GARD:0006734,Hypophosphatasia,247638,Prenatal benign hypophosphatasia,HGNC:438,ALPL,Disease-causing germline mutation(s) (loss of function) in,Assessed
442,GARD:0001487,Congenital hypothyroidism,95716,Familial thyroid dyshormonogenesis,HGNC:13273,DUOX2,Disease-causing germline mutation(s) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,443073,Charcot-Marie-Tooth disease type 2S,HGNC:5542,IGHMBP2,Disease-causing germline mutation(s) (loss of function) in,Assessed
1048,GARD:0005808,Anencephaly,563609,Isolated anencephaly,HGNC:7436,MTHFR,Major susceptibility factor in,Assessed
68356,GARD:0006895,Leukodystrophy,99853,Ovarioleukodystrophy,HGNC:21022,AARS2,Disease-causing germline mutation(s) (loss of function) in,Assessed
53739,GARD:0012683,Distal hereditary motor neuropathy,139589,Distal hereditary motor neuropathy type 7,HGNC:2711,DCTN1,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:12155,TRB,Part of a fusion gene in,Assessed
2781,GARD:0004155,Osteopetrosis,500548,Osteosclerotic metaphyseal dysplasia,HGNC:18608,LRRK1,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,320401,Autosomal recessive spastic paraplegia type 44,HGNC:17494,GJC2,Disease-causing germline mutation(s) in,Assessed
251355,GARD:0012459,Sickle cell disease associated with an other hemoglobin anomaly,251380,Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome,HGNC:4831,HBG1,Disease-causing germline mutation(s) in,Assessed
1531,GARD:0006209,Craniosynostosis,93259,Pfeiffer syndrome type 2,HGNC:3689,FGFR2,Disease-causing germline mutation(s) (gain of function) in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293910,"Familial isolated arrhythmogenic ventricular dysplasia, right dominant form",HGNC:28472,TMEM43,Disease-causing germline mutation(s) (loss of function) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:24316,TACO1,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:2621,CYP2C19,Candidate gene tested in,Not yet assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:2745,DDX3X,Part of a fusion gene in,Assessed
251612,GARD:0009808,Pilocytic astrocytoma,251615,Pilomyxoid astrocytoma,HGNC:19744,SRGAP3,Part of a fusion gene in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,521390,Spastic paraplegia-intellectual disability-nystagmus-obesity syndrome,HGNC:29508,KIDINS220,Disease-causing germline mutation(s) in,Assessed
88661,GARD:0005791,Amelogenesis imperfecta,100034,Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism,HGNC:2916,DLX3,Disease-causing germline mutation(s) in,Assessed
26791,GARD:0006523,Glutaric acidemia type II,394532,"Multiple acyl-CoA dehydrogenase deficiency, mild type",HGNC:3483,ETFDH,Disease-causing germline mutation(s) in,Assessed
264665,GARD:0010559,Children's interstitial lung disease,440402,Interstitial lung disease due to ABCA3 deficiency,HGNC:33,ABCA3,Disease-causing germline mutation(s) (loss of function) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,90118,Severe early-onset axonal neuropathy due to MFN2 deficiency,HGNC:16877,MFN2,Disease-causing germline mutation(s) in,Assessed
116,GARD:0003343,Beckwith-Wiedemann syndrome,231117,Beckwith-Wiedemann syndrome due to imprinting defect of 11p15,HGNC:4713,H19,Role in the phenotype of,Assessed
55,GARD:0010958,Oculocutaneous albinism,352745,Oculocutaneous albinism type 7,HGNC:23405,LRMDA,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:3823,FOXP1,Part of a fusion gene in,Assessed
3394,GARD:0004898,Soft tissue sarcoma,99970,Dedifferentiated liposarcoma,HGNC:5009,HMGA2,Role in the phenotype of,Assessed
448,GARD:0010418,Hemophilia,169805,Moderate hemophilia A,HGNC:3546,F8,Disease-causing germline mutation(s) in,Assessed
593,GARD:0010529,Myofibrillar myopathy,98911,Distal myotilinopathy,HGNC:12399,MYOT,Disease-causing germline mutation(s) in,Assessed
216,GARD:0010739,Neuronal ceroid lipofuscinosis,314629,CLN11 disease,HGNC:4601,GRN,Disease-causing germline mutation(s) in,Assessed
261494,GARD:0008672,Kleefstra syndrome,261652,Kleefstra syndrome due to a point mutation,HGNC:24650,EHMT1,Disease-causing germline mutation(s) (loss of function) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,309162,"Sandhoff disease, juvenile form",HGNC:4879,HEXB,Disease-causing germline mutation(s) (loss of function) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,370968,Congenital muscular dystrophy with intellectual disability,HGNC:6511,LARGE1,Disease-causing germline mutation(s) in,Assessed
79225,GARD:0007672,Sphingolipidosis,216972,"Niemann-Pick disease type C, severe perinatal form",HGNC:14537,NPC2,Disease-causing germline mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,464443,COG6-CGD,HGNC:18621,COG6,Disease-causing germline mutation(s) in,Assessed
261,GARD:0006329,Emery-Dreifuss muscular dystrophy,98853,Autosomal dominant Emery-Dreifuss muscular dystrophy,HGNC:28472,TMEM43,Disease-causing germline mutation(s) in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,402014,Acute myeloid leukemia with t(6;9)(p23;q34),HGNC:8064,NUP214,Part of a fusion gene in,Assessed
79213,GARD:0007065,Mucopolysaccharidosis,276223,"Mucopolysaccharidosis type 6, slowly progressing",HGNC:714,ARSB,Disease-causing germline mutation(s) in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293910,"Familial isolated arrhythmogenic ventricular dysplasia, right dominant form",HGNC:6636,LMNA,Disease-causing germline mutation(s) in,Not yet assessed
2875,GARD:0004312,Phacomatosis pigmentovascularis,79483,Phakomatosis cesioflammea,HGNC:4379,GNA11,Disease-causing somatic mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,457185,Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome,HGNC:19693,COQ4,Disease-causing germline mutation(s) (loss of function) in,Assessed
308166,GARD:0010923,Erythrokeratodermia variabilis et progressiva,317,Erythrokeratodermia variabilis,HGNC:4021,KDSR,Disease-causing germline mutation(s) (loss of function) in,Assessed
98722,GARD:0000802,Atrioventricular septal defect,99067,Complete atrioventricular septal defect with ventricular hypoplasia,HGNC:14630,CRELD1,Major susceptibility factor in,Assessed
97242,GARD:0009138,Congenital muscular dystrophy,370980,Congenital muscular dystrophy without intellectual disability,HGNC:9202,POMT1,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268752,Thoracolumbosacral spina bifida cystica,HGNC:7436,MTHFR,Major susceptibility factor in,Assessed
93969,GARD:0003475,Myelomeningocele,268748,Total spina bifida cystica,HGNC:7436,MTHFR,Major susceptibility factor in,Assessed
226298,GARD:0012280,Central congenital hypothyroidism,226307,Hypothyroidism due to deficient transcription factors involved in pituitary development or function,HGNC:9210,POU1F1,Disease-causing germline mutation(s) in,Assessed
1531,GARD:0006209,Craniosynostosis,93260,Pfeiffer syndrome type 3,HGNC:3689,FGFR2,Disease-causing germline mutation(s) (gain of function) in,Assessed
68356,GARD:0006895,Leukodystrophy,495844,C11ORF73-related autosomal recessive hypomyelinating leukodystrophy,HGNC:26938,HIKESHI,Disease-causing germline mutation(s) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,90120,Hereditary motor and sensory neuropathy type 6,HGNC:16877,MFN2,Disease-causing germline mutation(s) in,Assessed
646,GARD:0007207,Niemann-Pick disease type C1,216986,"Niemann-Pick disease type C, adult neurologic onset",HGNC:14537,NPC2,Disease-causing germline mutation(s) in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293899,"Familial isolated arrhythmogenic ventricular dysplasia, biventricular form",HGNC:3052,DSP,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:8632,PBX1,Part of a fusion gene in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,401820,Autosomal recessive spastic paraplegia type 67,HGNC:25712,PGAP1,Disease-causing germline mutation(s) in,Assessed
69078,GARD:0006913,Liposarcoma,99970,Dedifferentiated liposarcoma,HGNC:1773,CDK4,Role in the phenotype of,Assessed
85,GARD:0001999,Congenital dyserythropoietic anemia,363727,X-linked dyserythropoietic anemia with abnormal platelets and neutropenia,HGNC:4170,GATA1,Disease-causing germline mutation(s) in,Assessed
98249,GARD:0006322,Ehlers-Danlos syndromes,157965,SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome,HGNC:20859,SLC39A13,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:7685,NDUFA2,Disease-causing germline mutation(s) in,Assessed
251355,GARD:0012459,Sickle cell disease associated with an other hemoglobin anomaly,251375,Sickle cell-hemoglobin E disease syndrome,HGNC:4827,HBB,Disease-causing germline mutation(s) in,Assessed
450,GARD:0008591,X-linked visceral heterotaxy 1,157769,Situs ambiguus,HGNC:3122,LEFTY2,Major susceptibility factor in,Not yet assessed
63454,GARD:0009821,Pattern dystrophy,99002,Reticular dystrophy of the retinal pigment epithelium,HGNC:18243,RCBTB1,Disease-causing germline mutation(s) in,Assessed
442,GARD:0001487,Congenital hypothyroidism,95716,Familial thyroid dyshormonogenesis,HGNC:11040,SLC5A5,Disease-causing germline mutation(s) in,Assessed
26791,GARD:0006523,Glutaric acidemia type II,394529,"Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type",HGNC:3482,ETFB,Disease-causing germline mutation(s) in,Assessed
3394,GARD:0004898,Soft tissue sarcoma,252128,Malignant peripheral nerve sheath tumor with perineurial differentiation,HGNC:9476,HTRA1,Part of a fusion gene in,Assessed
282,GARD:0008436,Frontotemporal dementia,275864,Behavioral variant of frontotemporal dementia,HGNC:9508,PSEN1,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:11556,TAL1,Part of a fusion gene in,Assessed
97242,GARD:0009138,Congenital muscular dystrophy,370959,Congenital muscular dystrophy with cerebellar involvement,HGNC:22932,GMPPB,Disease-causing germline mutation(s) in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:7687,NDUFA4,Disease-causing germline mutation(s) (loss of function) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,171612,Autosomal dominant spastic paraplegia type 37,HGNC:6396,KPNA3,Disease-causing germline mutation(s) in,Assessed
370953,GARD:0012584,Congenital muscular dystrophy due to dystroglycanopathy ,370980,Congenital muscular dystrophy without intellectual disability,HGNC:17997,FKRP,Disease-causing germline mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,98853,Autosomal dominant Emery-Dreifuss muscular dystrophy,HGNC:6636,LMNA,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,464282,Spastic paraplegia-severe developmental delay-epilepsy syndrome,HGNC:21033,HACE1,Disease-causing germline mutation(s) (loss of function) in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:24316,TACO1,Disease-causing germline mutation(s) in,Assessed
209,GARD:0006227,Cutis laxa,35664,ALDH18A1-related De Barsy syndrome,HGNC:9722,ALDH18A1,Disease-causing germline mutation(s) in,Assessed
739,GARD:0005575,Prader-Willi syndrome,177907,Prader-Willi syndrome due to translocation,HGNC:11164,SNRPN,Role in the phenotype of,Assessed
450,GARD:0008591,X-linked visceral heterotaxy 1,157769,Situs ambiguus,HGNC:12874,ZIC3,Major susceptibility factor in,Not yet assessed
738,GARD:0010353,Porphyria,443057,Sporadic porphyria cutanea tarda,HGNC:4886,HFE,Major susceptibility factor in,Assessed
823,GARD:0007673,Spina bifida,268758,Lumbosacral spina bifida cystica,HGNC:15512,VANGL1,Major susceptibility factor in,Assessed
79225,GARD:0007672,Sphingolipidosis,352641,Autosomal recessive cerebellar ataxia with late-onset spasticity,HGNC:18986,GBA2,Disease-causing germline mutation(s) (loss of function) in,Assessed
823,GARD:0007673,Spina bifida,268766,Cervicothoracic spina bifida cystica,HGNC:11515,TBXT,Major susceptibility factor in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,370959,Congenital muscular dystrophy with cerebellar involvement,HGNC:9202,POMT1,Disease-causing germline mutation(s) in,Assessed
63454,GARD:0009821,Pattern dystrophy,99003,Multifocal pattern dystrophy simulating fundus flavimaculatus,HGNC:9942,PRPH2,Disease-causing germline mutation(s) in,Assessed
437,GARD:0006735,Hypophosphatemic rickets,93622,Dent disease type 1,HGNC:2023,CLCN5,Disease-causing germline mutation(s) (loss of function) in,Assessed
79225,GARD:0007672,Sphingolipidosis,216978,"Niemann-Pick disease type C, late infantile neurologic onset",HGNC:14537,NPC2,Disease-causing germline mutation(s) in,Assessed
2913,GARD:0004410,Polydactyly,93335,Postaxial polydactyly type B,HGNC:4319,GLI3,Disease-causing germline mutation(s) in,Assessed
69078,GARD:0006913,Liposarcoma,99970,Dedifferentiated liposarcoma,HGNC:5009,HMGA2,Role in the phenotype of,Assessed
2542,GARD:0012085,Microphthalmia,35612,Nanophthalmos,HGNC:409,ALDH1A3,Disease-causing germline mutation(s) in,Assessed
590,GARD:0011902,Congenital myasthenic syndromes,353327,Congenital myasthenic syndromes with glycosylation defect,HGNC:22932,GMPPB,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:7687,NDUFA4,Disease-causing germline mutation(s) (loss of function) in,Assessed
91378,GARD:0005979,Hereditary angioedema,537072,PLG-related hereditary angioedema with normal C1Inh,HGNC:9071,PLG,Disease-causing germline mutation(s) in,Assessed
511,GARD:0003228,Maple syrup urine disease,268162,Intermediate maple syrup urine disease,HGNC:987,BCKDHB,Disease-causing germline mutation(s) (loss of function) in,Assessed
183660,GARD:0007628,Severe combined immunodeficiency,397787,Severe combined immunodeficiency due to IKK2 deficiency,HGNC:5960,IKBKB,Disease-causing germline mutation(s) (loss of function) in,Assessed
282,GARD:0008436,Frontotemporal dementia,275864,Behavioral variant of frontotemporal dementia,HGNC:17761,TREM2,Major susceptibility factor in,Assessed
61,GARD:0006968,Alpha-mannosidosis,309282,"Alpha-mannosidosis, infantile form",HGNC:6826,MAN2B1,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93924,Lobar holoprosencephaly,HGNC:10889,SIX3,Disease-causing germline mutation(s) in,Assessed
289899,GARD:0009433,Organic acidemias,505208,3-methylglutaconic aciduria type 8,HGNC:14348,HTRA2,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,440706,Ribose-5-P isomerase deficiency,HGNC:10297,RPIA,Disease-causing germline mutation(s) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,466775,Autosomal recessive Charcot-Marie-Tooth disease type 2X,HGNC:11226,SPG11,Disease-causing germline mutation(s) in,Assessed
352,GARD:0002424,Galactosemia,308473,Erythrocyte galactose epimerase deficiency,HGNC:4116,GALE,Disease-causing germline mutation(s) in,Assessed
309144,GARD:0012510,Gangliosidosis,309155,"Sandhoff disease, infantile form",HGNC:4879,HEXB,Disease-causing germline mutation(s) (loss of function) in,Assessed
53739,GARD:0012683,Distal hereditary motor neuropathy,139589,Distal hereditary motor neuropathy type 7,HGNC:14025,SLC5A7,Disease-causing germline mutation(s) in,Assessed
304,GARD:0010752,Epidermolysis bullosa simplex,158684,Epidermolysis bullosa simplex with pyloric atresia,HGNC:9069,PLEC,Disease-causing germline mutation(s) in,Assessed
3394,GARD:0004898,Soft tissue sarcoma,99971,Well-differentiated liposarcoma,HGNC:1773,CDK4,Role in the phenotype of,Assessed
93969,GARD:0003475,Myelomeningocele,268766,Cervicothoracic spina bifida cystica,HGNC:15512,VANGL1,Major susceptibility factor in,Assessed
98473,GARD:0007922,Muscular dystrophy,352479,ISPD-related  limb-girdle muscular dystrophy R20,HGNC:37276,CRPPA,Disease-causing germline mutation(s) (loss of function) in,Assessed
167714,GARD:0012760,Unclassified acute myeloid leukemia ,329469,Acute megakaryoblastic leukemia without Down syndrome,HGNC:1537,CBFA2T3,Part of a fusion gene in,Assessed
2913,GARD:0004410,Polydactyly,93334,Postaxial polydactyly type A,HGNC:4319,GLI3,Disease-causing germline mutation(s) in,Assessed
99732,GARD:0003705,Molybdenum cofactor deficiency,308400,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C,HGNC:15465,GPHN,Disease-causing germline mutation(s) in,Assessed
79225,GARD:0007672,Sphingolipidosis,216986,"Niemann-Pick disease type C, adult neurologic onset",HGNC:7897,NPC1,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,99854,Cree leukoencephalopathy,HGNC:3260,EIF2B4,Disease-causing germline mutation(s) in,Assessed
683,GARD:0007471,Progressive supranuclear palsy,240103,Progressive supranuclear palsy-corticobasal syndrome,HGNC:6893,MAPT,Major susceptibility factor in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293899,"Familial isolated arrhythmogenic ventricular dysplasia, biventricular form",HGNC:10484,RYR2,Disease-causing germline mutation(s) in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293888,"Familial isolated arrhythmogenic ventricular dysplasia, left dominant form",HGNC:3052,DSP,Disease-causing germline mutation(s) in,Assessed
436,GARD:0006734,Hypophosphatasia,247623,Perinatal lethal hypophosphatasia,HGNC:438,ALPL,Disease-causing germline mutation(s) (loss of function) in,Assessed
589,GARD:0007122,Myasthenia gravis,391490,Adult-onset myasthenia gravis,HGNC:2505,CTLA4,Major susceptibility factor in,Assessed
580,GARD:0006675,Mucopolysaccharidosis type II,217085,"Mucopolysaccharidosis type 2, severe form",HGNC:5389,IDS,Disease-causing germline mutation(s) in,Assessed
52688,GARD:0007132,Myelodysplastic syndromes,508542,Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome,HGNC:29401,MYSM1,Disease-causing germline mutation(s) in,Assessed
90794,GARD:0012665,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,315306,"Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form",HGNC:2600,CYP21A2,Disease-causing germline mutation(s) in,Assessed
83,GARD:0005826,Antley Bixler syndrome,596008,Antley-Bixler syndrome without genital anomaly or disorder of steroidogenesis,HGNC:3689,FGFR2,Disease-causing germline mutation(s) in,Assessed
2781,GARD:0004155,Osteopetrosis,99844,Leukocyte adhesion deficiency type III,HGNC:23151,FERMT3,Disease-causing germline mutation(s) (loss of function) in,Assessed
1037,GARD:0000777,Arthrogryposis multiplex congenita,498693,MYBPC1-related autosomal recessive non-lethal arthrogryposis multiplex congenita syndrome,HGNC:7549,MYBPC1,Disease-causing germline mutation(s) in,Assessed
64746,GARD:0012431,Charcot-Marie-Tooth disease type 2,488333,Autosomal dominant Charcot-Marie-Tooth disease type 2W,HGNC:4816,HARS1,Disease-causing germline mutation(s) (loss of function) in,Assessed
823,GARD:0007673,Spina bifida,268377,Total spina bifida aperta,HGNC:15512,VANGL1,Major susceptibility factor in,Assessed
3148,GARD:0010872,Malignant peripheral nerve sheath tumor,252212,Malignant triton tumor,HGNC:9476,HTRA1,Part of a fusion gene in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,352479,ISPD-related  limb-girdle muscular dystrophy R20,HGNC:37276,CRPPA,Disease-causing germline mutation(s) (loss of function) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,139578,Mutilating hereditary sensory neuropathy with spastic paraplegia,HGNC:1618,CCT5,Disease-causing germline mutation(s) in,Assessed
2134,GARD:0008702,Atypical hemolytic uremic syndrome,544472,Atypical hemolytic uremic syndrome with complement gene abnormality,HGNC:4883,CFH,Disease-causing germline mutation(s) in,Assessed
3148,GARD:0008211,Neurofibrosarcoma,252128,Malignant peripheral nerve sheath tumor with perineurial differentiation,HGNC:9476,HTRA1,Part of a fusion gene in,Assessed
98277,GARD:0012758,Acute myeloid leukemia with recurrent genetic anomaly,102724,Acute myeloid leukemia with t(8;21)(q22;q22) translocation,HGNC:1535,RUNX1T1,Part of a fusion gene in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:8619,PAX5,Major susceptibility factor in,Assessed
68356,GARD:0006895,Leukodystrophy,51,Aicardi-Goutières syndrome,HGNC:18873,IFIH1,Disease-causing germline mutation(s) (gain of function) in,Assessed
512,GARD:0003230,Metachromatic leukodystrophy,309271,"Metachromatic leukodystrophy, adult form",HGNC:9498,PSAP,Disease-causing germline mutation(s) in,Assessed
309144,GARD:0012510,Gangliosidosis,309239,"Tay-Sachs disease, B1 variant",HGNC:4878,HEXA,Disease-causing germline mutation(s) in,Assessed
293642,GARD:0010892,Blepharophimosis intellectual disability syndromes,293707,"Blepharophimosis-intellectual disability syndrome, MKB type",HGNC:11957,MED12,Disease-causing germline mutation(s) in,Assessed
183660,GARD:0007628,Severe combined immunodeficiency,169154,T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency,HGNC:6024,IL7R,Disease-causing germline mutation(s) in,Assessed
35656,GARD:0010423,Coenzyme Q10 deficiency,254898,Deafness-encephaloneuropathy-obesity-valvulopathy syndrome,HGNC:17759,PDSS1,Disease-causing germline mutation(s) in,Assessed
220460,GARD:0008532,Attenuated familial adenomatous polyposis,447877,Polymerase proofreading-related adenomatous polyposis,HGNC:9175,POLD1,Disease-causing germline mutation(s) in,Assessed
1037,GARD:0000777,Arthrogryposis multiplex congenita,610569,KIAA1109-related early lethal congenital brain malformations-arthrogryposis syndrome,HGNC:26953,KIAA1109,Disease-causing germline mutation(s) (loss of function) in,Assessed
68356,GARD:0006895,Leukodystrophy,309263,"Metachromatic leukodystrophy, juvenile form",HGNC:9498,PSAP,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:5962,IL10,Major susceptibility factor in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:12930,ZBTB16,Part of a fusion gene in,Assessed
156005,GARD:0002490,Glaucoma 3 primary infantile B,98976,Congenital glaucoma,HGNC:11724,TEK,Disease-causing germline mutation(s) (loss of function) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:7553,MYC,Part of a fusion gene in,Assessed
68356,GARD:0006895,Leukodystrophy,137639,Hypomyelinating leukodystrophy-ataxia-hypodontia-hypomyelination syndrome,HGNC:30074,POLR3A,Disease-causing germline mutation(s) in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:11474,SURF1,Disease-causing germline mutation(s) (loss of function) in,Assessed
1531,GARD:0006209,Craniosynostosis,35098,Isolated plagiocephaly,HGNC:11623,TCF12,Disease-causing germline mutation(s) (loss of function) in,Assessed
2162,GARD:0006665,Holoprosencephaly,220386,Semilobar holoprosencephaly,HGNC:11355,STAG2,Disease-causing germline mutation(s) (loss of function) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,589522,Spinocerebellar ataxia type 46,HGNC:17158,PLD3,Disease-causing germline mutation(s) in,Assessed
2542,GARD:0012085,Microphthalmia,35612,Nanophthalmos,HGNC:18121,MFRP,Disease-causing germline mutation(s) in,Assessed
646,GARD:0007207,Niemann-Pick disease type C1,216972,"Niemann-Pick disease type C, severe perinatal form",HGNC:14537,NPC2,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,220386,Semilobar holoprosencephaly,HGNC:7865,NODAL,Disease-causing germline mutation(s) in,Assessed
1531,GARD:0006209,Craniosynostosis,596008,Antley-Bixler syndrome without genital anomaly or disorder of steroidogenesis,HGNC:3689,FGFR2,Disease-causing germline mutation(s) in,Assessed
799,GARD:0000166,Schizencephaly,485275,Acquired schizencephaly,HGNC:10889,SIX3,Major susceptibility factor in,Assessed
98292,GARD:0006987,Mastocytosis,566393,Acute mast cell leukemia,HGNC:6342,KIT,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93925,Alobar holoprosencephaly,HGNC:10879,STIL,Disease-causing germline mutation(s) in,Assessed
98757,GARD:0006801,Spinocerebellar ataxia 3,276241,Machado-Joseph disease type 2,HGNC:7106,ATXN3,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:11633,TCF3,Part of a fusion gene in,Assessed
2162,GARD:0006665,Holoprosencephaly,280195,Septopreoptic holoprosencephaly,HGNC:10889,SIX3,Disease-causing germline mutation(s) in,Assessed
79213,GARD:0007065,Mucopolysaccharidosis,217093,"Mucopolysaccharidosis type 2, attenuated form",HGNC:5389,IDS,Disease-causing germline mutation(s) in,Assessed
748,GARD:0012977,Mendelian susceptibility to mycobacterial diseases,319569,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency,HGNC:5439,IFNGR1,Disease-causing germline mutation(s) in,Assessed
2467,GARD:0008616,Systemic mastocytosis,158775,Smoldering systemic mastocytosis,HGNC:6342,KIT,Disease-causing somatic mutation(s) in,Assessed
98292,GARD:0006987,Mastocytosis,98849,Systemic mastocytosis with associated hematologic neoplasm,HGNC:6342,KIT,Disease-causing somatic mutation(s) in,Assessed
183660,GARD:0007628,Severe combined immunodeficiency,169160,T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta,HGNC:1674,CD3E,Disease-causing germline mutation(s) in,Assessed
97245,GARD:0005898,Myopathy congenital,178145,Moderate multiminicore disease with hand involvement,HGNC:10483,RYR1,Disease-causing germline mutation(s) in,Assessed
1330,GARD:0004229,Partial atrioventricular canal,576235,Partial atrioventricular septal defect without ventricular hypoplasia,HGNC:14630,CRELD1,Disease-causing germline mutation(s) (loss of function) in,Assessed
418,GARD:0001467,Congenital adrenal hyperplasia,315306,"Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form",HGNC:2600,CYP21A2,Disease-causing germline mutation(s) in,Assessed
2671,GARD:0000102,Neu Laxova syndrome,583602,Neu-laxova syndrome due to phosphoserine aminotransferase deficiency,HGNC:19129,PSAT1,Disease-causing germline mutation(s) in,Assessed
1037,GARD:0000777,Arthrogryposis multiplex congenita,2680,Hypomyelination neuropathy-arthrogryposis syndrome,HGNC:8011,CNTNAP1,Disease-causing germline mutation(s) in,Assessed
64746,GARD:0012431,Charcot-Marie-Tooth disease type 2,324611,Autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation,HGNC:6323,KIF5A,Disease-causing germline mutation(s) in,Assessed
156207,GARD:0003342,Macroglossia,231127,Beckwith-Wiedemann syndrome due to 11p15 microdeletion,HGNC:4713,H19,Role in the phenotype of,Assessed
68356,GARD:0006895,Leukodystrophy,466934,VPS11-related autosomal recessive hypomyelinating leukodystrophy,HGNC:14583,VPS11,Disease-causing germline mutation(s) (loss of function) in,Assessed
97242,GARD:0009138,Congenital muscular dystrophy,370959,Congenital muscular dystrophy with cerebellar involvement,HGNC:19139,POMGNT1,Disease-causing germline mutation(s) in,Assessed
251355,GARD:0012459,Sickle cell disease associated with an other hemoglobin anomaly,251380,Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome,HGNC:4827,HBB,Disease-causing germline mutation(s) in,Assessed
79225,GARD:0007672,Sphingolipidosis,216975,"Niemann-Pick disease type C, severe early infantile neurologic onset",HGNC:7897,NPC1,Disease-causing germline mutation(s) in,Assessed
182058,GARD:0012959,Primary orthostatic hypotension,2828,Young-onset Parkinson disease,HGNC:8607,PRKN,Disease-causing germline mutation(s) in,Assessed
444116,GARD:0006611,Hereditary amyloidosis,314652,Variant ABeta2M amyloidosis,HGNC:914,B2M,Disease-causing germline mutation(s) in,Assessed
411709,GARD:0009228,Renal agenesis,1848,"Renal agenesis, bilateral",HGNC:3677,FGF20,Disease-causing germline mutation(s) (loss of function) in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",251510,"46,XY partial gonadal dysgenesis",HGNC:17210,DHX37,Disease-causing germline mutation(s) in,Assessed
309144,GARD:0012510,Gangliosidosis,309178,"Tay-Sachs disease, B variant, infantile form",HGNC:4878,HEXA,Disease-causing germline mutation(s) in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,319465,Inherited acute myeloid leukemia,HGNC:26922,ERCC6L2,Disease-causing germline mutation(s) in,Assessed
370953,GARD:0012584,Congenital muscular dystrophy due to dystroglycanopathy ,370980,Congenital muscular dystrophy without intellectual disability,HGNC:9202,POMT1,Disease-causing germline mutation(s) in,Assessed
739,GARD:0005575,Prader-Willi syndrome,98754,Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15,HGNC:11164,SNRPN,Role in the phenotype of,Assessed
268994,GARD:0010190,Focal cortical dysplasia of Taylor,269008,Isolated focal cortical dysplasia type IIb,HGNC:12362,TSC1,Disease-causing somatic mutation(s) in,Assessed
98292,GARD:0006987,Mastocytosis,158769,Plaque-form urticaria pigmentosa,HGNC:6342,KIT,Disease-causing germline mutation(s) in,Assessed
3394,GARD:0004898,Soft tissue sarcoma,252212,Malignant triton tumor,HGNC:9476,HTRA1,Part of a fusion gene in,Assessed
91024,GARD:0012449,Autosomal recessive axonal Charcot-Marie-Tooth disease type 2,466775,Autosomal recessive Charcot-Marie-Tooth disease type 2X,HGNC:11226,SPG11,Disease-causing germline mutation(s) in,Assessed
182067,GARD:0006513,Glioma,251579,Giant cell glioblastoma,HGNC:3690,FGFR3,Part of a fusion gene in,Assessed
828,GARD:0010782,Stickler syndrome,250984,Autosomal recessive Stickler syndrome,HGNC:2218,COL9A2,Disease-causing germline mutation(s) (loss of function) in,Assessed
93548,GARD:0012736,Glomerular disease,255249,Leigh syndrome with nephrotic syndrome,HGNC:25223,COQ2,Disease-causing germline mutation(s) in,Assessed
98878,GARD:0006591,Hemophilia A,169808,Mild hemophilia A,HGNC:3546,F8,Disease-causing germline mutation(s) in,Assessed
97245,GARD:0005898,Myopathy congenital,324581,Benign Samaritan congenital myopathy,HGNC:10483,RYR1,Disease-causing germline mutation(s) in,Assessed
93969,GARD:0003475,Myelomeningocele,268770,Upper thoracic spina bifida cystica,HGNC:11515,TBXT,Major susceptibility factor in,Assessed
407,GARD:0007219,Glycine encephalopathy,289860,Infantile glycine encephalopathy,HGNC:11056,SLC6A9,Disease-causing germline mutation(s) in,Assessed
2962,GARD:0000049,De Barsy syndrome,35664,ALDH18A1-related De Barsy syndrome,HGNC:9722,ALDH18A1,Disease-causing germline mutation(s) in,Assessed
98261,GARD:0007140,Progressive myoclonic epilepsy,314629,CLN11 disease,HGNC:4601,GRN,Disease-causing germline mutation(s) in,Assessed
1531,GARD:0006209,Craniosynostosis,284149,Craniosynostosis-dental anomalies,HGNC:5967,IL11RA,Disease-causing germline mutation(s) (loss of function) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,309239,"Tay-Sachs disease, B1 variant",HGNC:4878,HEXA,Disease-causing germline mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,370968,Congenital muscular dystrophy with intellectual disability,HGNC:22932,GMPPB,Disease-causing germline mutation(s) in,Assessed
98261,GARD:0007140,Progressive myoclonic epilepsy,435438,Progressive myoclonic epilepsy type 7,HGNC:6233,KCNC1,Disease-causing germline mutation(s) (loss of function) in,Assessed
442,GARD:0001487,Congenital hypothyroidism,95713,Athyreosis,HGNC:8818,SLC26A4,Disease-causing germline mutation(s) (loss of function) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93926,Midline interhemispheric variant of holoprosencephaly,HGNC:10879,STIL,Disease-causing germline mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,370933,GM3 synthase deficiency,HGNC:10872,ST3GAL5,Disease-causing germline mutation(s) (loss of function) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:1014,BCR,Part of a fusion gene in,Assessed
206647,GARD:0010419,Myotonic dystrophy,589821,Congenital-onset Steinert myotonic dystrophy,HGNC:2933,DMPK,Disease-causing germline mutation(s) in,Assessed
137807,GARD:0000132,Primary cutaneous amyloidosis,353220,Familial primary localized cutaneous amyloidosis,HGNC:18969,IL31RA,Disease-causing germline mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,370959,Congenital muscular dystrophy with cerebellar involvement,HGNC:22932,GMPPB,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268384,Thoracolumbosacral spina bifida aperta,HGNC:15512,VANGL1,Major susceptibility factor in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:12027,TRA,Part of a fusion gene in,Assessed
93293,GARD:0009182,Duane-radial ray syndrome,261638,Okihiro syndrome due to 20q13 microdeletion,HGNC:15924,SALL4,Role in the phenotype of,Assessed
418,GARD:0001467,Congenital adrenal hyperplasia,315311,"Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form",HGNC:2600,CYP21A2,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,280195,Septopreoptic holoprosencephaly,HGNC:3814,FOXH1,Disease-causing germline mutation(s) in,Assessed
657,GARD:0003947,Congenital hyperinsulinism,276556,Hyperinsulinism due to UCP2 deficiency,HGNC:12518,UCP2,Disease-causing germline mutation(s) (loss of function) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:8806,PDHA1,Disease-causing germline mutation(s) in,Assessed
765,GARD:0007513,Pyruvate dehydrogenase complex deficiency,79244,Pyruvate dehydrogenase E2 deficiency,HGNC:2896,DLAT,Disease-causing germline mutation(s) (loss of function) in,Assessed
238468,GARD:0000076,Hypohidrotic ectodermal dysplasia,1810,Autosomal dominant hypohidrotic ectodermal dysplasia,HGNC:14341,EDARADD,Disease-causing germline mutation(s) in,Assessed
309144,GARD:0012510,Gangliosidosis,309192,"Tay-Sachs disease, B variant, adult form",HGNC:4878,HEXA,Disease-causing germline mutation(s) in,Assessed
64746,GARD:0012431,Charcot-Marie-Tooth disease type 2,487814,Autosomal dominant Charcot-Marie-Tooth disease type 2 due to DGAT2 mutation,HGNC:16940,DGAT2,Disease-causing germline mutation(s) in,Assessed
2152,GARD:0009673,Mowat-Wilson syndrome,261537,Mowat-Wilson syndrome due to monosomy 2q22,HGNC:14881,ZEB2,Role in the phenotype of,Assessed
823,GARD:0007673,Spina bifida,268397,Cervicothoracic spina bifida aperta,HGNC:15512,VANGL1,Major susceptibility factor in,Assessed
646,GARD:0007207,Niemann-Pick disease type C1,216981,"Niemann-Pick disease type C, juvenile neurologic onset",HGNC:7897,NPC1,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:76,ABL1,Part of a fusion gene in,Assessed
436,GARD:0006734,Hypophosphatasia,247651,Infantile hypophosphatasia,HGNC:438,ALPL,Disease-causing germline mutation(s) (loss of function) in,Assessed
93969,GARD:0003475,Myelomeningocele,268770,Upper thoracic spina bifida cystica,HGNC:7436,MTHFR,Major susceptibility factor in,Assessed
251355,GARD:0012459,Sickle cell disease associated with an other hemoglobin anomaly,251380,Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome,HGNC:6345,KLF1,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,329903,Immunoglobulin-mediated membranoproliferative glomerulonephritis,HGNC:2852,DGKE,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,280282,Pelizaeus-Merzbacher-like disease due to GJC2 mutation,HGNC:17494,GJC2,Disease-causing germline mutation(s) in,Assessed
370953,GARD:0012584,Congenital muscular dystrophy due to dystroglycanopathy ,370968,Congenital muscular dystrophy with intellectual disability,HGNC:6511,LARGE1,Disease-causing germline mutation(s) in,Assessed
370953,GARD:0012584,Congenital muscular dystrophy due to dystroglycanopathy ,370959,Congenital muscular dystrophy with cerebellar involvement,HGNC:19139,POMGNT1,Disease-causing germline mutation(s) in,Assessed
1531,GARD:0006209,Craniosynostosis,93262,Crouzon syndrome-acanthosis nigricans syndrome,HGNC:3690,FGFR3,Disease-causing germline mutation(s) in,Assessed
796,GARD:0007604,Sandhoff disease,309155,"Sandhoff disease, infantile form",HGNC:4879,HEXB,Disease-causing germline mutation(s) (loss of function) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,357074,"Autosomal recessive cutis laxa type 2, classic type",HGNC:18481,ATP6V0A2,Disease-causing germline mutation(s) (loss of function) in,Assessed
593,GARD:0010529,Myofibrillar myopathy,280553,Fatal infantile hypertonic myofibrillar myopathy,HGNC:2389,CRYAB,Disease-causing germline mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,370959,Congenital muscular dystrophy with cerebellar involvement,HGNC:17997,FKRP,Disease-causing germline mutation(s) in,Assessed
612,GARD:0004459,Potassium aggravated myotonia,99736,Acetazolamide-responsive myotonia,HGNC:10591,SCN4A,Disease-causing germline mutation(s) in,Assessed
182058,GARD:0012959,Primary orthostatic hypotension,411602,Hereditary late-onset Parkinson disease,HGNC:18618,LRRK2,Disease-causing germline mutation(s) (gain of function) in,Assessed
1293,GARD:0010903,Brachyolmia,448242,Autosomal recessive brachyolmia,HGNC:8604,PAPSS2,Disease-causing germline mutation(s) (loss of function) in,Assessed
36388,GARD:0007326,Paraneoplastic cerebellar degeneration,163908,Limbic encephalitis with LGI1 antibodies,HGNC:4944,HLA-DQB1,Major susceptibility factor in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:7708,NDUFS2,Disease-causing germline mutation(s) in,Assessed
370953,GARD:0012584,Congenital muscular dystrophy due to dystroglycanopathy ,370959,Congenital muscular dystrophy with cerebellar involvement,HGNC:22932,GMPPB,Disease-causing germline mutation(s) in,Assessed
655,GARD:0000206,Nephronophthisis,93591,Infantile nephronophthisis,HGNC:26724,ANKS6,Disease-causing germline mutation(s) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,466768,Autosomal dominant Charcot-Marie-Tooth disease type 2Z,HGNC:23573,MORC2,Disease-causing germline mutation(s) in,Assessed
182067,GARD:0006513,Glioma,251615,Pilomyxoid astrocytoma,HGNC:9829,RAF1,Part of a fusion gene in,Assessed
216675,GARD:0007795,Transposition of the great arteries,216718,Isolated congenitally uncorrected transposition of the great arteries,HGNC:22962,MED13L,Major susceptibility factor in,Not yet assessed
79430,GARD:0006643,Hermansky-Pudlak syndrome,231531,Hermansky-Pudlak syndrome due to BLOC-1 deficiency,HGNC:8549,BLOC1S6,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93924,Lobar holoprosencephaly,HGNC:7865,NODAL,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,309271,"Metachromatic leukodystrophy, adult form",HGNC:9498,PSAP,Disease-causing germline mutation(s) in,Assessed
79225,GARD:0007672,Sphingolipidosis,309239,"Tay-Sachs disease, B1 variant",HGNC:4878,HEXA,Disease-causing germline mutation(s) in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293899,"Familial isolated arrhythmogenic ventricular dysplasia, biventricular form",HGNC:28472,TMEM43,Disease-causing germline mutation(s) (loss of function) in,Assessed
289899,GARD:0009433,Organic acidemias,88639,Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency,HGNC:4908,HIBCH,Disease-causing germline mutation(s) in,Assessed
88661,GARD:0005791,Amelogenesis imperfecta,100032,Hypocalcified amelogenesis imperfecta,HGNC:10978,SLC24A4,Disease-causing germline mutation(s) in,Assessed
98292,GARD:0006987,Mastocytosis,158766,Typical urticaria pigmentosa,HGNC:6342,KIT,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268770,Upper thoracic spina bifida cystica,HGNC:15512,VANGL1,Major susceptibility factor in,Assessed
182067,GARD:0006513,Glioma,251615,Pilomyxoid astrocytoma,HGNC:19744,SRGAP3,Part of a fusion gene in,Assessed
407,GARD:0007219,Glycine encephalopathy,289863,Atypical glycine encephalopathy,HGNC:11056,SLC6A9,Disease-causing germline mutation(s) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,157716,Late infantile CACH syndrome,HGNC:3260,EIF2B4,Disease-causing germline mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,370980,Congenital muscular dystrophy without intellectual disability,HGNC:17997,FKRP,Disease-causing germline mutation(s) in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,102724,Acute myeloid leukemia with t(8;21)(q22;q22) translocation,HGNC:1535,RUNX1T1,Part of a fusion gene in,Assessed
411709,GARD:0009228,Renal agenesis,93100,"Renal agenesis, unilateral",HGNC:29043,DSTYK,Disease-causing germline mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,98853,Autosomal dominant Emery-Dreifuss muscular dystrophy,HGNC:17089,SYNE1,Disease-causing germline mutation(s) in,Not yet assessed
437,GARD:0006735,Hypophosphatemic rickets,157215,Hereditary hypophosphatemic rickets with hypercalciuria,HGNC:11019,SLC34A1,Disease-causing germline mutation(s) in,Assessed
182058,GARD:0012959,Primary orthostatic hypotension,2828,Young-onset Parkinson disease,HGNC:23594,VPS13C,Disease-causing germline mutation(s) (loss of function) in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293899,"Familial isolated arrhythmogenic ventricular dysplasia, biventricular form",HGNC:6636,LMNA,Disease-causing germline mutation(s) in,Not yet assessed
79167,GARD:0007837,Urea cycle disorders,247573,Adult-onset citrullinemia type I,HGNC:758,ASS1,Disease-causing germline mutation(s) (loss of function) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,459056,Autosomal recessive spastic paraplegia type 75,HGNC:6783,MAG,Disease-causing germline mutation(s) (loss of function) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,370980,Congenital muscular dystrophy without intellectual disability,HGNC:9202,POMT1,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:10526,SALL2,Part of a fusion gene in,Assessed
823,GARD:0007673,Spina bifida,268762,Cervical spina bifida cystica,HGNC:11515,TBXT,Major susceptibility factor in,Assessed
226298,GARD:0012280,Central congenital hypothyroidism,226307,Hypothyroidism due to deficient transcription factors involved in pituitary development or function,HGNC:4877,HESX1,Disease-causing germline mutation(s) in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:3151,ECHS1,Disease-causing germline mutation(s) in,Assessed
98293,GARD:0002714,Hodgkin lymphoma,98843,"Classic Hodgkin lymphoma, nodular sclerosis type",HGNC:28557,KLHDC8B,Candidate gene tested in,Not yet assessed
2929,GARD:0003065,Juvenile polyposis syndrome,329971,Generalized juvenile polyposis/juvenile polyposis coli,HGNC:1076,BMPR1A,Disease-causing germline mutation(s) in,Assessed
88632,GARD:0010025,Anterior segment dysgenesis,261619,Alagille syndrome due to a JAG1 point mutation,HGNC:6188,JAG1,Disease-causing germline mutation(s) in,Assessed
442,GARD:0001487,Congenital hypothyroidism,95713,Athyreosis,HGNC:8622,PAX8,Disease-causing germline mutation(s) (loss of function) in,Assessed
217,GARD:0006242,Dandy-Walker complex,269215,Isolated Dandy-Walker malformation without hydrocephalus,HGNC:20393,ZIC4,Role in the phenotype of,Assessed
72,GARD:0005810,Angelman syndrome,411515,Angelman syndrome due to imprinting defect in 15q11-q13,HGNC:13542,ATP10A,Role in the phenotype of,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,139512,Neuropathy with hearing impairment,HGNC:4285,GJB3,Disease-causing germline mutation(s) in,Assessed
646,GARD:0007207,Niemann-Pick disease type C1,216986,"Niemann-Pick disease type C, adult neurologic onset",HGNC:7897,NPC1,Disease-causing germline mutation(s) in,Assessed
3394,GARD:0004898,Soft tissue sarcoma,466962,SMARCA4-deficient sarcoma of thorax,HGNC:11100,SMARCA4,Disease-causing somatic mutation(s) in,Assessed
263543,GARD:0012862,Generalized peeling skin syndrome,263548,Peeling skin syndrome type A,HGNC:15993,CHST8,Disease-causing germline mutation(s) (loss of function) in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,86849,Acute basophilic leukemia,HGNC:4170,GATA1,Part of a fusion gene in,Assessed
178382,GARD:0005488,Congenital vertical talus,295201,"Congenital vertical talus, unilateral",HGNC:5133,HOXD10,Disease-causing germline mutation(s) in,Assessed
251595,GARD:0005907,Diffuse astrocytoma,251604,Gemistocytic astrocytoma,HGNC:5383,IDH2,Biomarker tested in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,320411,Autosomal recessive spastic paraplegia type 56,HGNC:20582,CYP2U1,Disease-causing germline mutation(s) in,Assessed
593,GARD:0010529,Myofibrillar myopathy,98912,"Late-onset distal myopathy, Markesbery-Griggs type",HGNC:15710,LDB3,Disease-causing germline mutation(s) in,Assessed
370953,GARD:0012584,Congenital muscular dystrophy due to dystroglycanopathy ,370968,Congenital muscular dystrophy with intellectual disability,HGNC:9202,POMT1,Disease-causing germline mutation(s) in,Assessed
407,GARD:0007219,Glycine encephalopathy,289860,Infantile glycine encephalopathy,HGNC:4208,GCSH,Disease-causing germline mutation(s) in,Assessed
182058,GARD:0012959,Primary orthostatic hypotension,411602,Hereditary late-onset Parkinson disease,HGNC:11960,GIGYF2,Candidate gene tested in,Not yet assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:2336,CR2,Major susceptibility factor in,Assessed
2542,GARD:0012085,Microphthalmia,35612,Nanophthalmos,HGNC:12703,BEST1,Disease-causing germline mutation(s) in,Assessed
848,GARD:0000871,Beta-thalassemia,231222,Beta-thalassemia intermedia,HGNC:4827,HBB,Disease-causing germline mutation(s) in,Assessed
217071,GARD:0008417,Renal cell carcinoma 4,319308,MiT family translocation renal cell carcinoma,HGNC:7871,NONO,Part of a fusion gene in,Assessed
583,GARD:0007095,Mucopolysaccharidosis type VI,276212,"Mucopolysaccharidosis type 6, rapidly progressing",HGNC:714,ARSB,Disease-causing germline mutation(s) in,Assessed
370953,GARD:0012584,Congenital muscular dystrophy due to dystroglycanopathy ,370968,Congenital muscular dystrophy with intellectual disability,HGNC:17997,FKRP,Disease-causing germline mutation(s) in,Assessed
93969,GARD:0003475,Myelomeningocele,268748,Total spina bifida cystica,HGNC:11515,TBXT,Major susceptibility factor in,Assessed
182067,GARD:0006513,Glioma,251579,Giant cell glioblastoma,HGNC:9236,PPARG,Biomarker tested in,Assessed
91024,GARD:0012449,Autosomal recessive axonal Charcot-Marie-Tooth disease type 2,90120,Hereditary motor and sensory neuropathy type 6,HGNC:16877,MFN2,Disease-causing germline mutation(s) in,Assessed
646,GARD:0007207,Niemann-Pick disease type C1,216975,"Niemann-Pick disease type C, severe early infantile neurologic onset",HGNC:14537,NPC2,Disease-causing germline mutation(s) in,Assessed
79225,GARD:0007672,Sphingolipidosis,216986,"Niemann-Pick disease type C, adult neurologic onset",HGNC:14537,NPC2,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:8619,PAX5,Part of a fusion gene in,Assessed
655,GARD:0000206,Nephronophthisis,93592,Juvenile nephronophthisis,HGNC:18340,WDR19,Disease-causing germline mutation(s) in,Assessed
99927,GARD:0010263,Hydatidiform mole,254688,Complete hydatidiform mole,HGNC:28613,MEI1,Disease-causing germline mutation(s) in,Assessed
98249,GARD:0006322,Ehlers-Danlos syndromes,536532,Classical-like Ehlers-Danlos syndrome type 2,HGNC:303,AEBP1,Disease-causing germline mutation(s) (loss of function) in,Assessed
100092,GARD:0002437,Gastro-enteropancreatic neuroendocrine tumor,100075,Neuroendocrine tumor of stomach,HGNC:886,ATRX,Candidate gene tested in,Not yet assessed
213500,GARD:0007295,Ovarian cancer,213524,Hereditary site-specific ovarian cancer syndrome,HGNC:1100,BRCA1,Major susceptibility factor in,Assessed
79225,GARD:0007672,Sphingolipidosis,309263,"Metachromatic leukodystrophy, juvenile form",HGNC:9498,PSAP,Disease-causing germline mutation(s) in,Assessed
93969,GARD:0003475,Myelomeningocele,268758,Lumbosacral spina bifida cystica,HGNC:11515,TBXT,Major susceptibility factor in,Assessed
796,GARD:0007604,Sandhoff disease,309162,"Sandhoff disease, juvenile form",HGNC:4879,HEXB,Disease-causing germline mutation(s) (loss of function) in,Assessed
98473,GARD:0007922,Muscular dystrophy,98853,Autosomal dominant Emery-Dreifuss muscular dystrophy,HGNC:17084,SYNE2,Disease-causing germline mutation(s) in,Not yet assessed
182067,GARD:0006513,Glioma,251579,Giant cell glioblastoma,HGNC:11522,TACC1,Part of a fusion gene in,Assessed
182058,GARD:0012959,Primary orthostatic hypotension,2828,Young-onset Parkinson disease,HGNC:9171,PODXL,Disease-causing germline mutation(s) (loss of function) in,Assessed
79373,GARD:0006317,Ectodermal dysplasia,1810,Autosomal dominant hypohidrotic ectodermal dysplasia,HGNC:26624,KDF1,Disease-causing germline mutation(s) in,Assessed
79430,GARD:0006643,Hermansky-Pudlak syndrome,231531,Hermansky-Pudlak syndrome due to BLOC-1 deficiency,HGNC:20914,BLOC1S3,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,447753,Autosomal dominant spastic paraplegia type 9A,HGNC:9722,ALDH18A1,Disease-causing germline mutation(s) (loss of function) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,447760,Autosomal recessive spastic paraplegia type 9B,HGNC:9722,ALDH18A1,Disease-causing germline mutation(s) (loss of function) in,Assessed
655,GARD:0000206,Nephronophthisis,93592,Juvenile nephronophthisis,HGNC:19104,NPHP4,Disease-causing germline mutation(s) in,Assessed
612,GARD:0004459,Potassium aggravated myotonia,99734,Myotonia fluctuans,HGNC:10591,SCN4A,Disease-causing germline mutation(s) in,Assessed
264665,GARD:0010559,Children's interstitial lung disease,572428,Infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia,HGNC:8086,OAS1,Disease-causing germline mutation(s) in,Assessed
2913,GARD:0004410,Polydactyly,93334,Postaxial polydactyly type A,HGNC:30452,CIBAR1,Disease-causing germline mutation(s) in,Assessed
93969,GARD:0003475,Myelomeningocele,268748,Total spina bifida cystica,HGNC:15512,VANGL1,Major susceptibility factor in,Assessed
3148,GARD:0008211,Neurofibrosarcoma,252212,Malignant triton tumor,HGNC:9476,HTRA1,Part of a fusion gene in,Assessed
442,GARD:0001487,Congenital hypothyroidism,95713,Athyreosis,HGNC:11825,NKX2-1,Candidate gene tested in,Not yet assessed
85450,GARD:0008282,Amyloidosis familial visceral,93560,AApoAI amyloidosis,HGNC:600,APOA1,Disease-causing germline mutation(s) in,Assessed
739,GARD:0005575,Prader-Willi syndrome,177904,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2,HGNC:7675,NDN,Role in the phenotype of,Assessed
68356,GARD:0006895,Leukodystrophy,157713,Congenital or early infantile CACH syndrome,HGNC:3260,EIF2B4,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268388,Lumbosacral spina bifida aperta,HGNC:15512,VANGL1,Major susceptibility factor in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,102724,Acute myeloid leukemia with t(8;21)(q22;q22) translocation,HGNC:6342,KIT,Biomarker tested in,Assessed
289899,GARD:0009433,Organic acidemias,445038,3-methylglutaconic aciduria type 7,HGNC:30664,CLPB,Disease-causing germline mutation(s) (loss of function) in,Assessed
68356,GARD:0006895,Leukodystrophy,51,Aicardi-Goutières syndrome,HGNC:225,ADAR,Disease-causing germline mutation(s) in,Assessed
79225,GARD:0007672,Sphingolipidosis,309162,"Sandhoff disease, juvenile form",HGNC:4879,HEXB,Disease-causing germline mutation(s) (loss of function) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:10680,SDHA,Disease-causing germline mutation(s) in,Assessed
1531,GARD:0006209,Craniosynostosis,35098,Isolated plagiocephaly,HGNC:12872,ZIC1,Disease-causing germline mutation(s) (gain of function) in,Assessed
796,GARD:0007604,Sandhoff disease,309169,"Sandhoff disease, adult form",HGNC:4879,HEXB,Disease-causing germline mutation(s) (loss of function) in,Assessed
182067,GARD:0006513,Glioma,530792,RELA fusion-positive ependymoma,HGNC:9955,RELA,Part of a fusion gene in,Assessed
268994,GARD:0010190,Focal cortical dysplasia of Taylor,269008,Isolated focal cortical dysplasia type IIb,HGNC:3942,MTOR,Disease-causing somatic mutation(s) in,Assessed
280270,GARD:0012300,Pelizaeus-Merzbacher-like disease,280282,Pelizaeus-Merzbacher-like disease due to GJC2 mutation,HGNC:17494,GJC2,Disease-causing germline mutation(s) in,Assessed
98277,GARD:0012758,Acute myeloid leukemia with recurrent genetic anomaly,102724,Acute myeloid leukemia with t(8;21)(q22;q22) translocation,HGNC:6342,KIT,Biomarker tested in,Assessed
823,GARD:0007673,Spina bifida,268388,Lumbosacral spina bifida aperta,HGNC:7436,MTHFR,Major susceptibility factor in,Assessed
655,GARD:0000206,Nephronophthisis,93591,Infantile nephronophthisis,HGNC:25660,TTC21B,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,504476,Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome,HGNC:9969,RFC1,Disease-causing germline mutation(s) in,Assessed
444116,GARD:0006611,Hereditary amyloidosis,100008,ACys amyloidosis,HGNC:2475,CST3,Disease-causing germline mutation(s) in,Assessed
289899,GARD:0009433,Organic acidemias,369962,"Methylmalonic acidemia with homocystinuria, type cblX",HGNC:4839,HCFC1,Disease-causing germline mutation(s) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,487814,Autosomal dominant Charcot-Marie-Tooth disease type 2 due to DGAT2 mutation,HGNC:16940,DGAT2,Disease-causing germline mutation(s) in,Assessed
448,GARD:0010418,Hemophilia,169802,Severe hemophilia A,HGNC:3546,F8,Disease-causing germline mutation(s) in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293888,"Familial isolated arrhythmogenic ventricular dysplasia, left dominant form",HGNC:6636,LMNA,Disease-causing germline mutation(s) in,Not yet assessed
64746,GARD:0012431,Charcot-Marie-Tooth disease type 2,99947,Autosomal dominant Charcot-Marie-Tooth disease type 2A2,HGNC:16877,MFN2,Disease-causing germline mutation(s) in,Assessed
88632,GARD:0010025,Anterior segment dysgenesis,506307,Stromme syndrome,HGNC:1857,CENPF,Disease-causing germline mutation(s) in,Assessed
512,GARD:0003230,Metachromatic leukodystrophy,309263,"Metachromatic leukodystrophy, juvenile form",HGNC:9498,PSAP,Disease-causing germline mutation(s) in,Assessed
70,GARD:0004531,Proximal spinal muscular atrophy,83420,Proximal spinal muscular atrophy type 4,HGNC:11118,SMN2,Modifying germline mutation in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",251510,"46,XY partial gonadal dysgenesis",HGNC:16700,ZFPM2,Disease-causing germline mutation(s) in,Assessed
183660,GARD:0007628,Severe combined immunodeficiency,280142,Severe combined immunodeficiency due to LCK deficiency,HGNC:6524,LCK,Disease-causing germline mutation(s) in,Assessed
655,GARD:0000206,Nephronophthisis,93592,Juvenile nephronophthisis,HGNC:26724,ANKS6,Disease-causing germline mutation(s) in,Assessed
72,GARD:0005810,Angelman syndrome,411511,Angelman syndrome due to a point mutation,HGNC:12496,UBE3A,Disease-causing germline mutation(s) (loss of function) in,Assessed
79456,GARD:0012686,Diffuse cutaneous mastocytosis,280785,Bullous diffuse cutaneous mastocytosis,HGNC:6342,KIT,Disease-causing germline mutation(s) in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,402023,Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13),HGNC:14334,MRTFA,Part of a fusion gene in,Assessed
590,GARD:0011902,Congenital myasthenic syndromes,353327,Congenital myasthenic syndromes with glycosylation defect,HGNC:4241,GFPT1,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,280195,Septopreoptic holoprosencephaly,HGNC:7865,NODAL,Disease-causing germline mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,370921,STT3A-CDG,HGNC:6172,STT3A,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,157719,Juvenile or adult CACH syndrome,HGNC:3260,EIF2B4,Disease-causing germline mutation(s) in,Assessed
2467,GARD:0008616,Systemic mastocytosis,98849,Systemic mastocytosis with associated hematologic neoplasm,HGNC:6342,KIT,Disease-causing somatic mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93925,Alobar holoprosencephaly,HGNC:7865,NODAL,Disease-causing germline mutation(s) in,Assessed
2103,GARD:0006554,Guillain-Barre syndrome,98916,Acute inflammatory demyelinating polyradiculoneuropathy,HGNC:9118,PMP22,Major susceptibility factor in,Assessed
823,GARD:0007673,Spina bifida,268397,Cervicothoracic spina bifida aperta,HGNC:11515,TBXT,Major susceptibility factor in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293899,"Familial isolated arrhythmogenic ventricular dysplasia, biventricular form",HGNC:11769,TGFB3,Disease-causing germline mutation(s) in,Assessed
748,GARD:0012977,Mendelian susceptibility to mycobacterial diseases,331226,Susceptibility to infection due to TYK2 deficiency,HGNC:12440,TYK2,Disease-causing germline mutation(s) (loss of function) in,Assessed
54370,GARD:0011982,Membranoproliferative glomerulonephritis,329903,Immunoglobulin-mediated membranoproliferative glomerulonephritis,HGNC:4883,CFH,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,93561,ALys amyloidosis,HGNC:6740,LYZ,Disease-causing germline mutation(s) in,Assessed
813,GARD:0004870,Russell-Silver syndrome,231144,Silver-Russell syndrome due to 11p15 microduplication,HGNC:4713,H19,Role in the phenotype of,Assessed
1329,GARD:0001454,Complete atrioventricular canal,99067,Complete atrioventricular septal defect with ventricular hypoplasia,HGNC:14630,CRELD1,Major susceptibility factor in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:12155,TRB,Part of a fusion gene in,Assessed
253,GARD:0007687,Spondyloepiphyseal dysplasia,93283,"Spondyloepiphyseal dysplasia, Kimberley type",HGNC:319,ACAN,Disease-causing germline mutation(s) in,Assessed
98306,GARD:0011962,Familial partial lipodystrophy,280365,Autosomal semi-dominant severe lipodystrophic laminopathy,HGNC:6636,LMNA,Disease-causing germline mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,370980,Congenital muscular dystrophy without intellectual disability,HGNC:37276,CRPPA,Disease-causing germline mutation(s) (loss of function) in,Assessed
94075,GARD:0008689,Autoimmune enteropathy,280142,Severe combined immunodeficiency due to LCK deficiency,HGNC:6524,LCK,Disease-causing germline mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,370980,Congenital muscular dystrophy without intellectual disability,HGNC:17997,FKRP,Disease-causing germline mutation(s) in,Assessed
98292,GARD:0006987,Mastocytosis,566396,Chronic mast cell leukemia,HGNC:6342,KIT,Disease-causing germline mutation(s) in,Assessed
590,GARD:0011902,Congenital myasthenic syndromes,98915,Synaptic congenital myasthenic syndromes,HGNC:6487,LAMB2,Disease-causing germline mutation(s) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,363981,Charcot-Marie-Tooth disease type 4B3,HGNC:10542,SBF1,Disease-causing germline mutation(s) in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",251510,"46,XY partial gonadal dysgenesis",HGNC:12796,WT1,Candidate gene tested in,Not yet assessed
3394,GARD:0004898,Soft tissue sarcoma,370334,Extraskeletal Ewing sarcoma,HGNC:3508,EWSR1,Part of a fusion gene in,Assessed
657,GARD:0003947,Congenital hyperinsulinism,276575,Autosomal dominant hyperinsulinism due to SUR1 deficiency,HGNC:59,ABCC8,Disease-causing germline mutation(s) in,Assessed
217071,GARD:0008417,Renal cell carcinoma 4,404511,Clear cell papillary renal cell carcinoma,HGNC:7105,MITF,Major susceptibility factor in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,254898,Deafness-encephaloneuropathy-obesity-valvulopathy syndrome,HGNC:17759,PDSS1,Disease-causing germline mutation(s) in,Assessed
253,GARD:0007687,Spondyloepiphyseal dysplasia,436174,Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome,HGNC:29685,IARS2,Disease-causing germline mutation(s) (loss of function) in,Assessed
68356,GARD:0006895,Leukodystrophy,206436,Infantile Krabbe disease,HGNC:9498,PSAP,Disease-causing germline mutation(s) in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293910,"Familial isolated arrhythmogenic ventricular dysplasia, right dominant form",HGNC:15710,LDB3,Disease-causing germline mutation(s) in,Assessed
710,GARD:0007380,Pfeiffer syndrome,93259,Pfeiffer syndrome type 2,HGNC:3689,FGFR2,Disease-causing germline mutation(s) (gain of function) in,Assessed
2162,GARD:0006665,Holoprosencephaly,280195,Septopreoptic holoprosencephaly,HGNC:19711,DISP1,Disease-causing germline mutation(s) in,Assessed
26791,GARD:0006523,Glutaric acidemia type II,394529,"Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type",HGNC:3481,ETFA,Disease-causing germline mutation(s) in,Assessed
738,GARD:0010353,Porphyria,443062,Familial porphyria cutanea tarda,HGNC:4886,HFE,Modifying germline mutation in,Assessed
442,GARD:0001487,Congenital hypothyroidism,456312,Infantile multisystem neurologic-endocrine-pancreatic disease,HGNC:24265,PTRH2,Disease-causing germline mutation(s) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,456312,Infantile multisystem neurologic-endocrine-pancreatic disease,HGNC:24265,PTRH2,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,543470,Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome,HGNC:3642,FDXR,Disease-causing germline mutation(s) in,Assessed
91378,GARD:0005979,Hereditary angioedema,100050,Hereditary angioedema type 1,HGNC:1228,SERPING1,Disease-causing germline mutation(s) in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:2263,COX15,Disease-causing germline mutation(s) in,Assessed
98292,GARD:0006987,Mastocytosis,158772,Nodular urticaria pigmentosa,HGNC:6342,KIT,Disease-causing germline mutation(s) in,Assessed
70,GARD:0004531,Proximal spinal muscular atrophy,83420,Proximal spinal muscular atrophy type 4,HGNC:11117,SMN1,Disease-causing germline mutation(s) in,Assessed
53739,GARD:0012683,Distal hereditary motor neuropathy,404521,Spinal muscular atrophy with respiratory distress type 2,HGNC:25726,LAS1L,Disease-causing germline mutation(s) in,Assessed
309144,GARD:0012510,Gangliosidosis,309169,"Sandhoff disease, adult form",HGNC:4879,HEXB,Disease-causing germline mutation(s) (loss of function) in,Assessed
98473,GARD:0007922,Muscular dystrophy,319332,Autosomal recessive myogenic arthrogryposis multiplex congenita,HGNC:17089,SYNE1,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,280406,Familial steroid-resistant nephrotic syndrome with sensorineural deafness,HGNC:20233,COQ6,Disease-causing germline mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,247262,Hyperphosphatasia-intellectual disability syndrome,HGNC:23213,PIGW,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,320365,Autosomal dominant spastic paraplegia type 36,HGNC:33240,SPG36,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,401780,Autosomal recessive spastic paraplegia type 61,HGNC:697,ARL6IP1,Disease-causing germline mutation(s) in,Assessed
1531,GARD:0006209,Craniosynostosis,63269,Antley-Bixler syndrome with genital anomaly and disorder of steroidogenesis,HGNC:9208,POR,Disease-causing germline mutation(s) (loss of function) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,157716,Late infantile CACH syndrome,HGNC:3257,EIF2B1,Disease-causing germline mutation(s) in,Assessed
88632,GARD:0010025,Anterior segment dysgenesis,782,Axenfeld-Rieger syndrome,HGNC:3800,FOXC1,Disease-causing germline mutation(s) in,Assessed
251355,GARD:0012459,Sickle cell disease associated with an other hemoglobin anomaly,251380,Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome,HGNC:4832,HBG2,Disease-causing germline mutation(s) in,Assessed
52688,GARD:0007132,Myelodysplastic syndromes,100019,Refractory anemia with excess blasts type 1,HGNC:25941,TET2,Disease-causing somatic mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,445110,Limb-girdle muscular dystrophy due to POMK deficiency,HGNC:26267,POMK,Disease-causing germline mutation(s) (loss of function) in,Assessed
98634,GARD:0003026,Iridogoniodysgenesis type 2,98978,Axenfeld anomaly,HGNC:9005,PITX2,Disease-causing germline mutation(s) in,Assessed
182058,GARD:0012959,Primary orthostatic hypotension,411602,Hereditary late-onset Parkinson disease,HGNC:11138,SNCA,Disease-causing germline mutation(s) (gain of function) in,Assessed
68356,GARD:0006895,Leukodystrophy,85136,Cystic leukoencephalopathy without megalencephaly,HGNC:21686,RNASET2,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,438114,RARS-related autosomal recessive hypomyelinating leukodystrophy,HGNC:9870,RARS1,Disease-causing germline mutation(s) in,Assessed
357058,GARD:0001638,"Cutis laxa, autosomal recessive type 2A",357074,"Autosomal recessive cutis laxa type 2, classic type",HGNC:857,ATP6V1E1,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,220386,Semilobar holoprosencephaly,HGNC:11776,TGIF1,Disease-causing germline mutation(s) in,Assessed
97245,GARD:0005898,Myopathy congenital,324604,Classic multiminicore myopathy,HGNC:7577,MYH7,Disease-causing germline mutation(s) in,Assessed
93969,GARD:0003475,Myelomeningocele,268748,Total spina bifida cystica,HGNC:15511,VANGL2,Major susceptibility factor in,Assessed
360,GARD:0002491,Glioblastoma,251579,Giant cell glioblastoma,HGNC:5382,IDH1,Biomarker tested in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,488635,Early-onset epilepsy-intellectual disability-brain anomalies syndrome,HGNC:25985,PIGG,Disease-causing germline mutation(s) (loss of function) in,Assessed
79430,GARD:0006643,Hermansky-Pudlak syndrome,231500,Hermansky-Pudlak syndrome due to BLOC-3 deficiency,HGNC:5163,HPS1,Disease-causing germline mutation(s) in,Assessed
739,GARD:0005575,Prader-Willi syndrome,177910,Prader-Willi syndrome due to imprinting mutation,HGNC:32781,SNORD116@,Role in the phenotype of,Assessed
360,GARD:0002491,Glioblastoma,251579,Giant cell glioblastoma,HGNC:7797,NFKBIA,Biomarker tested in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,284139,"Larsen-like syndrome, B3GAT3 type",HGNC:923,B3GAT3,Disease-causing germline mutation(s) in,Assessed
251612,GARD:0009808,Pilocytic astrocytoma,251615,Pilomyxoid astrocytoma,HGNC:8032,NTRK2,Part of a fusion gene in,Assessed
370953,GARD:0012584,Congenital muscular dystrophy due to dystroglycanopathy ,370980,Congenital muscular dystrophy without intellectual disability,HGNC:3622,FKTN,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:17194,NDUFA13,Disease-causing germline mutation(s) in,Assessed
79373,GARD:0006317,Ectodermal dysplasia,33364,Trichothiodystrophy,HGNC:12974,RNF113A,Disease-causing germline mutation(s) in,Assessed
116,GARD:0003343,Beckwith-Wiedemann syndrome,238613,Beckwith-Wiedemann syndrome due to NSD1 mutation,HGNC:14234,NSD1,Disease-causing germline mutation(s) in,Assessed
94075,GARD:0008689,Autoimmune enteropathy,169100,Immunodeficiency due to CD25 deficiency,HGNC:6008,IL2RA,Disease-causing germline mutation(s) in,Assessed
93969,GARD:0003475,Myelomeningocele,268770,Upper thoracic spina bifida cystica,HGNC:26219,FUZ,Disease-causing germline mutation(s) in,Assessed
90790,GARD:0001465,Congenital lipoid adrenal hyperplasia,325524,Classic congenital lipoid adrenal hyperplasia due to STAR deficency,HGNC:11359,STAR,Disease-causing germline mutation(s) (loss of function) in,Assessed
748,GARD:0012977,Mendelian susceptibility to mycobacterial diseases,319595,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency,HGNC:11362,STAT1,Disease-causing germline mutation(s) in,Assessed
157,GARD:0001121,Carnitine palmitoyltransferase 2 deficiency,228302,"Carnitine palmitoyl transferase II deficiency, myopathic form",HGNC:2330,CPT2,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,157719,Juvenile or adult CACH syndrome,HGNC:3261,EIF2B5,Disease-causing germline mutation(s) in,Assessed
593,GARD:0010529,Myofibrillar myopathy,171445,Muscle filaminopathy,HGNC:3756,FLNC,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93925,Alobar holoprosencephaly,HGNC:4318,GLI2,Disease-causing germline mutation(s) in,Assessed
98292,GARD:0006987,Mastocytosis,98849,Systemic mastocytosis with associated hematologic neoplasm,HGNC:25941,TET2,Disease-causing somatic mutation(s) in,Assessed
264665,GARD:0010559,Children's interstitial lung disease,306504,Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome,HGNC:6139,ITGA3,Disease-causing germline mutation(s) (loss of function) in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,589534,Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2),HGNC:7132,KMT2A,Part of a fusion gene in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,370943,Autism spectrum disorder-epilepsy-arthrogryposis syndrome,HGNC:11023,SLC35A3,Disease-causing germline mutation(s) in,Assessed
702,GARD:0004265,Pelizaeus-Merzbacher disease,280210,"Pelizaeus-Merzbacher disease, connatal form",HGNC:9086,PLP1,Disease-causing germline mutation(s) in,Assessed
3394,GARD:0004898,Soft tissue sarcoma,209916,Extraskeletal myxoid chondrosarcoma,HGNC:11758,TFG,Part of a fusion gene in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293899,"Familial isolated arrhythmogenic ventricular dysplasia, biventricular form",HGNC:12403,TTN,Disease-causing germline mutation(s) (loss of function) in,Assessed
93969,GARD:0003475,Myelomeningocele,268758,Lumbosacral spina bifida cystica,HGNC:26219,FUZ,Disease-causing germline mutation(s) in,Assessed
98261,GARD:0007140,Progressive myoclonic epilepsy,424027,Progressive myoclonic epilepsy type 8,HGNC:14253,CERS1,Disease-causing germline mutation(s) in,Assessed
83,GARD:0005826,Antley Bixler syndrome,63269,Antley-Bixler syndrome with genital anomaly and disorder of steroidogenesis,HGNC:9208,POR,Disease-causing germline mutation(s) (loss of function) in,Assessed
823,GARD:0007673,Spina bifida,268748,Total spina bifida cystica,HGNC:7432,MTHFD1,Major susceptibility factor in,Assessed
68356,GARD:0006895,Leukodystrophy,280219,"Pelizaeus-Merzbacher disease, classic form",HGNC:9086,PLP1,Disease-causing germline mutation(s) in,Assessed
99927,GARD:0010263,Hydatidiform mole,254693,Partial hydatidiform mole,HGNC:22947,NLRP7,Disease-causing germline mutation(s) in,Assessed
817,GARD:0007347,Peeling skin syndrome,263553,Peeling skin syndrome type B,HGNC:1802,CDSN,Disease-causing germline mutation(s) in,Assessed
595,GARD:0000101,Centronuclear myopathy,456328,X-linked myotubular myopathy-abnormal genitalia syndrome,HGNC:7448,MTM1,Role in the phenotype of,Assessed
1305,GARD:0008407,Feingold syndrome,391646,Feingold syndrome type 2,HGNC:23564,MIR17HG,Disease-causing germline mutation(s) in,Assessed
79373,GARD:0006317,Ectodermal dysplasia,33364,Trichothiodystrophy,HGNC:4651,GTF2E2,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,157713,Congenital or early infantile CACH syndrome,HGNC:3258,EIF2B2,Disease-causing germline mutation(s) in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:17194,NDUFA13,Disease-causing germline mutation(s) in,Assessed
314822,GARD:0007552,Renal tubular acidosis,93607,Autosomal recessive proximal renal tubular acidosis,HGNC:11030,SLC4A4,Disease-causing germline mutation(s) in,Assessed
443909,GARD:0008533,Familial colorectal cancer,144,Lynch syndrome,HGNC:7127,MLH1,Disease-causing germline mutation(s) in,Assessed
53739,GARD:0012683,Distal hereditary motor neuropathy,1216,Autosomal dominant congenital benign spinal muscular atrophy,HGNC:18083,TRPV4,Disease-causing germline mutation(s) in,Assessed
282,GARD:0008436,Frontotemporal dementia,275864,Behavioral variant of frontotemporal dementia,HGNC:12666,VCP,Major susceptibility factor in,Not yet assessed
79225,GARD:0007672,Sphingolipidosis,309256,"Metachromatic leukodystrophy, late infantile form",HGNC:713,ARSA,Disease-causing germline mutation(s) (loss of function) in,Assessed
79225,GARD:0007672,Sphingolipidosis,309263,"Metachromatic leukodystrophy, juvenile form",HGNC:713,ARSA,Disease-causing germline mutation(s) (loss of function) in,Assessed
823,GARD:0007673,Spina bifida,268762,Cervical spina bifida cystica,HGNC:7432,MTHFD1,Major susceptibility factor in,Assessed
846,GARD:0000621,Alpha-thalassemia,93616,Hemoglobin H disease,HGNC:4823,HBA1,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268377,Total spina bifida aperta,HGNC:15511,VANGL2,Major susceptibility factor in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,477817,PMP22-RAI1 contiguous gene duplication syndrome,HGNC:9834,RAI1,Role in the phenotype of,Assessed
64746,GARD:0012431,Charcot-Marie-Tooth disease type 2,228179,Autosomal dominant Charcot-Marie-Tooth disease type 2M,HGNC:2974,DNM2,Disease-causing germline mutation(s) in,Assessed
790,GARD:0007563,Retinoblastoma,357027,Hereditary retinoblastoma,HGNC:9884,RB1,Disease-causing germline mutation(s) (loss of function) in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293888,"Familial isolated arrhythmogenic ventricular dysplasia, left dominant form",HGNC:12403,TTN,Disease-causing germline mutation(s) (loss of function) in,Assessed
88661,GARD:0005791,Amelogenesis imperfecta,100032,Hypocalcified amelogenesis imperfecta,HGNC:24797,FAM83H,Disease-causing germline mutation(s) in,Assessed
79225,GARD:0007672,Sphingolipidosis,2072,Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,HGNC:4177,GBA,Disease-causing germline mutation(s) in,Assessed
263440,GARD:0010902,Neuroacanthocytosis,216866,Classic pantothenate kinase-associated neurodegeneration,HGNC:15894,PANK2,Disease-causing germline mutation(s) in,Assessed
3008,GARD:0007512,Pyruvate carboxylase deficiency,353308,"Pyruvate carboxylase deficiency, infantile type",HGNC:8636,PC,Disease-causing germline mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,435934,COG2-CDG,HGNC:6546,COG2,Disease-causing germline mutation(s) (loss of function) in,Assessed
702,GARD:0004265,Pelizaeus-Merzbacher disease,280234,Null syndrome,HGNC:9086,PLP1,Disease-causing germline mutation(s) in,Assessed
289899,GARD:0009433,Organic acidemias,314918,Mild Canavan disease,HGNC:756,ASPA,Disease-causing germline mutation(s) (loss of function) in,Assessed
407,GARD:0007219,Glycine encephalopathy,289860,Infantile glycine encephalopathy,HGNC:4313,GLDC,Disease-causing germline mutation(s) in,Assessed
182067,GARD:0006513,Glioma,251615,Pilomyxoid astrocytoma,HGNC:22219,KIAA1549,Part of a fusion gene in,Assessed
216675,GARD:0007795,Transposition of the great arteries,216718,Isolated congenitally uncorrected transposition of the great arteries,HGNC:18292,CFC1,Candidate gene tested in,Not yet assessed
53739,GARD:0012683,Distal hereditary motor neuropathy,496756,Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome,HGNC:11582,TBCE,Disease-causing germline mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,370968,Congenital muscular dystrophy with intellectual disability,HGNC:19743,POMT2,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268397,Cervicothoracic spina bifida aperta,HGNC:26219,FUZ,Disease-causing germline mutation(s) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,521411,Autosomal recessive axonal Charcot-Marie-Tooth disease due to copper metabolism defect,HGNC:10604,SCO2,Disease-causing germline mutation(s) in,Assessed
182067,GARD:0006513,Glioma,251615,Pilomyxoid astrocytoma,HGNC:1097,BRAF,Part of a fusion gene in,Assessed
68356,GARD:0006895,Leukodystrophy,157719,Juvenile or adult CACH syndrome,HGNC:3257,EIF2B1,Disease-causing germline mutation(s) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,99853,Ovarioleukodystrophy,HGNC:3259,EIF2B3,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:16266,SLC19A3,Disease-causing germline mutation(s) in,Assessed
444116,GARD:0006611,Hereditary amyloidosis,85451,ATTRV122I amyloidosis,HGNC:12405,TTR,Disease-causing germline mutation(s) in,Assessed
207073,GARD:0002003,Dysferlinopathy,178400,Distal myopathy with anterior tibial onset,HGNC:3097,DYSF,Disease-causing germline mutation(s) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,466794,Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome,HGNC:14372,SCYL1,Disease-causing germline mutation(s) in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293899,"Familial isolated arrhythmogenic ventricular dysplasia, biventricular form",HGNC:9024,PKP2,Disease-causing germline mutation(s) in,Assessed
385,GARD:0011899,Neurodegeneration with brain iron accumulation,216866,Classic pantothenate kinase-associated neurodegeneration,HGNC:15894,PANK2,Disease-causing germline mutation(s) in,Assessed
2442,GARD:0007906,X-linked lymphoproliferative disease due to SH2D1A deficiency,538934,X-linked lymphoproliferative disease due to XIAP deficiency,HGNC:592,XIAP,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:1787,CDKN2A,Disease-causing somatic mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93925,Alobar holoprosencephaly,HGNC:2908,DLL1,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268740,Upper thoracic spina bifida aperta,HGNC:15511,VANGL2,Major susceptibility factor in,Assessed
407,GARD:0007219,Glycine encephalopathy,289860,Infantile glycine encephalopathy,HGNC:473,AMT,Disease-causing germline mutation(s) (loss of function) in,Assessed
104008,GARD:0001502,Short bowel syndrome,2301,Congenital short bowel syndrome,HGNC:3754,FLNA,Disease-causing germline mutation(s) in,Assessed
577,GARD:0003806,Mucolipidosis III alpha/beta,423470,Mucolipidosis type III gamma,HGNC:23026,GNPTG,Disease-causing germline mutation(s) (loss of function) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:4933,HLA-C,Major susceptibility factor in,Assessed
64746,GARD:0012431,Charcot-Marie-Tooth disease type 2,397735,Autosomal dominant Charcot-Marie-Tooth disease type 2U,HGNC:6898,MARS1,Disease-causing germline mutation(s) (loss of function) in,Assessed
97245,GARD:0005898,Myopathy congenital,544602,Congenital myopathy with reduced type 2 muscle fibers,HGNC:7582,MYL1,Disease-causing germline mutation(s) (loss of function) in,Assessed
98261,GARD:0007140,Progressive myoclonic epilepsy,228346,CLN3 disease,HGNC:2074,CLN3,Disease-causing germline mutation(s) in,Assessed
2913,GARD:0004410,Polydactyly,498494,Mirror-image polydactyly,HGNC:9004,PITX1,Role in the phenotype of,Assessed
411709,GARD:0009228,Renal agenesis,93100,"Renal agenesis, unilateral",HGNC:23399,FREM1,Disease-causing germline mutation(s) in,Assessed
98277,GARD:0012758,Acute myeloid leukemia with recurrent genetic anomaly,370026,Acute myeloid leukemia with t(8;16)(p11;p13) translocation,HGNC:13013,KAT6A,Part of a fusion gene in,Assessed
2929,GARD:0003065,Juvenile polyposis syndrome,329971,Generalized juvenile polyposis/juvenile polyposis coli,HGNC:3349,ENG,Candidate gene tested in,Not yet assessed
1329,GARD:0001454,Complete atrioventricular canal,99067,Complete atrioventricular septal defect with ventricular hypoplasia,HGNC:4173,GATA4,Disease-causing germline mutation(s) in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",456328,X-linked myotubular myopathy-abnormal genitalia syndrome,HGNC:2568,MAMLD1,Role in the phenotype of,Assessed
91024,GARD:0012449,Autosomal recessive axonal Charcot-Marie-Tooth disease type 2,443950,DNAJB2-related Charcot-Marie-Tooth disease type 2,HGNC:5228,DNAJB2,Disease-causing germline mutation(s) in,Assessed
79262,GARD:0010973,Adult neuronal ceroid lipofuscinosis,352709,CLN13 disease,HGNC:2531,CTSF,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,280195,Septopreoptic holoprosencephaly,HGNC:4318,GLI2,Disease-causing germline mutation(s) in,Assessed
35656,GARD:0010423,Coenzyme Q10 deficiency,255249,Leigh syndrome with nephrotic syndrome,HGNC:23041,PDSS2,Disease-causing germline mutation(s) in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",251510,"46,XY partial gonadal dysgenesis",HGNC:11486,VAMP7,Role in the phenotype of,Assessed
79373,GARD:0006317,Ectodermal dysplasia,50944,Schöpf-Schulz-Passarge syndrome,HGNC:13829,WNT10A,Disease-causing germline mutation(s) in,Assessed
268337,GARD:0012452,Autosomal recessive intermediate Charcot-Marie-Tooth disease ,369867,Autosomal recessive intermediate Charcot-Marie-Tooth disease type C,HGNC:29105,PLEKHG5,Disease-causing germline mutation(s) in,Assessed
53739,GARD:0012683,Distal hereditary motor neuropathy,139525,Distal hereditary motor neuropathy type 2,HGNC:5248,HSPB3,Disease-causing germline mutation(s) in,Assessed
141,GARD:0005984,Canavan disease,314918,Mild Canavan disease,HGNC:756,ASPA,Disease-causing germline mutation(s) (loss of function) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:4977,HLF,Part of a fusion gene in,Assessed
1037,GARD:0000777,Arthrogryposis multiplex congenita,2680,Hypomyelination neuropathy-arthrogryposis syndrome,HGNC:237,ADCY6,Disease-causing germline mutation(s) in,Assessed
303,GARD:0002150,Dystrophic epidermolysis bullosa,158676,"Localized dystrophic epidermolysis bullosa, nails only",HGNC:2214,COL7A1,Disease-causing germline mutation(s) (loss of function) in,Assessed
544,GARD:0003178,Diffuse Large B-Cell Lymphoma,98839,Intravascular large B-cell lymphoma,HGNC:1001,BCL6,Disease-causing somatic mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:14262,AUTS2,Part of a fusion gene in,Assessed
91024,GARD:0012449,Autosomal recessive axonal Charcot-Marie-Tooth disease type 2,495274,Charcot-Marie-Tooth disease type 2T,HGNC:7154,MME,Disease-causing germline mutation(s) (loss of function) in,Assessed
214,GARD:0006237,Cystinuria,93613,Cystinuria type B,HGNC:11067,SLC7A9,Disease-causing germline mutation(s) in,Assessed
156005,GARD:0002490,Glaucoma 3 primary infantile B,98977,Juvenile glaucoma,HGNC:2597,CYP1B1,Major susceptibility factor in,Assessed
55,GARD:0010958,Oculocutaneous albinism,597733,Oculocutaneous albinism type 8,HGNC:2709,DCT,Disease-causing germline mutation(s) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,99854,Cree leukoencephalopathy,HGNC:3257,EIF2B1,Disease-causing germline mutation(s) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,157716,Late infantile CACH syndrome,HGNC:3259,EIF2B3,Disease-causing germline mutation(s) in,Assessed
156005,GARD:0002490,Glaucoma 3 primary infantile B,98976,Congenital glaucoma,HGNC:7610,MYOC,Disease-causing germline mutation(s) in,Assessed
442,GARD:0001487,Congenital hypothyroidism,95716,Familial thyroid dyshormonogenesis,HGNC:11764,TG,Disease-causing germline mutation(s) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,157716,Late infantile CACH syndrome,HGNC:3261,EIF2B5,Disease-causing germline mutation(s) in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,98831,Acute myeloid leukemia with 11q23 abnormalities,HGNC:7132,KMT2A,Role in the phenotype of,Assessed
87876,GARD:0007183,"Sialidosis, type II",93399,Juvenile sialidosis type 2,HGNC:7758,NEU1,Disease-causing germline mutation(s) in,Assessed
93383,GARD:0000985,Brachydactyly type B,572385,Brachydactyly type B1,HGNC:10257,ROR2,Disease-causing germline mutation(s) (gain of function) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,99854,Cree leukoencephalopathy,HGNC:3259,EIF2B3,Disease-causing germline mutation(s) in,Assessed
27,GARD:0003586,Methylmalonyl-Coenzyme A mutase deficiency,289916,Vitamin B12-unresponsive methylmalonic acidemia type mut0,HGNC:7526,MMUT,Disease-causing germline mutation(s) (loss of function) in,Assessed
98277,GARD:0012758,Acute myeloid leukemia with recurrent genetic anomaly,402023,Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13),HGNC:14959,RBM15,Part of a fusion gene in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255138,Pyruvate dehydrogenase E1-beta deficiency,HGNC:8808,PDHB,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268384,Thoracolumbosacral spina bifida aperta,HGNC:15511,VANGL2,Major susceptibility factor in,Assessed
487,GARD:0006844,Krabbe disease,206443,Late-infantile/juvenile Krabbe disease,HGNC:4115,GALC,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:5525,IGHG1,Modifying germline mutation in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:3620,FCGR3B,Major susceptibility factor in,Assessed
53739,GARD:0012683,Distal hereditary motor neuropathy,314485,Young adult-onset distal hereditary motor neuropathy,HGNC:5228,DNAJB2,Disease-causing germline mutation(s) (loss of function) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,397946,Autosomal spastic paraplegia type 58,HGNC:6317,KIF1C,Disease-causing germline mutation(s) (loss of function) in,Assessed
2913,GARD:0004410,Polydactyly,93334,Postaxial polydactyly type A,HGNC:4317,GLI1,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:1787,CDKN2A,Disease-causing somatic mutation(s) in,Assessed
443909,GARD:0008533,Familial colorectal cancer,144,Lynch syndrome,HGNC:11529,EPCAM,Disease-causing germline mutation(s) in,Assessed
79213,GARD:0007065,Mucopolysaccharidosis,67041,Hyaluronidase deficiency,HGNC:5320,HYAL1,Disease-causing germline mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,369837,Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome,HGNC:14938,PIGT,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,157716,Late infantile CACH syndrome,HGNC:3258,EIF2B2,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:7545,MYB,Part of a fusion gene in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293910,"Familial isolated arrhythmogenic ventricular dysplasia, right dominant form",HGNC:9024,PKP2,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,280195,Septopreoptic holoprosencephaly,HGNC:11776,TGIF1,Disease-causing germline mutation(s) in,Assessed
156207,GARD:0003342,Macroglossia,238613,Beckwith-Wiedemann syndrome due to NSD1 mutation,HGNC:14234,NSD1,Disease-causing germline mutation(s) in,Assessed
518,GARD:0000524,Acute megakaryoblastic leukemia,329469,Acute megakaryoblastic leukemia without Down syndrome,HGNC:29450,GLIS2,Part of a fusion gene in,Assessed
97242,GARD:0009138,Congenital muscular dystrophy,370968,Congenital muscular dystrophy with intellectual disability,HGNC:19743,POMT2,Disease-causing germline mutation(s) in,Assessed
444116,GARD:0006611,Hereditary amyloidosis,324708,"ABeta amyloidosis, Iowa type",HGNC:620,APP,Disease-causing germline mutation(s) in,Assessed
352731,GARD:0004037,Oculocutaneous albinism type 1,352734,Minimal pigment oculocutaneous albinism type 1,HGNC:12442,TYR,Disease-causing germline mutation(s) (loss of function) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,353327,Congenital myasthenic syndromes with glycosylation defect,HGNC:2995,DPAGT1,Disease-causing germline mutation(s) in,Assessed
280886,GARD:0010941,Anterior uveitis,797,Sarcoidosis,HGNC:1142,BTNL2,Major susceptibility factor in,Assessed
91024,GARD:0012449,Autosomal recessive axonal Charcot-Marie-Tooth disease type 2,521411,Autosomal recessive axonal Charcot-Marie-Tooth disease due to copper metabolism defect,HGNC:10604,SCO2,Disease-causing germline mutation(s) in,Assessed
590,GARD:0011902,Congenital myasthenic syndromes,353327,Congenital myasthenic syndromes with glycosylation defect,HGNC:23159,ALG2,Disease-causing germline mutation(s) in,Assessed
289899,GARD:0009433,Organic acidemias,66634,Dilated cardiomyopathy with ataxia,HGNC:30528,DNAJC19,Disease-causing germline mutation(s) in,Assessed
253,GARD:0007687,Spondyloepiphyseal dysplasia,250984,Autosomal recessive Stickler syndrome,HGNC:13869,LOXL3,Disease-causing germline mutation(s) in,Assessed
98274,GARD:0009319,Chronic myeloproliferative disorders,314950,Primary hypereosinophilic syndrome,HGNC:19124,FIP1L1,Part of a fusion gene in,Assessed
93969,GARD:0003475,Myelomeningocele,268758,Lumbosacral spina bifida cystica,HGNC:7432,MTHFD1,Major susceptibility factor in,Assessed
98261,GARD:0007140,Progressive myoclonic epilepsy,324290,Early-onset Lafora body disease,HGNC:13993,PRDM8,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:6112,IRAK1,Major susceptibility factor in,Assessed
823,GARD:0007673,Spina bifida,268770,Upper thoracic spina bifida cystica,HGNC:26219,FUZ,Disease-causing germline mutation(s) in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:29666,MTFMT,Disease-causing germline mutation(s) (loss of function) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,157719,Juvenile or adult CACH syndrome,HGNC:3259,EIF2B3,Disease-causing germline mutation(s) in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",443087,"46,XY disorder of sex development due to testicular 17,20-desmolase deficiency",HGNC:385,AKR1C2,Disease-causing germline mutation(s) (loss of function) in,Assessed
253,GARD:0007687,Spondyloepiphyseal dysplasia,250984,Autosomal recessive Stickler syndrome,HGNC:2186,COL11A1,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,314911,Severe Canavan disease,HGNC:756,ASPA,Disease-causing germline mutation(s) (loss of function) in,Assessed
790,GARD:0007563,Retinoblastoma,357034,Non-hereditary retinoblastoma,HGNC:7559,MYCN,Candidate gene tested in,Not yet assessed
2162,GARD:0006665,Holoprosencephaly,93924,Lobar holoprosencephaly,HGNC:4165,GAS1,Disease-causing germline mutation(s) in,Assessed
182067,GARD:0006513,Glioma,251615,Pilomyxoid astrocytoma,HGNC:1097,BRAF,Disease-causing somatic mutation(s) in,Assessed
511,GARD:0003228,Maple syrup urine disease,268184,Thiamine-responsive maple syrup urine disease,HGNC:986,BCKDHA,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,220386,Semilobar holoprosencephaly,HGNC:3688,FGFR1,Disease-causing germline mutation(s) in,Assessed
1048,GARD:0005808,Anencephaly,563612,Isolated exencephaly,HGNC:15511,VANGL2,Major susceptibility factor in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,435998,Autosomal recessive intermediate Charcot-Marie-Tooth disease type D,HGNC:2277,COX6A1,Disease-causing germline mutation(s) (loss of function) in,Assessed
3394,GARD:0004898,Soft tissue sarcoma,231108,Familial rhabdoid tumor,HGNC:11103,SMARCB1,Disease-causing germline mutation(s) (loss of function) in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:7716,NDUFV1,Disease-causing germline mutation(s) in,Assessed
411709,GARD:0009228,Renal agenesis,93100,"Renal agenesis, unilateral",HGNC:12580,UPK3A,Disease-causing germline mutation(s) in,Assessed
442,GARD:0001487,Congenital hypothyroidism,95716,Familial thyroid dyshormonogenesis,HGNC:12015,TPO,Disease-causing germline mutation(s) in,Assessed
280892,GARD:0004457,Posterior uveitis,797,Sarcoidosis,HGNC:4948,HLA-DRB1,Major susceptibility factor in,Assessed
93548,GARD:0012736,Glomerular disease,567550,Idiopathic multidrug-resistant nephrotic syndrome,HGNC:18143,DAAM2,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93924,Lobar holoprosencephaly,HGNC:3686,FGF8,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,306504,Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome,HGNC:6139,ITGA3,Disease-causing germline mutation(s) (loss of function) in,Assessed
450,GARD:0008591,X-linked visceral heterotaxy 1,157769,Situs ambiguus,HGNC:14357,MMP21,Disease-causing germline mutation(s) (loss of function) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93926,Midline interhemispheric variant of holoprosencephaly,HGNC:9585,PTCH1,Disease-causing germline mutation(s) in,Assessed
98722,GARD:0000802,Atrioventricular septal defect,99067,Complete atrioventricular septal defect with ventricular hypoplasia,HGNC:7976,NR2F2,Major susceptibility factor in,Assessed
68356,GARD:0006895,Leukodystrophy,99854,Cree leukoencephalopathy,HGNC:3257,EIF2B1,Disease-causing germline mutation(s) in,Assessed
220460,GARD:0008532,Attenuated familial adenomatous polyposis,247806,APC-related attenuated familial adenomatous polyposis,HGNC:583,APC,Disease-causing germline mutation(s) in,Assessed
2442,GARD:0010915,X-linked lymphoproliferative syndrome,538934,X-linked lymphoproliferative disease due to XIAP deficiency,HGNC:592,XIAP,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,320355,Autosomal dominant spastic paraplegia type 41,HGNC:34382,SPG41,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:4172,GATA3,Major susceptibility factor in,Assessed
535,GARD:0006225,Cutaneous lupus erythematosus,481662,Familial Chilblain lupus,HGNC:27962,STING1,Disease-causing germline mutation(s) (gain of function) in,Assessed
69077,GARD:0007572,Rhabdoid tumor,99966,Atypical teratoid rhabdoid tumor,HGNC:11103,SMARCB1,Disease-causing somatic mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,466703,TMEM199-CDG,HGNC:18085,TMEM199,Disease-causing germline mutation(s) (loss of function) in,Assessed
163892,GARD:0008742,Limbic encephalitis,163908,Limbic encephalitis with LGI1 antibodies,HGNC:4948,HLA-DRB1,Major susceptibility factor in,Assessed
2467,GARD:0008616,Systemic mastocytosis,98849,Systemic mastocytosis with associated hematologic neoplasm,HGNC:18318,ASXL1,Disease-causing somatic mutation(s) in,Assessed
182058,GARD:0012959,Primary orthostatic hypotension,411602,Hereditary late-onset Parkinson disease,HGNC:3296,EIF4G1,Candidate gene tested in,Not yet assessed
182058,GARD:0012959,Primary orthostatic hypotension,411602,Hereditary late-onset Parkinson disease,HGNC:13487,VPS35,Disease-causing germline mutation(s) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,48431,Congenital cataracts-facial dysmorphism-neuropathy syndrome,HGNC:2498,CTDP1,Disease-causing germline mutation(s) (loss of function) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,320406,Spastic paraplegia-optic atrophy-neuropathy syndrome,HGNC:20716,KLC2,Disease-causing germline mutation(s) (gain of function) in,Assessed
828,GARD:0010782,Stickler syndrome,90653,Stickler syndrome type 1,HGNC:2200,COL2A1,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268388,Lumbosacral spina bifida aperta,HGNC:26219,FUZ,Disease-causing germline mutation(s) in,Assessed
69078,GARD:0006913,Liposarcoma,99970,Dedifferentiated liposarcoma,HGNC:6973,MDM2,Role in the phenotype of,Assessed
183660,GARD:0007628,Severe combined immunodeficiency,169160,T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta,HGNC:1677,CD247,Disease-causing germline mutation(s) in,Assessed
370953,GARD:0012584,Congenital muscular dystrophy due to dystroglycanopathy ,370997,Muscle-eye-brain disease with bilateral multicystic leucodystrophy,HGNC:2666,DAG1,Disease-causing germline mutation(s) in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:40038,PET100,Disease-causing germline mutation(s) (loss of function) in,Assessed
98722,GARD:0000802,Atrioventricular septal defect,99068,Complete atrioventricular septal defect-tetralogy of Fallot,HGNC:7976,NR2F2,Major susceptibility factor in,Assessed
93548,GARD:0012736,Glomerular disease,93552,Pediatric systemic lupus erythematosus,HGNC:6112,IRAK1,Major susceptibility factor in,Assessed
3394,GARD:0004898,Soft tissue sarcoma,252212,Malignant triton tumor,HGNC:23664,SH3PXD2A,Part of a fusion gene in,Assessed
93969,GARD:0003475,Myelomeningocele,268762,Cervical spina bifida cystica,HGNC:26219,FUZ,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:12252,TRD,Part of a fusion gene in,Assessed
140471,GARD:0012688,Hereditary sensory and autonomic neuropathy,478664,Hereditary sensory and autonomic neuropathy type 8,HGNC:13997,PRDM12,Disease-causing germline mutation(s) in,Assessed
95708,GARD:0007446,Precocious puberty,169615,Idiopathic central precocious puberty,HGNC:2907,DLK1,Role in the phenotype of,Assessed
93969,GARD:0003475,Myelomeningocele,268748,Total spina bifida cystica,HGNC:26219,FUZ,Disease-causing germline mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,370930,XYLT1-CDG,HGNC:15516,XYLT1,Disease-causing germline mutation(s) (loss of function) in,Assessed
448,GARD:0010418,Hemophilia,169796,Moderate hemophilia B,HGNC:3551,F9,Disease-causing germline mutation(s) in,Assessed
1037,GARD:0000777,Arthrogryposis multiplex congenita,486811,Prenatal-onset spinal muscular atrophy with congenital bone fractures,HGNC:24268,ASCC1,Disease-causing germline mutation(s) in,Assessed
655,GARD:0000206,Nephronophthisis,93592,Juvenile nephronophthisis,HGNC:13202,ADAMTS9,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,329475,Spastic paraplegia-Paget disease of bone syndrome,HGNC:12666,VCP,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93926,Midline interhemispheric variant of holoprosencephaly,HGNC:4318,GLI2,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,506334,Familial steroid-resistant nephrotic syndrome with adrenal insufficiency,HGNC:10817,SGPL1,Disease-causing germline mutation(s) in,Assessed
98249,GARD:0006322,Ehlers-Danlos syndromes,75497,X-linked Ehlers-Danlos syndrome,HGNC:3754,FLNA,Disease-causing germline mutation(s) (loss of function) in,Assessed
98722,GARD:0000802,Atrioventricular septal defect,99067,Complete atrioventricular septal defect with ventricular hypoplasia,HGNC:4173,GATA4,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,363722,Alexander disease type II,HGNC:4235,GFAP,Disease-causing germline mutation(s) (gain of function) in,Assessed
1576,GARD:0005040,Striatonigral degeneration infantile,225154,Familial infantile bilateral striatal necrosis,HGNC:8066,NUP62,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:7715,NDUFS8,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93924,Lobar holoprosencephaly,HGNC:2908,DLL1,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:29569,LIPT1,Disease-causing germline mutation(s) in,Assessed
401854,GARD:0012679,Lipoic acid biosynthesis defects,401874,Multiple mitochondrial dysfunctions syndrome type 2,HGNC:24415,BOLA3,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,69063,Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization,HGNC:7154,MME,Disease-causing germline mutation(s) in,Assessed
1037,GARD:0000777,Arthrogryposis multiplex congenita,2680,Hypomyelination neuropathy-arthrogryposis syndrome,HGNC:18712,LGI4,Disease-causing germline mutation(s) (loss of function) in,Assessed
79373,GARD:0006317,Ectodermal dysplasia,69088,Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome,HGNC:5961,IKBKG,Disease-causing germline mutation(s) in,Assessed
100092,GARD:0002437,Gastro-enteropancreatic neuroendocrine tumor,100075,Neuroendocrine tumor of stomach,HGNC:2681,DAXX,Candidate gene tested in,Not yet assessed
2162,GARD:0006665,Holoprosencephaly,93925,Alobar holoprosencephaly,HGNC:11776,TGIF1,Disease-causing germline mutation(s) in,Assessed
261,GARD:0006329,Emery-Dreifuss muscular dystrophy,98863,X-linked Emery-Dreifuss muscular dystrophy,HGNC:3331,EMD,Disease-causing germline mutation(s) in,Assessed
308166,GARD:0010923,Erythrokeratodermia variabilis et progressiva,317,Erythrokeratodermia variabilis,HGNC:4274,GJA1,Disease-causing germline mutation(s) in,Assessed
79373,GARD:0006317,Ectodermal dysplasia,69084,Pure hair and nail ectodermal dysplasia,HGNC:6462,KRT85,Disease-causing germline mutation(s) in,Assessed
93969,GARD:0003475,Myelomeningocele,268752,Thoracolumbosacral spina bifida cystica,HGNC:15511,VANGL2,Major susceptibility factor in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:18233,BANK1,Major susceptibility factor in,Assessed
363579,GARD:0009325,Extragonadal germ cell tumor,91352,Germinoma of the central nervous system,HGNC:12313,JMJD1C,Major susceptibility factor in,Assessed
828,GARD:0010782,Stickler syndrome,250984,Autosomal recessive Stickler syndrome,HGNC:13869,LOXL3,Disease-causing germline mutation(s) in,Assessed
828,GARD:0010782,Stickler syndrome,250984,Autosomal recessive Stickler syndrome,HGNC:2219,COL9A3,Disease-causing germline mutation(s) (loss of function) in,Assessed
68356,GARD:0006895,Leukodystrophy,99853,Ovarioleukodystrophy,HGNC:3259,EIF2B3,Disease-causing germline mutation(s) in,Assessed
182067,GARD:0006513,Glioma,530792,RELA fusion-positive ependymoma,HGNC:28449,ZFTA,Part of a fusion gene in,Assessed
2909,GARD:0004392,Rothmund-Thomson syndrome,221008,Rothmund-Thomson syndrome type 1,HGNC:19988,ANAPC1,Disease-causing germline mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,370959,Congenital muscular dystrophy with cerebellar involvement,HGNC:19743,POMT2,Disease-causing germline mutation(s) in,Assessed
182058,GARD:0012959,Primary orthostatic hypotension,2828,Young-onset Parkinson disease,HGNC:11138,SNCA,Candidate gene tested in,Not yet assessed
64746,GARD:0012431,Charcot-Marie-Tooth disease type 2,435819,Autosomal dominant Charcot-Marie-Tooth disease type 2 due to TFG mutation,HGNC:11758,TFG,Disease-causing germline mutation(s) (gain of function) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,140481,Autosomal dominant slowed nerve conduction velocity,HGNC:14103,ARHGEF10,Disease-causing germline mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,466801,LIMS2-related limb-girdle muscular dystrophy,HGNC:16084,LIMS2,Disease-causing germline mutation(s) in,Assessed
263,GARD:0006907,Limb-girdle muscular dystrophy,466801,LIMS2-related limb-girdle muscular dystrophy,HGNC:16084,LIMS2,Disease-causing germline mutation(s) in,Assessed
511,GARD:0003228,Maple syrup urine disease,268184,Thiamine-responsive maple syrup urine disease,HGNC:2698,DBT,Disease-causing germline mutation(s) (loss of function) in,Assessed
98473,GARD:0007922,Muscular dystrophy,178461,X-linked myopathy with postural muscle atrophy,HGNC:3702,FHL1,Disease-causing germline mutation(s) in,Assessed
79373,GARD:0006317,Ectodermal dysplasia,33364,Trichothiodystrophy,HGNC:11572,TARS1,Disease-causing germline mutation(s) in,Assessed
593,GARD:0010529,Myofibrillar myopathy,476406,Congenital generalized hypercontractile muscle stiffness syndrome,HGNC:12012,TPM3,Disease-causing germline mutation(s) (gain of function) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,228374,Charcot-Marie-Tooth disease type 2B5,HGNC:7739,NEFL,Disease-causing germline mutation(s) in,Assessed
2781,GARD:0004155,Osteopetrosis,69088,Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome,HGNC:5961,IKBKG,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:8803,PDGFRA,Part of a fusion gene in,Assessed
401854,GARD:0012679,Lipoic acid biosynthesis defects,401862,Lipoyl transferase 1 deficiency,HGNC:29569,LIPT1,Disease-causing germline mutation(s) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,435387,Autosomal dominant Charcot-Marie-Tooth disease type 2Y,HGNC:12666,VCP,Disease-causing germline mutation(s) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,99854,Cree leukoencephalopathy,HGNC:3258,EIF2B2,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,157716,Late infantile CACH syndrome,HGNC:3261,EIF2B5,Disease-causing germline mutation(s) in,Assessed
765,GARD:0007513,Pyruvate dehydrogenase complex deficiency,255138,Pyruvate dehydrogenase E1-beta deficiency,HGNC:8808,PDHB,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,99852,Ravine syndrome,HGNC:54925,SLC7A2-IT1,Disease-causing germline mutation(s) in,Assessed
289899,GARD:0009433,Organic acidemias,391457,"HSD10 disease, neonatal type",HGNC:4800,HSD17B10,Disease-causing germline mutation(s) in,Assessed
1048,GARD:0005808,Anencephaly,563609,Isolated anencephaly,HGNC:15511,VANGL2,Major susceptibility factor in,Assessed
408,GARD:0002807,Hyperglycerolemia,284414,"Glycerol kinase deficiency, adult form",HGNC:4289,GK,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268388,Lumbosacral spina bifida aperta,HGNC:7432,MTHFD1,Major susceptibility factor in,Assessed
823,GARD:0007673,Spina bifida,268392,Cervical spina bifida aperta,HGNC:7432,MTHFD1,Major susceptibility factor in,Assessed
442,GARD:0001487,Congenital hypothyroidism,95716,Familial thyroid dyshormonogenesis,HGNC:21071,IYD,Disease-causing germline mutation(s) in,Assessed
370953,GARD:0012584,Congenital muscular dystrophy due to dystroglycanopathy ,370959,Congenital muscular dystrophy with cerebellar involvement,HGNC:26267,POMK,Disease-causing germline mutation(s) (loss of function) in,Assessed
2781,GARD:0004155,Osteopetrosis,94063,12q14 microdeletion syndrome,HGNC:28887,LEMD3,Role in the phenotype of,Assessed
2781,GARD:0004155,Osteopetrosis,166119,Isolated osteopoikilosis,HGNC:28887,LEMD3,Disease-causing germline mutation(s) (loss of function) in,Assessed
511,GARD:0003228,Maple syrup urine disease,268173,Intermittent maple syrup urine disease,HGNC:987,BCKDHB,Disease-causing germline mutation(s) (loss of function) in,Assessed
93548,GARD:0012736,Glomerular disease,329903,Immunoglobulin-mediated membranoproliferative glomerulonephritis,HGNC:4883,CFH,Disease-causing germline mutation(s) in,Assessed
309279,GARD:0010670,Glycoproteinosis,423461,Mucolipidosis type III alpha/beta,HGNC:29670,GNPTAB,Disease-causing germline mutation(s) (loss of function) in,Assessed
93969,GARD:0003475,Myelomeningocele,268762,Cervical spina bifida cystica,HGNC:7436,MTHFR,Major susceptibility factor in,Assessed
252057,GARD:0012697,Tumor of cranial and spinal nerves,252128,Malignant peripheral nerve sheath tumor with perineurial differentiation,HGNC:9476,HTRA1,Part of a fusion gene in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:9652,PTPN22,Major susceptibility factor in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:11474,SURF1,Disease-causing germline mutation(s) (loss of function) in,Assessed
1531,GARD:0006209,Craniosynostosis,35099,Isolated brachycephaly,HGNC:12872,ZIC1,Disease-causing germline mutation(s) (gain of function) in,Assessed
823,GARD:0007673,Spina bifida,268770,Upper thoracic spina bifida cystica,HGNC:7436,MTHFR,Major susceptibility factor in,Assessed
98757,GARD:0006801,Spinocerebellar ataxia 3,276244,Machado-Joseph disease type 3,HGNC:7106,ATXN3,Disease-causing germline mutation(s) in,Assessed
178029,GARD:0006015,Central diabetes insipidus,30925,Hereditary central diabetes insipidus,HGNC:894,AVP,Disease-causing germline mutation(s) (loss of function) in,Assessed
352,GARD:0002424,Galactosemia,79239,Classic galactosemia,HGNC:4135,GALT,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268758,Lumbosacral spina bifida cystica,HGNC:7436,MTHFR,Major susceptibility factor in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,309155,"Sandhoff disease, infantile form",HGNC:4879,HEXB,Disease-causing germline mutation(s) (loss of function) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,324611,Autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation,HGNC:6323,KIF5A,Disease-causing germline mutation(s) in,Assessed
253,GARD:0007687,Spondyloepiphyseal dysplasia,228387,Spondylo-megaepiphyseal-metaphyseal dysplasia,HGNC:951,NKX3-2,Disease-causing germline mutation(s) in,Assessed
98878,GARD:0006591,Hemophilia A,169805,Moderate hemophilia A,HGNC:3546,F8,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,280195,Septopreoptic holoprosencephaly,HGNC:10879,STIL,Disease-causing germline mutation(s) in,Assessed
308166,GARD:0010923,Erythrokeratodermia variabilis et progressiva,317,Erythrokeratodermia variabilis,HGNC:4285,GJB3,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,309178,"Tay-Sachs disease, B variant, infantile form",HGNC:4878,HEXA,Disease-causing germline mutation(s) in,Assessed
357058,GARD:0001638,"Cutis laxa, autosomal recessive type 2A",357074,"Autosomal recessive cutis laxa type 2, classic type",HGNC:18481,ATP6V0A2,Disease-causing germline mutation(s) (loss of function) in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:3618,FCGR2B,Major susceptibility factor in,Assessed
226298,GARD:0012280,Central congenital hypothyroidism,226307,Hypothyroidism due to deficient transcription factors involved in pituitary development or function,HGNC:9455,PROP1,Disease-causing germline mutation(s) in,Assessed
407,GARD:0007219,Glycine encephalopathy,289857,Neonatal glycine encephalopathy,HGNC:4208,GCSH,Disease-causing germline mutation(s) in,Assessed
263,GARD:0006907,Limb-girdle muscular dystrophy,352479,ISPD-related  limb-girdle muscular dystrophy R20,HGNC:37276,CRPPA,Disease-causing germline mutation(s) (loss of function) in,Assessed
98277,GARD:0012758,Acute myeloid leukemia with recurrent genetic anomaly,402026,Acute myeloid leukemia with NPM1 somatic mutations,HGNC:7910,NPM1,Disease-causing somatic mutation(s) in,Assessed
319276,GARD:0009574,Clear cell renal cell carcinoma,404511,Clear cell papillary renal cell carcinoma,HGNC:7105,MITF,Major susceptibility factor in,Assessed
101330,GARD:0007433,Porphyria cutanea tarda,443062,Familial porphyria cutanea tarda,HGNC:4886,HFE,Modifying germline mutation in,Assessed
1048,GARD:0005808,Anencephaly,563612,Isolated exencephaly,HGNC:7436,MTHFR,Major susceptibility factor in,Assessed
28,GARD:0012623,Adenosylcobalamin deficiency,308442,"Vitamin B12-responsive methylmalonic acidemia, type cblDv2",HGNC:25221,MMADHC,Disease-causing germline mutation(s) in,Assessed
183660,GARD:0007628,Severe combined immunodeficiency,228003,Severe combined immunodeficiency due to CORO1A deficiency,HGNC:2252,CORO1A,Disease-causing germline mutation(s) in,Assessed
64749,GARD:0012440,Charcot-Marie-Tooth disease type 4,391351,SURF1-related Charcot-Marie-Tooth disease type 4,HGNC:11474,SURF1,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,309169,"Sandhoff disease, adult form",HGNC:4879,HEXB,Disease-causing germline mutation(s) (loss of function) in,Assessed
61,GARD:0006968,Alpha-mannosidosis,309288,"Alpha-mannosidosis, adult form",HGNC:6826,MAN2B1,Disease-causing germline mutation(s) in,Assessed
646,GARD:0007207,Niemann-Pick disease type C1,216975,"Niemann-Pick disease type C, severe early infantile neurologic onset",HGNC:7897,NPC1,Disease-causing germline mutation(s) in,Assessed
817,GARD:0007347,Peeling skin syndrome,263548,Peeling skin syndrome type A,HGNC:15993,CHST8,Disease-causing germline mutation(s) (loss of function) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:7684,NDUFA10,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93926,Midline interhemispheric variant of holoprosencephaly,HGNC:3814,FOXH1,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99860,Precursor B-cell acute lymphoblastic leukemia,HGNC:23063,NUDT15,Candidate gene tested in,Not yet assessed
590,GARD:0011902,Congenital myasthenic syndromes,98915,Synaptic congenital myasthenic syndromes,HGNC:2226,COLQ,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,488594,Autosomal recessive spastic paraplegia type 76,HGNC:1476,CAPN1,Disease-causing germline mutation(s) (loss of function) in,Assessed
182067,GARD:0006513,Glioma,251579,Giant cell glioblastoma,HGNC:33280,SEPTIN14,Part of a fusion gene in,Assessed
79373,GARD:0006317,Ectodermal dysplasia,589608,"Linear hypopigmentation and craniofacial asymmetry with acral, ocular and brain anomalies",HGNC:667,RHOA,Disease-causing germline mutation(s) in,Assessed
282,GARD:0008436,Frontotemporal dementia,275864,Behavioral variant of frontotemporal dementia,HGNC:4601,GRN,Major susceptibility factor in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:10879,STIL,Part of a fusion gene in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293888,"Familial isolated arrhythmogenic ventricular dysplasia, left dominant form",HGNC:28472,TMEM43,Disease-causing germline mutation(s) (loss of function) in,Assessed
85,GARD:0001999,Congenital dyserythropoietic anemia,293825,Congenital dyserythropoietic anemia type IV,HGNC:6345,KLF1,Disease-causing germline mutation(s) in,Assessed
268994,GARD:0010190,Focal cortical dysplasia of Taylor,269001,Isolated focal cortical dysplasia type IIa,HGNC:3942,MTOR,Disease-causing somatic mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268766,Cervicothoracic spina bifida cystica,HGNC:15512,VANGL1,Major susceptibility factor in,Assessed
289899,GARD:0009433,Organic acidemias,308425,Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency,HGNC:16732,MCEE,Disease-causing germline mutation(s) in,Assessed
85458,GARD:0010266,Hereditary cerebral hemorrhage with amyloidosis,100008,ACys amyloidosis,HGNC:2475,CST3,Disease-causing germline mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,370968,Congenital muscular dystrophy with intellectual disability,HGNC:22932,GMPPB,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:8619,PAX5,Major susceptibility factor in,Assessed
206428,GARD:0002943,Hypoxanthine guanine phosphoribosyltransferase deficiency,79233,Hypoxanthine guanine phosphoribosyltransferase partial deficiency,HGNC:5157,HPRT1,Disease-causing germline mutation(s) (loss of function) in,Assessed
98473,GARD:0007922,Muscular dystrophy,98853,Autosomal dominant Emery-Dreifuss muscular dystrophy,HGNC:28472,TMEM43,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:2621,CYP2C19,Candidate gene tested in,Not yet assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,521414,Autosomal dominant Charcot-Marie-Tooth disease type 2DD,HGNC:799,ATP1A1,Disease-causing germline mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,401820,Autosomal recessive spastic paraplegia type 67,HGNC:25712,PGAP1,Disease-causing germline mutation(s) in,Assessed
91378,GARD:0005979,Hereditary angioedema,599418,Hereditary angioedema with normal C1Inh not related to F12 or PLG variant,HGNC:3656,MYOF,Disease-causing germline mutation(s) in,Assessed
182067,GARD:0006513,Glioma,251604,Gemistocytic astrocytoma,HGNC:5383,IDH2,Biomarker tested in,Assessed
2134,GARD:0008702,Atypical hemolytic uremic syndrome,93581,Atypical hemolytic uremic syndrome with anti-factor H antibodies,HGNC:16980,CFHR3,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,171612,Autosomal dominant spastic paraplegia type 37,HGNC:33472,SPG37,Disease-causing germline mutation(s) in,Assessed
98634,GARD:0002978,Iridogoniodysgenesis type 1,519388,Autosomal recessive anterior segment dysgenesis,HGNC:23228,CPAMD8,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:76,ABL1,Part of a fusion gene in,Assessed
97242,GARD:0009138,Congenital muscular dystrophy,370959,Congenital muscular dystrophy with cerebellar involvement,HGNC:17997,FKRP,Disease-causing germline mutation(s) in,Assessed
167714,GARD:0012760,Unclassified acute myeloid leukemia ,99887,Acute megakaryoblastic leukemia in Down syndrome,HGNC:4170,GATA1,Disease-causing somatic mutation(s) in,Assessed
79456,GARD:0012686,Diffuse cutaneous mastocytosis,280794,Pseudoxanthomatous diffuse cutaneous mastocytosis,HGNC:6342,KIT,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268740,Upper thoracic spina bifida aperta,HGNC:15512,VANGL1,Major susceptibility factor in,Assessed
2162,GARD:0006665,Holoprosencephaly,93925,Alobar holoprosencephaly,HGNC:19711,DISP1,Disease-causing germline mutation(s) in,Assessed
2542,GARD:0012085,Microphthalmia,35612,Nanophthalmos,HGNC:18662,RAX,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,171607,X-linked spastic paraplegia type 34,HGNC:32944,SPG34,Disease-causing germline mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,370968,Congenital muscular dystrophy with intellectual disability,HGNC:17997,FKRP,Disease-causing germline mutation(s) in,Assessed
79430,GARD:0006643,Hermansky-Pudlak syndrome,231512,Hermansky-Pudlak syndrome due to BLOC-2 deficiency,HGNC:18817,HPS6,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268392,Cervical spina bifida aperta,HGNC:15512,VANGL1,Major susceptibility factor in,Assessed
79225,GARD:0007672,Sphingolipidosis,309155,"Sandhoff disease, infantile form",HGNC:4879,HEXB,Disease-causing germline mutation(s) (loss of function) in,Assessed
710,GARD:0007380,Pfeiffer syndrome,93258,Pfeiffer syndrome type 1,HGNC:3689,FGFR2,Disease-causing germline mutation(s) (gain of function) in,Assessed
360,GARD:0002491,Glioblastoma,251579,Giant cell glioblastoma,HGNC:6742,LZTR1,Disease-causing somatic mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,447757,Autosomal dominant spastic paraplegia type 9B,HGNC:9722,ALDH18A1,Disease-causing germline mutation(s) (loss of function) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,157719,Juvenile or adult CACH syndrome,HGNC:3260,EIF2B4,Disease-causing germline mutation(s) in,Assessed
66646,GARD:0007842,Cutaneous mastocytosis,158766,Typical urticaria pigmentosa,HGNC:6342,KIT,Disease-causing germline mutation(s) in,Assessed
251595,GARD:0005907,Diffuse astrocytoma,251601,Fibrillary astrocytoma,HGNC:5383,IDH2,Biomarker tested in,Assessed
370953,GARD:0012584,Congenital muscular dystrophy due to dystroglycanopathy ,370980,Congenital muscular dystrophy without intellectual disability,HGNC:37276,CRPPA,Disease-causing germline mutation(s) (loss of function) in,Assessed
182058,GARD:0012959,Primary orthostatic hypotension,2828,Young-onset Parkinson disease,HGNC:15469,DNAJC6,Disease-causing germline mutation(s) (loss of function) in,Assessed
98306,GARD:0011962,Familial partial lipodystrophy,435660,LIPE-related familial partial lipodystrophy,HGNC:6621,LIPE,Disease-causing germline mutation(s) in,Assessed
848,GARD:0000871,Beta-thalassemia,231226,Dominant beta-thalassemia,HGNC:4827,HBB,Disease-causing germline mutation(s) in,Assessed
646,GARD:0007207,Niemann-Pick disease type C1,216972,"Niemann-Pick disease type C, severe perinatal form",HGNC:7897,NPC1,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:11648,TCL1A,Part of a fusion gene in,Assessed
98878,GARD:0006591,Hemophilia A,169802,Severe hemophilia A,HGNC:3546,F8,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93926,Midline interhemispheric variant of holoprosencephaly,HGNC:7865,NODAL,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,220386,Semilobar holoprosencephaly,HGNC:10889,SIX3,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268748,Total spina bifida cystica,HGNC:7436,MTHFR,Major susceptibility factor in,Assessed
96169,GARD:0010727,Koolen de Vries syndrome,363965,Koolen-De Vries syndrome due to a point mutation,HGNC:24565,KANSL1,Disease-causing germline mutation(s) (loss of function) in,Assessed
273,GARD:0008310,Myotonic dystrophy type 1,589821,Congenital-onset Steinert myotonic dystrophy,HGNC:2933,DMPK,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93924,Lobar holoprosencephaly,HGNC:19711,DISP1,Disease-causing germline mutation(s) in,Assessed
436,GARD:0006734,Hypophosphatasia,247685,Odontohypophosphatasia,HGNC:438,ALPL,Disease-causing germline mutation(s) (loss of function) in,Assessed
2542,GARD:0012085,Microphthalmia,35612,Nanophthalmos,HGNC:11195,SOX2,Disease-causing germline mutation(s) in,Assessed
72,GARD:0005810,Angelman syndrome,411515,Angelman syndrome due to imprinting defect in 15q11-q13,HGNC:12496,UBE3A,Role in the phenotype of,Assessed
91378,GARD:0005979,Hereditary angioedema,100054,F12-related hereditary angioedema with normal C1Inh,HGNC:3530,F12,Disease-causing germline mutation(s) (gain of function) in,Assessed
3033,GARD:0000379,Renal tubular dysgenesis,97369,Renal tubular dysgenesis of genetic origin,HGNC:333,AGT,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268740,Upper thoracic spina bifida aperta,HGNC:11515,TBXT,Major susceptibility factor in,Assessed
739,GARD:0005575,Prader-Willi syndrome,177910,Prader-Willi syndrome due to imprinting mutation,HGNC:7675,NDN,Role in the phenotype of,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:7707,NDUFS1,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:7708,NDUFS2,Disease-causing germline mutation(s) in,Assessed
739,GARD:0005575,Prader-Willi syndrome,177901,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1,HGNC:11164,SNRPN,Role in the phenotype of,Assessed
411709,GARD:0009228,Renal agenesis,93100,"Renal agenesis, unilateral",HGNC:1071,BMP4,Disease-causing germline mutation(s) in,Assessed
1531,GARD:0006209,Craniosynostosis,35099,Isolated brachycephaly,HGNC:11623,TCF12,Disease-causing germline mutation(s) (loss of function) in,Assessed
68356,GARD:0006895,Leukodystrophy,51,Aicardi-Goutières syndrome,HGNC:18518,RNASEH2A,Disease-causing germline mutation(s) in,Assessed
309279,GARD:0010670,Glycoproteinosis,309288,"Alpha-mannosidosis, adult form",HGNC:6826,MAN2B1,Disease-causing germline mutation(s) in,Assessed
72,GARD:0005810,Angelman syndrome,98794,Angelman syndrome due to maternal 15q11q13 deletion,HGNC:12496,UBE3A,Role in the phenotype of,Assessed
823,GARD:0007673,Spina bifida,268740,Upper thoracic spina bifida aperta,HGNC:7436,MTHFR,Major susceptibility factor in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,99887,Acute megakaryoblastic leukemia in Down syndrome,HGNC:4170,GATA1,Disease-causing somatic mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:7553,MYC,Part of a fusion gene in,Assessed
93969,GARD:0003475,Myelomeningocele,268752,Thoracolumbosacral spina bifida cystica,HGNC:11515,TBXT,Major susceptibility factor in,Assessed
217071,GARD:0008417,Renal cell carcinoma 4,319298,Papillary renal cell carcinoma,HGNC:7029,MET,Disease-causing somatic mutation(s) in,Assessed
79225,GARD:0007672,Sphingolipidosis,216981,"Niemann-Pick disease type C, juvenile neurologic onset",HGNC:14537,NPC2,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,309256,"Metachromatic leukodystrophy, late infantile form",HGNC:9498,PSAP,Disease-causing germline mutation(s) in,Assessed
93402,GARD:0005081,Syndactyly type 1,295191,Zygodactyly type 3,HGNC:5136,HOXD13,Disease-causing germline mutation(s) in,Assessed
156005,GARD:0002490,Glaucoma 3 primary infantile B,98976,Congenital glaucoma,HGNC:6715,LTBP2,Disease-causing germline mutation(s) in,Assessed
370953,GARD:0012584,Congenital muscular dystrophy due to dystroglycanopathy ,370968,Congenital muscular dystrophy with intellectual disability,HGNC:22932,GMPPB,Disease-causing germline mutation(s) in,Assessed
181393,GARD:0003924,Growth hormone insensitivity with immunodeficiency,220465,Laron syndrome with immunodeficiency,HGNC:11367,STAT5B,Disease-causing germline mutation(s) in,Assessed
657,GARD:0003947,Congenital hyperinsulinism,79644,Autosomal recessive hyperinsulinism due to Kir6.2 deficiency,HGNC:6257,KCNJ11,Disease-causing germline mutation(s) in,Assessed
66646,GARD:0007842,Cutaneous mastocytosis,158769,Plaque-form urticaria pigmentosa,HGNC:6342,KIT,Disease-causing germline mutation(s) in,Assessed
683,GARD:0007471,Progressive supranuclear palsy,240071,Classic progressive supranuclear palsy syndrome,HGNC:6893,MAPT,Major susceptibility factor in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:11556,TAL1,Part of a fusion gene in,Assessed
226298,GARD:0012280,Central congenital hypothyroidism,99832,Resistance to thyrotropin-releasing hormone syndrome,HGNC:12299,TRHR,Disease-causing germline mutation(s) (loss of function) in,Assessed
739,GARD:0005575,Prader-Willi syndrome,98754,Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15,HGNC:7675,NDN,Role in the phenotype of,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:2745,DDX3X,Part of a fusion gene in,Assessed
98473,GARD:0007922,Muscular dystrophy,370959,Congenital muscular dystrophy with cerebellar involvement,HGNC:22932,GMPPB,Disease-causing germline mutation(s) in,Assessed
98261,GARD:0007140,Progressive myoclonic epilepsy,402082,Progressive myoclonic epilepsy type 5,HGNC:20340,PRICKLE2,Candidate gene tested in,Not yet assessed
98261,GARD:0007140,Progressive myoclonic epilepsy,457265,Progressive myoclonic epilepsy type 9,HGNC:6638,LMNB2,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,85136,Cystic leukoencephalopathy without megalencephaly,HGNC:7685,NDUFA2,Disease-causing germline mutation(s) (loss of function) in,Assessed
2134,GARD:0008702,Atypical hemolytic uremic syndrome,544472,Atypical hemolytic uremic syndrome with complement gene abnormality,HGNC:11784,THBD,Disease-causing germline mutation(s) in,Assessed
309144,GARD:0012510,Gangliosidosis,309162,"Sandhoff disease, juvenile form",HGNC:4879,HEXB,Disease-causing germline mutation(s) (loss of function) in,Assessed
79373,GARD:0006317,Ectodermal dysplasia,69084,Pure hair and nail ectodermal dysplasia,HGNC:28929,KRT74,Disease-causing germline mutation(s) (loss of function) in,Assessed
748,GARD:0012977,Mendelian susceptibility to mycobacterial diseases,319623,X-linked mendelian susceptibility to mycobacterial diseases due to CYBB deficiency,HGNC:2578,CYBB,Disease-causing germline mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,370968,Congenital muscular dystrophy with intellectual disability,HGNC:17997,FKRP,Disease-causing germline mutation(s) in,Assessed
518,GARD:0000524,Acute megakaryoblastic leukemia,99887,Acute megakaryoblastic leukemia in Down syndrome,HGNC:4170,GATA1,Disease-causing somatic mutation(s) in,Assessed
85,GARD:0001999,Congenital dyserythropoietic anemia,67044,Thrombocytopenia with congenital dyserythropoietic anemia,HGNC:4170,GATA1,Disease-causing germline mutation(s) in,Assessed
91024,GARD:0012449,Autosomal recessive axonal Charcot-Marie-Tooth disease type 2,443073,Charcot-Marie-Tooth disease type 2S,HGNC:5542,IGHMBP2,Disease-causing germline mutation(s) (loss of function) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,353327,Congenital myasthenic syndromes with glycosylation defect,HGNC:22932,GMPPB,Disease-causing germline mutation(s) in,Assessed
140471,GARD:0012688,Hereditary sensory and autonomic neuropathy,453510,Congenital insensitivity to pain with severe intellectual disability,HGNC:2093,CLTCL1,Disease-causing germline mutation(s) in,Assessed
268994,GARD:0010190,Focal cortical dysplasia of Taylor,269001,Isolated focal cortical dysplasia type IIa,HGNC:12363,TSC2,Disease-causing somatic mutation(s) in,Assessed
91385,GARD:0008605,Acquired angioedema,100057,Renin-angiotensin-aldosterone system-blocker-induced angioedema,HGNC:12823,XPNPEP2,Major susceptibility factor in,Not yet assessed
1329,GARD:0001454,Complete atrioventricular canal,99067,Complete atrioventricular septal defect with ventricular hypoplasia,HGNC:4174,GATA6,Disease-causing germline mutation(s) in,Not yet assessed
748,GARD:0012977,Mendelian susceptibility to mycobacterial diseases,319563,Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency,HGNC:4053,ISG15,Disease-causing germline mutation(s) in,Assessed
54370,GARD:0011982,Membranoproliferative glomerulonephritis,329903,Immunoglobulin-mediated membranoproliferative glomerulonephritis,HGNC:2852,DGKE,Disease-causing germline mutation(s) in,Assessed
443909,GARD:0008533,Familial colorectal cancer,440437,Familial colorectal cancer Type X,HGNC:1076,BMPR1A,Candidate gene tested in,Not yet assessed
748,GARD:0012977,Mendelian susceptibility to mycobacterial diseases,319558,Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency,HGNC:5970,IL12B,Disease-causing germline mutation(s) in,Assessed
66646,GARD:0007842,Cutaneous mastocytosis,280785,Bullous diffuse cutaneous mastocytosis,HGNC:6342,KIT,Disease-causing germline mutation(s) in,Assessed
66646,GARD:0007842,Cutaneous mastocytosis,280794,Pseudoxanthomatous diffuse cutaneous mastocytosis,HGNC:6342,KIT,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268758,Lumbosacral spina bifida cystica,HGNC:11515,TBXT,Major susceptibility factor in,Assessed
442,GARD:0001487,Congenital hypothyroidism,95712,Thyroid ectopia,HGNC:2488,NKX2-5,Disease-causing germline mutation(s) in,Assessed
93969,GARD:0003475,Myelomeningocele,268770,Upper thoracic spina bifida cystica,HGNC:15512,VANGL1,Major susceptibility factor in,Assessed
823,GARD:0007673,Spina bifida,268762,Cervical spina bifida cystica,HGNC:15512,VANGL1,Major susceptibility factor in,Assessed
263543,GARD:0012862,Generalized peeling skin syndrome,263548,Peeling skin syndrome type A,HGNC:33276,FLG2,Disease-causing germline mutation(s) (loss of function) in,Assessed
710,GARD:0007380,Pfeiffer syndrome,93260,Pfeiffer syndrome type 3,HGNC:3689,FGFR2,Disease-causing germline mutation(s) (gain of function) in,Assessed
261,GARD:0006329,Emery-Dreifuss muscular dystrophy,98853,Autosomal dominant Emery-Dreifuss muscular dystrophy,HGNC:17089,SYNE1,Disease-causing germline mutation(s) in,Not yet assessed
97242,GARD:0009138,Congenital muscular dystrophy,370968,Congenital muscular dystrophy with intellectual disability,HGNC:9202,POMT1,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255249,Leigh syndrome with nephrotic syndrome,HGNC:25223,COQ2,Disease-causing germline mutation(s) in,Assessed
97242,GARD:0009138,Congenital muscular dystrophy,370968,Congenital muscular dystrophy with intellectual disability,HGNC:6511,LARGE1,Disease-causing germline mutation(s) in,Assessed
26791,GARD:0006523,Glutaric acidemia type II,394529,"Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type",HGNC:24671,FLAD1,Disease-causing germline mutation(s) (loss of function) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:1014,BCR,Part of a fusion gene in,Assessed
217,GARD:0006242,Dandy-Walker complex,269212,Isolated Dandy-Walker malformation with hydrocephalus,HGNC:12872,ZIC1,Role in the phenotype of,Assessed
79373,GARD:0006317,Ectodermal dysplasia,1810,Autosomal dominant hypohidrotic ectodermal dysplasia,HGNC:2895,EDAR,Disease-causing germline mutation(s) in,Assessed
3148,GARD:0010872,Malignant peripheral nerve sheath tumor,252128,Malignant peripheral nerve sheath tumor with perineurial differentiation,HGNC:9476,HTRA1,Part of a fusion gene in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:10879,STIL,Part of a fusion gene in,Assessed
264665,GARD:0010559,Children's interstitial lung disease,70587,Infant acute respiratory distress syndrome,HGNC:10802,SFTPC,Major susceptibility factor in,Not yet assessed
1576,GARD:0005040,Striatonigral degeneration infantile,225154,Familial infantile bilateral striatal necrosis,HGNC:225,ADAR,Disease-causing germline mutation(s) (loss of function) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,79244,Pyruvate dehydrogenase E2 deficiency,HGNC:2896,DLAT,Disease-causing germline mutation(s) (loss of function) in,Assessed
79430,GARD:0006643,Hermansky-Pudlak syndrome,231531,Hermansky-Pudlak syndrome due to BLOC-1 deficiency,HGNC:17328,DTNBP1,Disease-causing germline mutation(s) in,Assessed
646,GARD:0007207,Niemann-Pick disease type C1,216978,"Niemann-Pick disease type C, late infantile neurologic onset",HGNC:7897,NPC1,Disease-causing germline mutation(s) in,Assessed
79373,GARD:0006317,Ectodermal dysplasia,33364,Trichothiodystrophy,HGNC:21157,GTF2H5,Disease-causing germline mutation(s) in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293899,"Familial isolated arrhythmogenic ventricular dysplasia, biventricular form",HGNC:6207,JUP,Disease-causing germline mutation(s) in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293888,"Familial isolated arrhythmogenic ventricular dysplasia, left dominant form",HGNC:6207,JUP,Disease-causing germline mutation(s) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,99853,Ovarioleukodystrophy,HGNC:21022,AARS2,Disease-causing germline mutation(s) (loss of function) in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293910,"Familial isolated arrhythmogenic ventricular dysplasia, right dominant form",HGNC:3052,DSP,Disease-causing germline mutation(s) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,157713,Congenital or early infantile CACH syndrome,HGNC:3260,EIF2B4,Disease-causing germline mutation(s) in,Assessed
79373,GARD:0006317,Ectodermal dysplasia,33364,Trichothiodystrophy,HGNC:3435,ERCC3,Disease-causing germline mutation(s) in,Assessed
93969,GARD:0003475,Myelomeningocele,268758,Lumbosacral spina bifida cystica,HGNC:15512,VANGL1,Major susceptibility factor in,Assessed
68356,GARD:0006895,Leukodystrophy,363540,Leukoencephalopathy with mild cerebellar ataxia and white matter edema,HGNC:2020,CLCN2,Disease-causing germline mutation(s) (loss of function) in,Assessed
35656,GARD:0010423,Coenzyme Q10 deficiency,457185,Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome,HGNC:19693,COQ4,Disease-causing germline mutation(s) (loss of function) in,Assessed
442,GARD:0001487,Congenital hypothyroidism,90673,Hypothyroidism due to TSH receptor mutations,HGNC:12373,TSHR,Disease-causing germline mutation(s) (loss of function) in,Assessed
845,GARD:0007737,Tay-Sachs disease,309178,"Tay-Sachs disease, B variant, infantile form",HGNC:4878,HEXA,Disease-causing germline mutation(s) in,Assessed
739,GARD:0005575,Prader-Willi syndrome,177901,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1,HGNC:6814,MAGEL2,Role in the phenotype of,Assessed
102,GARD:0007079,Multiple system atrophy,227510,"Multiple system atrophy, cerebellar type",HGNC:25223,COQ2,Major susceptibility factor in,Assessed
2162,GARD:0006665,Holoprosencephaly,280195,Septopreoptic holoprosencephaly,HGNC:17104,CDON,Disease-causing germline mutation(s) in,Assessed
2467,GARD:0008616,Systemic mastocytosis,98850,Aggressive systemic mastocytosis,HGNC:10471,RUNX1,Disease-causing somatic mutation(s) in,Assessed
309144,GARD:0012510,Gangliosidosis,309185,"Tay-Sachs disease, B variant, juvenile form",HGNC:4878,HEXA,Disease-causing germline mutation(s) in,Assessed
85450,GARD:0008282,Amyloidosis familial visceral,238269,AApoAII amyloidosis,HGNC:601,APOA2,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:2505,CTLA4,Major susceptibility factor in,Assessed
97245,GARD:0005898,Myopathy congenital,424107,Congenital myopathy with myasthenic-like onset,HGNC:10483,RYR1,Disease-causing germline mutation(s) in,Assessed
590,GARD:0011902,Congenital myasthenic syndromes,353327,Congenital myasthenic syndromes with glycosylation defect,HGNC:28287,ALG14,Disease-causing germline mutation(s) in,Assessed
2442,GARD:0007906,X-linked lymphoproliferative disease due to SH2D1A deficiency,538931,X-linked lymphoproliferative disease due to SH2D1A deficiency,HGNC:10820,SH2D1A,Disease-causing germline mutation(s) in,Assessed
209,GARD:0006227,Cutis laxa,357074,"Autosomal recessive cutis laxa type 2, classic type",HGNC:18481,ATP6V0A2,Disease-causing germline mutation(s) (loss of function) in,Assessed
181393,GARD:0003924,Growth hormone insensitivity with immunodeficiency,140941,Short stature due to primary acid-labile subunit deficiency,HGNC:5468,IGFALS,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93925,Alobar holoprosencephaly,HGNC:12873,ZIC2,Disease-causing germline mutation(s) in,Assessed
437,GARD:0006735,Hypophosphatemic rickets,289176,Autosomal recessive hypophosphatemic rickets,HGNC:3356,ENPP1,Disease-causing germline mutation(s) in,Assessed
98277,GARD:0012758,Acute myeloid leukemia with recurrent genetic anomaly,370026,Acute myeloid leukemia with t(8;16)(p11;p13) translocation,HGNC:2348,CREBBP,Part of a fusion gene in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:8997,PIP4K2A,Major susceptibility factor in,Assessed
282,GARD:0008436,Frontotemporal dementia,275864,Behavioral variant of frontotemporal dementia,HGNC:28337,C9ORF72,Major susceptibility factor in,Assessed
442,GARD:0001487,Congenital hypothyroidism,95713,Athyreosis,HGNC:2488,NKX2-5,Disease-causing germline mutation(s) in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:7693,NDUFA9,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,320396,Autosomal recessive spastic paraplegia type 45,HGNC:8022,NT5C2,Disease-causing germline mutation(s) in,Assessed
217,GARD:0006242,Dandy-Walker complex,269215,Isolated Dandy-Walker malformation without hydrocephalus,HGNC:7821,NID1,Disease-causing germline mutation(s) in,Assessed
1531,GARD:0006209,Craniosynostosis,35098,Isolated plagiocephaly,HGNC:3690,FGFR3,Disease-causing germline mutation(s) in,Assessed
846,GARD:0000621,Alpha-thalassemia,93616,Hemoglobin H disease,HGNC:4824,HBA2,Disease-causing germline mutation(s) in,Assessed
98292,GARD:0006987,Mastocytosis,158778,Isolated bone marrow mastocytosis,HGNC:6342,KIT,Disease-causing somatic mutation(s) in,Assessed
655,GARD:0000206,Nephronophthisis,93589,Late-onset nephronophthisis,HGNC:7907,NPHP3,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93924,Lobar holoprosencephaly,HGNC:17104,CDON,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,401840,Autosomal recessive spastic paraplegia type 71,HGNC:17277,ZFR,Disease-causing germline mutation(s) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,476394,PMP2-related Charcot-Marie-Tooth disease type 1,HGNC:9117,PMP2,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,309263,"Metachromatic leukodystrophy, juvenile form",HGNC:9498,PSAP,Disease-causing germline mutation(s) in,Assessed
101330,GARD:0007433,Porphyria cutanea tarda,443062,Familial porphyria cutanea tarda,HGNC:12591,UROD,Disease-causing germline mutation(s) (loss of function) in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293899,"Familial isolated arrhythmogenic ventricular dysplasia, biventricular form",HGNC:3049,DSG2,Disease-causing germline mutation(s) in,Assessed
97360,GARD:0000312,Robinow syndrome,3107,Autosomal dominant Robinow syndrome,HGNC:12784,WNT5A,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:2956,DNASE1,Major susceptibility factor in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:16063,MLLT10,Part of a fusion gene in,Assessed
263,GARD:0006907,Limb-girdle muscular dystrophy,480682,POGLUT1-related  limb-girdle muscular dystrophy R21,HGNC:22954,POGLUT1,Disease-causing germline mutation(s) in,Assessed
289899,GARD:0009433,Organic acidemias,308442,"Vitamin B12-responsive methylmalonic acidemia, type cblDv2",HGNC:25221,MMADHC,Disease-causing germline mutation(s) in,Assessed
97360,GARD:0000312,Robinow syndrome,3107,Autosomal dominant Robinow syndrome,HGNC:3087,DVL3,Disease-causing germline mutation(s) in,Assessed
544,GARD:0003178,Diffuse Large B-Cell Lymphoma,98838,Primary mediastinal large B-cell lymphoma,HGNC:12825,XPO1,Candidate gene tested in,Assessed
79225,GARD:0007672,Sphingolipidosis,309185,"Tay-Sachs disease, B variant, juvenile form",HGNC:4878,HEXA,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,220386,Semilobar holoprosencephaly,HGNC:3814,FOXH1,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99860,Precursor B-cell acute lymphoblastic leukemia,HGNC:2621,CYP2C19,Candidate gene tested in,Not yet assessed
182067,GARD:0006513,Glioma,251636,Ependymoma,HGNC:9955,RELA,Part of a fusion gene in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,496689,Kyphoscoliosis-lateral tongue atrophy-hereditary spastic paraplegia syndrome,HGNC:26576,KY,Disease-causing germline mutation(s) in,Assessed
1531,GARD:0006209,Craniosynostosis,502430,Metopic ridging-ptosis-facial dysmorphism syndrome,HGNC:21684,ZNF462,Disease-causing germline mutation(s) in,Assessed
182058,GARD:0012959,Primary orthostatic hypotension,227510,"Multiple system atrophy, cerebellar type",HGNC:25223,COQ2,Major susceptibility factor in,Assessed
407,GARD:0007219,Glycine encephalopathy,289863,Atypical glycine encephalopathy,HGNC:4208,GCSH,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268748,Total spina bifida cystica,HGNC:15512,VANGL1,Major susceptibility factor in,Assessed
253,GARD:0007687,Spondyloepiphyseal dysplasia,157965,SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome,HGNC:20859,SLC39A13,Disease-causing germline mutation(s) in,Assessed
280886,GARD:0010941,Anterior uveitis,85408,Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis,HGNC:9652,PTPN22,Major susceptibility factor in,Assessed
182090,GARD:0007501,Pulmonary arterial hypertension,275786,Drug- or toxin-induced pulmonary arterial hypertension,HGNC:1078,BMPR2,Major susceptibility factor in,Assessed
331223,GARD:0002816,Autosomal recessive hyper IgE syndrome,369992,Severe dermatitis-multiple allergies-metabolic wasting syndrome,HGNC:3052,DSP,Disease-causing germline mutation(s) in,Assessed
98375,GARD:0005870,Autoimmune hemolytic anemia,438159,STAT3-related early-onset multisystem autoimmune disease,HGNC:11364,STAT3,Disease-causing germline mutation(s) (gain of function) in,Assessed
360,GARD:0002491,Glioblastoma,251579,Giant cell glioblastoma,HGNC:7059,MGMT,Biomarker tested in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,444099,Autosomal dominant spastic paraplegia type 73,HGNC:18540,CPT1C,Disease-causing germline mutation(s) in,Assessed
1531,GARD:0006209,Craniosynostosis,35093,Isolated scaphocephaly,HGNC:12428,TWIST1,Disease-causing germline mutation(s) in,Assessed
365,GARD:0005714,Glycogen storage disease type 2,308552,"Glycogen storage disease due to acid maltase deficiency, infantile onset",HGNC:4065,GAA,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,70474,Leigh syndrome with cardiomyopathy,HGNC:29918,NDUFAF3,Disease-causing germline mutation(s) in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,329469,Acute megakaryoblastic leukemia without Down syndrome,HGNC:1537,CBFA2T3,Part of a fusion gene in,Assessed
655,GARD:0000206,Nephronophthisis,93589,Late-onset nephronophthisis,HGNC:29536,MAPKBP1,Disease-causing germline mutation(s) (loss of function) in,Assessed
98722,GARD:0000802,Atrioventricular septal defect,99068,Complete atrioventricular septal defect-tetralogy of Fallot,HGNC:14630,CRELD1,Major susceptibility factor in,Assessed
140471,GARD:0012688,Hereditary sensory and autonomic neuropathy,157820,Cold-induced sweating syndrome,HGNC:17412,CLCF1,Disease-causing germline mutation(s) in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:10680,SDHA,Disease-causing germline mutation(s) in,Assessed
79373,GARD:0006317,Ectodermal dysplasia,1401,CHAND syndrome,HGNC:496,RIPK4,Disease-causing germline mutation(s) in,Assessed
217,GARD:0006242,Dandy-Walker complex,269212,Isolated Dandy-Walker malformation with hydrocephalus,HGNC:20393,ZIC4,Role in the phenotype of,Assessed
796,GARD:0002521,"GM2 gangliosidosis, 0 variant",309155,"Sandhoff disease, infantile form",HGNC:4879,HEXB,Disease-causing germline mutation(s) (loss of function) in,Assessed
182090,GARD:0007501,Pulmonary arterial hypertension,275798,Pulmonary arterial hypertension associated with connective tissue disease,HGNC:4932,HLA-B,Major susceptibility factor in,Not yet assessed
2781,GARD:0004155,Osteopetrosis,94063,12q14 microdeletion syndrome,HGNC:5009,HMGA2,Role in the phenotype of,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:12488,UBE2L3,Major susceptibility factor in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:12930,ZBTB16,Part of a fusion gene in,Assessed
823,GARD:0007673,Spina bifida,268766,Cervicothoracic spina bifida cystica,HGNC:7436,MTHFR,Major susceptibility factor in,Assessed
178382,GARD:0005488,Congenital vertical talus,295203,"Congenital vertical talus, bilateral",HGNC:5133,HOXD10,Disease-causing germline mutation(s) in,Assessed
2445,GARD:0008189,Conotruncal heart malformations,3384,Truncus arteriosus,HGNC:9107,PLXND1,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,70474,Leigh syndrome with cardiomyopathy,HGNC:11474,SURF1,Disease-causing germline mutation(s) (loss of function) in,Assessed
796,GARD:0002521,"GM2 gangliosidosis, 0 variant",309169,"Sandhoff disease, adult form",HGNC:4879,HEXB,Disease-causing germline mutation(s) (loss of function) in,Assessed
268994,GARD:0010190,Focal cortical dysplasia of Taylor,269008,Isolated focal cortical dysplasia type IIb,HGNC:12363,TSC2,Disease-causing somatic mutation(s) in,Assessed
655,GARD:0000206,Nephronophthisis,93592,Juvenile nephronophthisis,HGNC:7905,NPHP1,Disease-causing germline mutation(s) in,Assessed
583,GARD:0007095,Mucopolysaccharidosis type VI,276223,"Mucopolysaccharidosis type 6, slowly progressing",HGNC:714,ARSB,Disease-causing germline mutation(s) in,Assessed
251612,GARD:0009808,Pilocytic astrocytoma,251615,Pilomyxoid astrocytoma,HGNC:9829,RAF1,Part of a fusion gene in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:1323,C4A,Major susceptibility factor in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:25547,CEP72,Candidate gene tested in,Not yet assessed
2162,GARD:0006665,Holoprosencephaly,220386,Semilobar holoprosencephaly,HGNC:11111,SMC1A,Disease-causing germline mutation(s) (loss of function) in,Assessed
823,GARD:0007673,Spina bifida,268377,Total spina bifida aperta,HGNC:11515,TBXT,Major susceptibility factor in,Assessed
845,GARD:0007737,Tay-Sachs disease,309185,"Tay-Sachs disease, B variant, juvenile form",HGNC:4878,HEXA,Disease-causing germline mutation(s) in,Assessed
79225,GARD:0007672,Sphingolipidosis,216978,"Niemann-Pick disease type C, late infantile neurologic onset",HGNC:7897,NPC1,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:8064,NUP214,Part of a fusion gene in,Assessed
2162,GARD:0006665,Holoprosencephaly,220386,Semilobar holoprosencephaly,HGNC:19711,DISP1,Disease-causing germline mutation(s) in,Assessed
199647,GARD:0006333,Encephalocele,268823,Occipital encephalocele,HGNC:17748,DACT1,Disease-causing germline mutation(s) in,Assessed
593,GARD:0010529,Myofibrillar myopathy,496686,Kyphosis-lateral tongue atrophy-myofibrillar myopathy syndrome,HGNC:26576,KY,Disease-causing germline mutation(s) in,Assessed
98634,GARD:0002978,Iridogoniodysgenesis type 1,98978,Axenfeld anomaly,HGNC:9005,PITX2,Disease-causing germline mutation(s) in,Assessed
748,GARD:0012977,Mendelian susceptibility to mycobacterial diseases,477857,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency,HGNC:10260,RORC,Disease-causing germline mutation(s) in,Assessed
97242,GARD:0009138,Congenital muscular dystrophy,486815,Congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome,HGNC:12310,TRIP4,Disease-causing germline mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,468699,SLC39A8-CDG,HGNC:20862,SLC39A8,Disease-causing germline mutation(s) in,Assessed
253,GARD:0007687,Spondyloepiphyseal dysplasia,90653,Stickler syndrome type 1,HGNC:2200,COL2A1,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:7132,KMT2A,Part of a fusion gene in,Assessed
3033,GARD:0000379,Renal tubular dysgenesis,97369,Renal tubular dysgenesis of genetic origin,HGNC:9958,REN,Disease-causing germline mutation(s) in,Assessed
251612,GARD:0009808,Pilocytic astrocytoma,251615,Pilomyxoid astrocytoma,HGNC:1097,BRAF,Part of a fusion gene in,Assessed
511,GARD:0003228,Maple syrup urine disease,268173,Intermittent maple syrup urine disease,HGNC:2698,DBT,Disease-causing germline mutation(s) (loss of function) in,Assessed
91024,GARD:0012449,Autosomal recessive axonal Charcot-Marie-Tooth disease type 2,228374,Charcot-Marie-Tooth disease type 2B5,HGNC:7739,NEFL,Disease-causing germline mutation(s) in,Assessed
182067,GARD:0006513,Glioma,251579,Giant cell glioblastoma,HGNC:11524,TACC3,Part of a fusion gene in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293899,"Familial isolated arrhythmogenic ventricular dysplasia, biventricular form",HGNC:3036,DSC2,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,320375,Autosomal recessive spastic paraplegia type 55,HGNC:26784,MTRFR,Disease-causing germline mutation(s) in,Assessed
93969,GARD:0003475,Myelomeningocele,268758,Lumbosacral spina bifida cystica,HGNC:15511,VANGL2,Major susceptibility factor in,Assessed
53739,GARD:0012683,Distal hereditary motor neuropathy,314485,Young adult-onset distal hereditary motor neuropathy,HGNC:30910,VWA1,Disease-causing germline mutation(s) in,Assessed
443909,GARD:0008533,Familial colorectal cancer,144,Lynch syndrome,HGNC:8975,PIK3CA,Biomarker tested in,Assessed
182090,GARD:0007501,Pulmonary arterial hypertension,275777,Heritable pulmonary arterial hypertension,HGNC:11603,TBX4,Disease-causing germline mutation(s) in,Assessed
98841,GARD:0003112,Anaplastic large cell lymphoma,300895,ALK-positive anaplastic large cell lymphoma,HGNC:427,ALK,Disease-causing somatic mutation(s) in,Assessed
156207,GARD:0003342,Macroglossia,231117,Beckwith-Wiedemann syndrome due to imprinting defect of 11p15,HGNC:6295,KCNQ1OT1,Role in the phenotype of,Assessed
1329,GARD:0001454,Complete atrioventricular canal,99068,Complete atrioventricular septal defect-tetralogy of Fallot,HGNC:7976,NR2F2,Major susceptibility factor in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,448010,CAD-CDG,HGNC:1424,CAD,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268384,Thoracolumbosacral spina bifida aperta,HGNC:7432,MTHFD1,Major susceptibility factor in,Assessed
93548,GARD:0012736,Glomerular disease,300333,Nephrotic syndrome-epidermolysis bullosa-sensorineural deafness syndrome,HGNC:1630,CD151,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:4933,HLA-C,Major susceptibility factor in,Assessed
251,GARD:0010756,Multiple epiphyseal dysplasia,166011,"Multiple epiphyseal dysplasia, Beighton type",HGNC:2200,COL2A1,Disease-causing germline mutation(s) in,Assessed
98292,GARD:0006987,Mastocytosis,98850,Aggressive systemic mastocytosis,HGNC:18318,ASXL1,Disease-causing somatic mutation(s) in,Assessed
264665,GARD:0010559,Children's interstitial lung disease,440427,Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency,HGNC:6898,MARS1,Disease-causing germline mutation(s) (loss of function) in,Assessed
98634,GARD:0003026,Iridogoniodysgenesis type 2,488197,Familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome,HGNC:31582,MIR204,Disease-causing germline mutation(s) (gain of function) in,Assessed
216675,GARD:0007795,Transposition of the great arteries,216729,Congenitally uncorrected transposition of the great arteries with cardiac malformation,HGNC:18292,CFC1,Candidate gene tested in,Not yet assessed
63454,GARD:0009821,Pattern dystrophy,99001,Butterfly-shaped pigment dystrophy,HGNC:8522,OTX2,Disease-causing germline mutation(s) in,Assessed
98261,GARD:0007140,Progressive myoclonic epilepsy,228354,CLN8 disease,HGNC:2079,CLN8,Disease-causing germline mutation(s) in,Assessed
2467,GARD:0008616,Systemic mastocytosis,98849,Systemic mastocytosis with associated hematologic neoplasm,HGNC:10783,SRSF2,Disease-causing somatic mutation(s) in,Assessed
309279,GARD:0010670,Glycoproteinosis,79281,Alpha-N-acetylgalactosaminidase deficiency type 3,HGNC:7631,NAGA,Disease-causing germline mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,431272,X-linked scapuloperoneal muscular dystrophy,HGNC:3702,FHL1,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,320380,Autosomal recessive spastic paraplegia type 54,HGNC:29106,DDHD2,Disease-causing germline mutation(s) in,Assessed
755,GARD:0003244,Leydig cell hypoplasia,96266,Leydig cell hypoplasia due to partial LH resistance,HGNC:6585,LHCGR,Disease-causing germline mutation(s) (loss of function) in,Assessed
93969,GARD:0003475,Myelomeningocele,268766,Cervicothoracic spina bifida cystica,HGNC:26219,FUZ,Disease-causing germline mutation(s) in,Assessed
79373,GARD:0006317,Ectodermal dysplasia,69084,Pure hair and nail ectodermal dysplasia,HGNC:5125,HOXC13,Disease-causing germline mutation(s) (loss of function) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:12271,TRG,Candidate gene tested in,Not yet assessed
391417,GARD:0010716,HSD10 disease,391457,"HSD10 disease, neonatal type",HGNC:4800,HSD17B10,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93925,Alobar holoprosencephaly,HGNC:3686,FGF8,Disease-causing germline mutation(s) in,Assessed
280886,GARD:0010941,Anterior uveitis,85408,Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis,HGNC:11365,STAT4,Major susceptibility factor in,Assessed
93548,GARD:0012736,Glomerular disease,329481,Lipoprotein glomerulopathy,HGNC:613,APOE,Disease-causing germline mutation(s) in,Assessed
97245,GARD:0005898,Myopathy congenital,363409,Fetal akinesia-cerebral and retinal hemorrhage syndrome,HGNC:2974,DNM2,Disease-causing germline mutation(s) in,Assessed
116,GARD:0003343,Beckwith-Wiedemann syndrome,231117,Beckwith-Wiedemann syndrome due to imprinting defect of 11p15,HGNC:5466,IGF2,Role in the phenotype of,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,497757,MME-related autosomal dominant Charcot Marie Tooth disease type 2,HGNC:7154,MME,Disease-causing germline mutation(s) (loss of function) in,Assessed
367,GARD:0002520,Glycogen storage disease type 4,308712,"Glycogen storage disease due to glycogen branching enzyme deficiency, adult neuromuscular form",HGNC:4180,GBE1,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:11934,TNFSF4,Major susceptibility factor in,Assessed
68356,GARD:0006895,Leukodystrophy,206443,Late-infantile/juvenile Krabbe disease,HGNC:4115,GALC,Disease-causing germline mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,370959,Congenital muscular dystrophy with cerebellar involvement,HGNC:26267,POMK,Disease-causing germline mutation(s) (loss of function) in,Assessed
112,GARD:0005893,Bartter syndrome,93604,Antenatal Bartter syndrome,HGNC:16353,MAGED2,Disease-causing germline mutation(s) (loss of function) in,Assessed
2913,GARD:0004410,Polydactyly,93334,Postaxial polydactyly type A,HGNC:28532,KIAA0825,Disease-causing germline mutation(s) in,Assessed
385,GARD:0011899,Neurodegeneration with brain iron accumulation,216873,Atypical pantothenate kinase-associated neurodegeneration,HGNC:15894,PANK2,Disease-causing germline mutation(s) in,Assessed
442,GARD:0001487,Congenital hypothyroidism,226307,Hypothyroidism due to deficient transcription factors involved in pituitary development or function,HGNC:6595,LHX3,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,93562,AFib amyloidosis,HGNC:3661,FGA,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:4977,HLF,Part of a fusion gene in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,320385,Hereditary sensory and autonomic neuropathy due to TECPR2 mutation,HGNC:19957,TECPR2,Disease-causing germline mutation(s) in,Assessed
52688,GARD:0007132,Myelodysplastic syndromes,98827,Unclassified myelodysplastic syndrome,HGNC:4171,GATA2,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:5056,TLX1,Part of a fusion gene in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,401810,Autosomal recessive spastic paraplegia type 64,HGNC:3363,ENTPD1,Disease-causing germline mutation(s) in,Assessed
1037,GARD:0000777,Arthrogryposis multiplex congenita,486811,Prenatal-onset spinal muscular atrophy with congenital bone fractures,HGNC:12310,TRIP4,Disease-causing germline mutation(s) in,Assessed
252057,GARD:0012697,Tumor of cranial and spinal nerves,252128,Malignant peripheral nerve sheath tumor with perineurial differentiation,HGNC:23664,SH3PXD2A,Part of a fusion gene in,Assessed
367,GARD:0002520,Glycogen storage disease type 4,308621,"Glycogen storage disease due to glycogen branching enzyme deficiency, progressive hepatic form",HGNC:4180,GBE1,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:12252,TRD,Part of a fusion gene in,Assessed
68356,GARD:0006895,Leukodystrophy,280229,Pelizaeus-Merzbacher disease in female carriers,HGNC:9086,PLP1,Disease-causing germline mutation(s) in,Assessed
168956,GARD:0002804,Hypereosinophilic syndrome,314950,Primary hypereosinophilic syndrome,HGNC:3688,FGFR1,Part of a fusion gene in,Assessed
823,GARD:0007673,Spina bifida,268388,Lumbosacral spina bifida aperta,HGNC:15511,VANGL2,Major susceptibility factor in,Assessed
1531,GARD:0006209,Craniosynostosis,565858,Craniosynostosis-microretrognathia-severe intellectual disability syndrome,HGNC:9314,PPP3CA,Disease-causing germline mutation(s) in,Assessed
32,GARD:0010047,Glutathione synthetase deficiency,289846,Glutathione synthetase deficiency with 5-oxoprolinuria,HGNC:4624,GSS,Disease-causing germline mutation(s) (loss of function) in,Assessed
93969,GARD:0003475,Myelomeningocele,268762,Cervical spina bifida cystica,HGNC:7432,MTHFD1,Major susceptibility factor in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:28625,NDUFAF6,Disease-causing germline mutation(s) in,Assessed
1037,GARD:0000777,Arthrogryposis multiplex congenita,210163,"Congenital lethal myopathy, Compton-North type",HGNC:2171,CNTN1,Disease-causing germline mutation(s) in,Assessed
655,GARD:0000206,Nephronophthisis,93591,Infantile nephronophthisis,HGNC:17966,CEP83,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,457406,Multiple mitochondrial dysfunctions syndrome type 4,HGNC:19857,ISCA2,Disease-causing germline mutation(s) in,Assessed
3148,GARD:0010872,Malignant peripheral nerve sheath tumor,252128,Malignant peripheral nerve sheath tumor with perineurial differentiation,HGNC:23664,SH3PXD2A,Part of a fusion gene in,Assessed
209,GARD:0006227,Cutis laxa,357074,"Autosomal recessive cutis laxa type 2, classic type",HGNC:851,ATP6V1A,Disease-causing germline mutation(s) in,Assessed
98634,GARD:0003026,Iridogoniodysgenesis type 2,98978,Axenfeld anomaly,HGNC:3800,FOXC1,Disease-causing germline mutation(s) in,Assessed
401854,GARD:0012679,Lipoic acid biosynthesis defects,401866,Childhood-onset spasticity with hyperglycinemia,HGNC:20134,GLRX5,Disease-causing germline mutation(s) in,Assessed
253,GARD:0007687,Spondyloepiphyseal dysplasia,459070,X-linked intellectual disability-cerebellar hypoplasia-spondylo-epiphyseal dysplasia syndrome,HGNC:10298,RPL10,Disease-causing germline mutation(s) in,Assessed
3242,GARD:0009509,Renpenning syndrome,93950,"X-linked intellectual disability, Sutherland-Haan type",HGNC:9330,PQBP1,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,436271,Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy,HGNC:20492,COA8,Disease-causing germline mutation(s) in,Assessed
253,GARD:0007687,Spondyloepiphyseal dysplasia,93279,Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis,HGNC:2200,COL2A1,Disease-causing germline mutation(s) in,Assessed
418,GARD:0001467,Congenital adrenal hyperplasia,63269,Antley-Bixler syndrome with genital anomaly and disorder of steroidogenesis,HGNC:9208,POR,Disease-causing germline mutation(s) (loss of function) in,Assessed
216675,GARD:0007795,Transposition of the great arteries,99042,Congenitally uncorrected transposition of the great arteries with coarctation,HGNC:18292,CFC1,Candidate gene tested in,Not yet assessed
168956,GARD:0002804,Hypereosinophilic syndrome,314950,Primary hypereosinophilic syndrome,HGNC:19124,FIP1L1,Part of a fusion gene in,Assessed
156207,GARD:0003342,Macroglossia,231117,Beckwith-Wiedemann syndrome due to imprinting defect of 11p15,HGNC:5466,IGF2,Role in the phenotype of,Assessed
739,GARD:0005575,Prader-Willi syndrome,177910,Prader-Willi syndrome due to imprinting mutation,HGNC:32780,SNORD115@,Role in the phenotype of,Assessed
182067,GARD:0006513,Glioma,251615,Pilomyxoid astrocytoma,HGNC:8032,NTRK2,Part of a fusion gene in,Assessed
68356,GARD:0006895,Leukodystrophy,99854,Cree leukoencephalopathy,HGNC:3261,EIF2B5,Disease-causing germline mutation(s) in,Assessed
140471,GARD:0012688,Hereditary sensory and autonomic neuropathy,320385,Hereditary sensory and autonomic neuropathy due to TECPR2 mutation,HGNC:19957,TECPR2,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,157716,Late infantile CACH syndrome,HGNC:3259,EIF2B3,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:12269,TREX1,Major susceptibility factor in,Assessed
141,GARD:0005984,Canavan disease,314911,Severe Canavan disease,HGNC:756,ASPA,Disease-causing germline mutation(s) (loss of function) in,Assessed
407,GARD:0007219,Glycine encephalopathy,289857,Neonatal glycine encephalopathy,HGNC:4313,GLDC,Disease-causing germline mutation(s) in,Assessed
34149,GARD:0010801,Autosomal dominant tubulointerstitial kidney disease,217330,REN-related autosomal dominant tubulointerstitial kidney disease,HGNC:9958,REN,Disease-causing germline mutation(s) in,Assessed
217071,GARD:0008417,Renal cell carcinoma 4,319308,MiT family translocation renal cell carcinoma,HGNC:2092,CLTC,Part of a fusion gene in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",90796,"46,XY disorder of sex development due to isolated 17,20-lyase deficiency",HGNC:2593,CYP17A1,Disease-causing germline mutation(s) in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",456328,X-linked myotubular myopathy-abnormal genitalia syndrome,HGNC:7448,MTM1,Role in the phenotype of,Assessed
2542,GARD:0012085,Microphthalmia,35612,Nanophthalmos,HGNC:8522,OTX2,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93926,Midline interhemispheric variant of holoprosencephaly,HGNC:11701,TDGF1,Disease-causing germline mutation(s) in,Assessed
352,GARD:0002424,Galactosemia,570422,Galactose mutarotase deficiency,HGNC:24063,GALM,Disease-causing germline mutation(s) in,Assessed
444116,GARD:0006611,Hereditary amyloidosis,324703,ABetaL34V amyloidosis,HGNC:620,APP,Disease-causing germline mutation(s) in,Assessed
411709,GARD:0009228,Renal agenesis,93100,"Renal agenesis, unilateral",HGNC:19185,FRAS1,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268740,Upper thoracic spina bifida aperta,HGNC:26219,FUZ,Disease-causing germline mutation(s) in,Assessed
511,GARD:0003228,Maple syrup urine disease,268145,Classic maple syrup urine disease,HGNC:2698,DBT,Disease-causing germline mutation(s) (loss of function) in,Assessed
58,GARD:0005774,Alexander disease,363722,Alexander disease type II,HGNC:4235,GFAP,Disease-causing germline mutation(s) (gain of function) in,Assessed
226298,GARD:0012280,Central congenital hypothyroidism,226307,Hypothyroidism due to deficient transcription factors involved in pituitary development or function,HGNC:6595,LHX3,Disease-causing germline mutation(s) in,Assessed
167714,GARD:0012760,Unclassified acute myeloid leukemia ,329469,Acute megakaryoblastic leukemia without Down syndrome,HGNC:29450,GLIS2,Part of a fusion gene in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,402017,Acute myeloid leukemia with t(9;11)(p22;q23),HGNC:7136,MLLT3,Part of a fusion gene in,Assessed
98473,GARD:0007922,Muscular dystrophy,476084,BVES-related limb-girdle muscular dystrophy,HGNC:1152,BVES,Disease-causing germline mutation(s) in,Assessed
401854,GARD:0012679,Lipoic acid biosynthesis defects,569290,Multiple mitochondrial dysfunctions syndrome type 6,HGNC:9119,PMPCB,Disease-causing germline mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,370968,Congenital muscular dystrophy with intellectual disability,HGNC:19743,POMT2,Disease-causing germline mutation(s) in,Assessed
86851,GARD:0008638,Acute leukemia of ambiguous lineage,589595,Mixed phenotype acute leukemia with t(v;11q23.3),HGNC:7132,KMT2A,Part of a fusion gene in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:13176,IKZF1,Biomarker tested in,Assessed
251612,GARD:0009808,Pilocytic astrocytoma,251615,Pilomyxoid astrocytoma,HGNC:3688,FGFR1,Disease-causing somatic mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:7545,MYB,Part of a fusion gene in,Assessed
93548,GARD:0012736,Glomerular disease,93552,Pediatric systemic lupus erythematosus,HGNC:11255,SPP1,Major susceptibility factor in,Not yet assessed
91024,GARD:0012449,Autosomal recessive axonal Charcot-Marie-Tooth disease type 2,466794,Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome,HGNC:14372,SCYL1,Disease-causing germline mutation(s) in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",325529,Non-classic congenital lipoid adrenal hyperplasia due to STAR deficency,HGNC:11359,STAR,Disease-causing germline mutation(s) (loss of function) in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:28086,NDUFAF2,Disease-causing germline mutation(s) in,Assessed
93969,GARD:0003475,Myelomeningocele,268748,Total spina bifida cystica,HGNC:7432,MTHFD1,Major susceptibility factor in,Assessed
68356,GARD:0006895,Leukodystrophy,99853,Ovarioleukodystrophy,HGNC:3261,EIF2B5,Disease-causing germline mutation(s) in,Assessed
443909,GARD:0008533,Familial colorectal cancer,144,Lynch syndrome,HGNC:6407,KRAS,Biomarker tested in,Assessed
314822,GARD:0007552,Renal tubular acidosis,324525,Hypertrophic cardiomyopathy and renal tubular disease due to mitochondrial DNA mutation,HGNC:7490,MT-TL1,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:13176,IKZF1,Biomarker tested in,Assessed
183660,GARD:0007628,Severe combined immunodeficiency,169157,T-B+ severe combined immunodeficiency due to CD45 deficiency,HGNC:9666,PTPRC,Disease-causing germline mutation(s) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,157713,Congenital or early infantile CACH syndrome,HGNC:3257,EIF2B1,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,363717,Alexander disease type I,HGNC:4235,GFAP,Disease-causing germline mutation(s) (gain of function) in,Assessed
2207,GARD:0002837,Familial isolated hyperparathyroidism,99879,Familial isolated hyperparathyroidism,HGNC:7010,MEN1,Disease-causing germline mutation(s) in,Assessed
116,GARD:0003343,Beckwith-Wiedemann syndrome,231117,Beckwith-Wiedemann syndrome due to imprinting defect of 11p15,HGNC:6295,KCNQ1OT1,Role in the phenotype of,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,319678,Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome,HGNC:25302,COQ9,Disease-causing germline mutation(s) in,Assessed
289573,GARD:0012632,Multiple mitochondrial dysfunctions syndrome,363424,Multiple mitochondrial dysfunctions syndrome type 3,HGNC:27302,IBA57,Disease-causing germline mutation(s) in,Assessed
411709,GARD:0009228,Renal agenesis,1848,"Renal agenesis, bilateral",HGNC:9967,RET,Disease-causing germline mutation(s) (loss of function) in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",251510,"46,XY partial gonadal dysgenesis",HGNC:7960,NR0B1,Role in the phenotype of,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:14262,AUTS2,Part of a fusion gene in,Assessed
68356,GARD:0006895,Leukodystrophy,599376,Hypomyelination of early myelinating structures,HGNC:9086,PLP1,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:7132,KMT2A,Part of a fusion gene in,Assessed
304,GARD:0010752,Epidermolysis bullosa simplex,412181,Epidermolysis bullosa simplex due to BP230 deficiency,HGNC:1090,DST,Disease-causing germline mutation(s) in,Assessed
289899,GARD:0009433,Organic acidemias,356978,"D,L-2-hydroxyglutaric aciduria",HGNC:10979,SLC25A1,Disease-causing germline mutation(s) in,Assessed
813,GARD:0004870,Russell-Silver syndrome,231140,Silver-Russell syndrome due to an imprinting defect of 11p15,HGNC:5466,IGF2,Role in the phenotype of,Assessed
655,GARD:0000206,Nephronophthisis,93591,Infantile nephronophthisis,HGNC:13387,NEK8,Disease-causing germline mutation(s) in,Assessed
99927,GARD:0010263,Hydatidiform mole,254688,Complete hydatidiform mole,HGNC:26197,C11ORF80,Disease-causing germline mutation(s) in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",96265,Leydig cell hypoplasia due to complete LH resistance,HGNC:6585,LHCGR,Disease-causing germline mutation(s) (loss of function) in,Assessed
93403,GARD:0005087,Syndactyly type 2,295197,Synpolydactyly type 2,HGNC:3600,FBLN1,Disease-causing germline mutation(s) in,Assessed
97360,GARD:0000312,Robinow syndrome,1507,Autosomal recessive Robinow syndrome,HGNC:18008,NXN,Disease-causing germline mutation(s) (loss of function) in,Assessed
68356,GARD:0006895,Leukodystrophy,527497,NKX6-2-related autosomal recessive hypomyelinating leukodystrophy,HGNC:19321,NKX6-2,Disease-causing germline mutation(s) in,Assessed
226298,GARD:0012280,Central congenital hypothyroidism,238670,Isolated thyrotropin-releasing hormone deficiency,HGNC:12298,TRH,Candidate gene tested in,Not yet assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,48431,Congenital cataracts-facial dysmorphism-neuropathy syndrome,HGNC:2498,CTDP1,Disease-causing germline mutation(s) (loss of function) in,Assessed
91024,GARD:0012449,Autosomal recessive axonal Charcot-Marie-Tooth disease type 2,423894,Microcephaly-complex motor and sensory axonal neuropathy syndrome,HGNC:12718,VRK1,Disease-causing germline mutation(s) in,Assessed
2467,GARD:0008616,Systemic mastocytosis,98850,Aggressive systemic mastocytosis,HGNC:25941,TET2,Disease-causing somatic mutation(s) in,Assessed
90790,GARD:0001465,Congenital lipoid adrenal hyperplasia,325529,Non-classic congenital lipoid adrenal hyperplasia due to STAR deficency,HGNC:11359,STAR,Disease-causing germline mutation(s) (loss of function) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,431329,Autosomal recessive spastic paraplegia type 57,HGNC:11758,TFG,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,309271,"Metachromatic leukodystrophy, adult form",HGNC:713,ARSA,Disease-causing germline mutation(s) (loss of function) in,Assessed
304,GARD:0010752,Epidermolysis bullosa simplex,89838,Autosomal recessive generalized epidermolysis bullosa simplex,HGNC:6416,KRT14,Disease-causing germline mutation(s) in,Assessed
1305,GARD:0008407,Feingold syndrome,391641,Feingold syndrome type 1,HGNC:7559,MYCN,Disease-causing germline mutation(s) in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,98832,Acute myeloid leukemia with minimal differentiation,HGNC:3765,FLT3,Disease-causing somatic mutation(s) in,Assessed
443909,GARD:0008533,Familial colorectal cancer,144,Lynch syndrome,HGNC:29170,FAN1,Disease-causing germline mutation(s) in,Assessed
813,GARD:0004870,Russell-Silver syndrome,397590,Silver-Russell syndrome due to a point mutation,HGNC:9045,PLAG1,Disease-causing germline mutation(s) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,157713,Congenital or early infantile CACH syndrome,HGNC:3261,EIF2B5,Disease-causing germline mutation(s) in,Assessed
98473,GARD:0007922,Muscular dystrophy,370980,Congenital muscular dystrophy without intellectual disability,HGNC:3622,FKTN,Disease-causing germline mutation(s) in,Assessed
263440,GARD:0010902,Neuroacanthocytosis,98934,Huntington disease-like 2,HGNC:14203,JPH3,Disease-causing germline mutation(s) in,Assessed
1531,GARD:0006209,Craniosynostosis,35093,Isolated scaphocephaly,HGNC:3444,ERF,Disease-causing germline mutation(s) (loss of function) in,Assessed
182090,GARD:0007501,Pulmonary arterial hypertension,275777,Heritable pulmonary arterial hypertension,HGNC:3349,ENG,Candidate gene tested in,Not yet assessed
99927,GARD:0010263,Hydatidiform mole,254688,Complete hydatidiform mole,HGNC:33699,KHDC3L,Disease-causing germline mutation(s) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,157716,Late infantile CACH syndrome,HGNC:3258,EIF2B2,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255249,Leigh syndrome with nephrotic syndrome,HGNC:23041,PDSS2,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268766,Cervicothoracic spina bifida cystica,HGNC:26219,FUZ,Disease-causing germline mutation(s) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,468661,Autosomal recessive spastic paraplegia type 74,HGNC:27302,IBA57,Disease-causing germline mutation(s) in,Assessed
506,GARD:0006877,Leigh syndrome,70474,Leigh syndrome with cardiomyopathy,HGNC:10604,SCO2,Candidate gene tested in,Not yet assessed
352731,GARD:0004037,Oculocutaneous albinism type 1,79431,Oculocutaneous albinism type 1A,HGNC:12442,TYR,Disease-causing germline mutation(s) (loss of function) in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:11365,STAT4,Major susceptibility factor in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293910,"Familial isolated arrhythmogenic ventricular dysplasia, right dominant form",HGNC:12403,TTN,Disease-causing germline mutation(s) in,Assessed
79225,GARD:0007672,Sphingolipidosis,309246,"GM2 gangliosidosis, AB variant",HGNC:4367,GM2A,Disease-causing germline mutation(s) in,Assessed
450,GARD:0008591,X-linked visceral heterotaxy 1,157769,Situs ambiguus,HGNC:174,ACVR2B,Major susceptibility factor in,Not yet assessed
360,GARD:0002491,Glioblastoma,251579,Giant cell glioblastoma,HGNC:11998,TP53,Biomarker tested in,Assessed
181393,GARD:0003924,Growth hormone insensitivity with immunodeficiency,314802,Short stature due to partial GHR deficiency,HGNC:4263,GHR,Disease-causing germline mutation(s) in,Assessed
157850,GARD:0006564,Pantothenate kinase-associated neurodegeneration,216866,Classic pantothenate kinase-associated neurodegeneration,HGNC:15894,PANK2,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268377,Total spina bifida aperta,HGNC:7432,MTHFD1,Major susceptibility factor in,Assessed
68356,GARD:0006895,Leukodystrophy,88637,Hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome,HGNC:30348,POLR3B,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:7879,CNOT3,Disease-causing somatic mutation(s) in,Not yet assessed
68356,GARD:0006895,Leukodystrophy,51,Aicardi-Goutières syndrome,HGNC:25671,RNASEH2B,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,157713,Congenital or early infantile CACH syndrome,HGNC:3261,EIF2B5,Disease-causing germline mutation(s) in,Assessed
86851,GARD:0008638,Acute leukemia of ambiguous lineage,589534,Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2),HGNC:3765,FLT3,Disease-causing somatic mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:3765,FLT3,Disease-causing somatic mutation(s) in,Assessed
251612,GARD:0009808,Pilocytic astrocytoma,251615,Pilomyxoid astrocytoma,HGNC:22219,KIAA1549,Part of a fusion gene in,Assessed
261,GARD:0006329,Emery-Dreifuss muscular dystrophy,98863,X-linked Emery-Dreifuss muscular dystrophy,HGNC:3702,FHL1,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,220386,Semilobar holoprosencephaly,HGNC:3686,FGF8,Disease-causing germline mutation(s) in,Assessed
702,GARD:0004265,Pelizaeus-Merzbacher disease,280219,"Pelizaeus-Merzbacher disease, classic form",HGNC:9086,PLP1,Disease-causing germline mutation(s) in,Assessed
2542,GARD:0012085,Microphthalmia,35612,Nanophthalmos,HGNC:10892,SIX6,Candidate gene tested in,Not yet assessed
631,GARD:0012556,Isolated growth hormone deficiency,67045,X-linked intellectual disability with isolated growth hormone deficiency,HGNC:11199,SOX3,Disease-causing germline mutation(s) in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",443087,"46,XY disorder of sex development due to testicular 17,20-desmolase deficiency",HGNC:387,AKR1C4,Modifying germline mutation in,Assessed
182067,GARD:0006513,Glioma,251579,Giant cell glioblastoma,HGNC:5382,IDH1,Biomarker tested in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,506353,Autosomal recessive complex spastic paraplegia due to Kennedy pathway dysfunction,HGNC:29361,SELENOI,Disease-causing germline mutation(s) (loss of function) in,Assessed
716,GARD:0007383,Phenylketonuria,79651,Mild hyperphenylalaninemia,HGNC:8582,PAH,Disease-causing germline mutation(s) (loss of function) in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:7715,NDUFS8,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93924,Lobar holoprosencephaly,HGNC:4318,GLI2,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:7714,NDUFS7,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:7717,NDUFV2,Disease-causing germline mutation(s) in,Assessed
319276,GARD:0009574,Clear cell renal cell carcinoma,404511,Clear cell papillary renal cell carcinoma,HGNC:11621,HNF1A,Biomarker tested in,Not yet assessed
2162,GARD:0006665,Holoprosencephaly,93926,Midline interhemispheric variant of holoprosencephaly,HGNC:3686,FGF8,Disease-causing germline mutation(s) in,Assessed
79373,GARD:0006317,Ectodermal dysplasia,1997,Blepharo-cheilo-odontic syndrome,HGNC:1748,CDH1,Disease-causing germline mutation(s) (loss of function) in,Assessed
85458,GARD:0010266,Hereditary cerebral hemorrhage with amyloidosis,324708,"ABeta amyloidosis, Iowa type",HGNC:620,APP,Disease-causing germline mutation(s) in,Assessed
135,GARD:0000231,Leukoencephalopathy with vanishing white matter,157719,Juvenile or adult CACH syndrome,HGNC:3257,EIF2B1,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,610573,CLCN6-related childhood-onset progressive neurodegeneration-peripheral neuropathy syndrome,HGNC:2024,CLCN6,Disease-causing germline mutation(s) in,Assessed
168956,GARD:0002804,Hypereosinophilic syndrome,314950,Primary hypereosinophilic syndrome,HGNC:8803,PDGFRA,Part of a fusion gene in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293899,"Familial isolated arrhythmogenic ventricular dysplasia, biventricular form",HGNC:2511,CTNNA3,Disease-causing germline mutation(s) in,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",325524,Classic congenital lipoid adrenal hyperplasia due to STAR deficency,HGNC:11359,STAR,Disease-causing germline mutation(s) (loss of function) in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,319465,Inherited acute myeloid leukemia,HGNC:4171,GATA2,Disease-causing germline mutation(s) in,Assessed
506,GARD:0006877,Leigh syndrome,70474,Leigh syndrome with cardiomyopathy,HGNC:7703,NDUFB8,Disease-causing germline mutation(s) in,Assessed
97245,GARD:0005898,Myopathy congenital,98904,Congenital myopathy with excess of thin filaments,HGNC:129,ACTA1,Disease-causing germline mutation(s) in,Assessed
88632,GARD:0010025,Anterior segment dysgenesis,91483,Rieger anomaly,HGNC:9005,PITX2,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,51,Aicardi-Goutières syndrome,HGNC:12269,TREX1,Disease-causing germline mutation(s) in,Assessed
2445,GARD:0008189,Conotruncal heart malformations,3384,Truncus arteriosus,HGNC:32940,NKX2-6,Major susceptibility factor in,Assessed
2162,GARD:0006665,Holoprosencephaly,93925,Alobar holoprosencephaly,HGNC:4165,GAS1,Disease-causing germline mutation(s) in,Assessed
790,GARD:0007563,Retinoblastoma,357034,Non-hereditary retinoblastoma,HGNC:9884,RB1,Disease-causing somatic mutation(s) in,Assessed
99927,GARD:0010263,Hydatidiform mole,254688,Complete hydatidiform mole,HGNC:22947,NLRP7,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,536,Systemic lupus erythematosus,HGNC:1324,C4B,Major susceptibility factor in,Assessed
3008,GARD:0007512,Pyruvate carboxylase deficiency,353320,"Pyruvate carboxylase deficiency, benign type",HGNC:8636,PC,Disease-causing germline mutation(s) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,443950,DNAJB2-related Charcot-Marie-Tooth disease type 2,HGNC:5228,DNAJB2,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,85447,ATTRV30M amyloidosis,HGNC:12405,TTR,Disease-causing germline mutation(s) in,Assessed
304,GARD:0010752,Epidermolysis bullosa simplex,158684,Epidermolysis bullosa simplex with pyloric atresia,HGNC:6158,ITGB4,Disease-causing germline mutation(s) in,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:3765,FLT3,Disease-causing somatic mutation(s) in,Assessed
2467,GARD:0008616,Systemic mastocytosis,98850,Aggressive systemic mastocytosis,HGNC:18318,ASXL1,Disease-causing somatic mutation(s) in,Assessed
263543,GARD:0012862,Generalized peeling skin syndrome,263553,Peeling skin syndrome type B,HGNC:1802,CDSN,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:3765,FLT3,Disease-causing somatic mutation(s) in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293910,"Familial isolated arrhythmogenic ventricular dysplasia, right dominant form",HGNC:1759,CDH2,Disease-causing germline mutation(s) in,Assessed
1041,GARD:0002783,Hydrops fetalis,363999,Non-immune hydrops fetalis,HGNC:17754,THSD1,Disease-causing germline mutation(s) in,Assessed
98879,GARD:0008732,Hemophilia B,169793,Severe hemophilia B,HGNC:3551,F9,Disease-causing germline mutation(s) in,Assessed
53739,GARD:0012683,Distal hereditary motor neuropathy,139536,Distal hereditary motor neuropathy type 5,HGNC:4162,GARS1,Disease-causing germline mutation(s) in,Assessed
98274,GARD:0009319,Chronic myeloproliferative disorders,314950,Primary hypereosinophilic syndrome,HGNC:3495,ETV6,Part of a fusion gene in,Assessed
442,GARD:0001487,Congenital hypothyroidism,95713,Athyreosis,HGNC:3806,FOXE1,Candidate gene tested in,Not yet assessed
823,GARD:0007673,Spina bifida,268752,Thoracolumbosacral spina bifida cystica,HGNC:26219,FUZ,Disease-causing germline mutation(s) in,Assessed
97360,GARD:0000312,Robinow syndrome,1507,Autosomal recessive Robinow syndrome,HGNC:10257,ROR2,Disease-causing germline mutation(s) (loss of function) in,Assessed
352731,GARD:0004037,Oculocutaneous albinism type 1,352737,Temperature-sensitive oculocutaneous albinism type 1,HGNC:12442,TYR,Disease-causing germline mutation(s) (loss of function) in,Assessed
448,GARD:0010418,Hemophilia,169799,Mild hemophilia B,HGNC:3551,F9,Disease-causing germline mutation(s) in,Assessed
85458,GARD:0010266,Hereditary cerebral hemorrhage with amyloidosis,324703,ABetaL34V amyloidosis,HGNC:620,APP,Disease-causing germline mutation(s) in,Assessed
95708,GARD:0007446,Precocious puberty,169615,Idiopathic central precocious puberty,HGNC:4510,KISS1R,Candidate gene tested in,Not yet assessed
93548,GARD:0012736,Glomerular disease,255249,Leigh syndrome with nephrotic syndrome,HGNC:23041,PDSS2,Disease-causing germline mutation(s) in,Assessed
2134,GARD:0008702,Atypical hemolytic uremic syndrome,544472,Atypical hemolytic uremic syndrome with complement gene abnormality,HGNC:5394,CFI,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,157716,Late infantile CACH syndrome,HGNC:3257,EIF2B1,Disease-causing germline mutation(s) in,Assessed
79373,GARD:0006317,Ectodermal dysplasia,398189,Focal facial dermal dysplasia type IV,HGNC:20577,CYP26C1,Disease-causing germline mutation(s) (loss of function) in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,319199,Autosomal recessive spastic paraplegia type 53,HGNC:24928,VPS37A,Disease-causing germline mutation(s) in,Assessed
98249,GARD:0006322,Ehlers-Danlos syndromes,536467,B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome,HGNC:17978,B3GALT6,Disease-causing germline mutation(s) (loss of function) in,Assessed
68356,GARD:0006895,Leukodystrophy,280210,"Pelizaeus-Merzbacher disease, connatal form",HGNC:9086,PLP1,Disease-causing germline mutation(s) in,Assessed
593,GARD:0010529,Myofibrillar myopathy,98909,Desminopathy,HGNC:2770,DES,Disease-causing germline mutation(s) in,Assessed
448,GARD:0010418,Hemophilia,177929,Bleeding disorder in hemophilia B carriers,HGNC:3551,F9,Disease-causing germline mutation(s) in,Assessed
99732,GARD:0003705,Molybdenum cofactor deficiency,308393,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B,HGNC:7193,MOCS2,Disease-causing germline mutation(s) (loss of function) in,Assessed
289573,GARD:0012632,Multiple mitochondrial dysfunctions syndrome,401874,Multiple mitochondrial dysfunctions syndrome type 2,HGNC:24415,BOLA3,Disease-causing germline mutation(s) in,Assessed
2913,GARD:0004410,Polydactyly,93335,Postaxial polydactyly type B,HGNC:4317,GLI1,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,309256,"Metachromatic leukodystrophy, late infantile form",HGNC:713,ARSA,Disease-causing germline mutation(s) (loss of function) in,Assessed
98274,GARD:0009319,Chronic myeloproliferative disorders,314950,Primary hypereosinophilic syndrome,HGNC:3688,FGFR1,Part of a fusion gene in,Assessed
506,GARD:0006877,Leigh syndrome,255249,Leigh syndrome with nephrotic syndrome,HGNC:23041,PDSS2,Disease-causing germline mutation(s) in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:29569,LIPT1,Disease-causing germline mutation(s) in,Assessed
295044,GARD:0008529,Macrodactyly of fingers,295239,"Macrodactyly of fingers, unilateral",HGNC:8975,PIK3CA,Disease-causing somatic mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,206436,Infantile Krabbe disease,HGNC:4115,GALC,Disease-causing germline mutation(s) in,Assessed
487,GARD:0006844,Krabbe disease,206448,Adult Krabbe disease,HGNC:4115,GALC,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:7716,NDUFV1,Disease-causing germline mutation(s) in,Assessed
52688,GARD:0007132,Myelodysplastic syndromes,100020,Refractory anemia with excess blasts type 2,HGNC:25941,TET2,Disease-causing somatic mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,99853,Ovarioleukodystrophy,HGNC:3258,EIF2B2,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,797,Sarcoidosis,HGNC:4948,HLA-DRB1,Major susceptibility factor in,Assessed
98292,GARD:0006987,Mastocytosis,98850,Aggressive systemic mastocytosis,HGNC:10783,SRSF2,Disease-causing somatic mutation(s) in,Assessed
2238,GARD:0002910,Familial isolated hypoparathyroidism,189466,Familial isolated hypoparathyroidism due to impaired PTH secretion,HGNC:360,AIRE,Disease-causing germline mutation(s) in,Assessed
828,GARD:0010782,Stickler syndrome,250984,Autosomal recessive Stickler syndrome,HGNC:2217,COL9A1,Disease-causing germline mutation(s) in,Assessed
308166,GARD:0010923,Erythrokeratodermia variabilis et progressiva,316,Progressive symmetric erythrokeratodermia,HGNC:6663,LORICRIN,Candidate gene tested in,Not yet assessed
280886,GARD:0010941,Anterior uveitis,85408,Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis,HGNC:6008,IL2RA,Major susceptibility factor in,Assessed
289573,GARD:0012632,Multiple mitochondrial dysfunctions syndrome,401869,Multiple mitochondrial dysfunctions syndrome type 1,HGNC:16287,NFU1,Disease-causing germline mutation(s) in,Assessed
252057,GARD:0012697,Tumor of cranial and spinal nerves,252212,Malignant triton tumor,HGNC:23664,SH3PXD2A,Part of a fusion gene in,Assessed
93548,GARD:0012736,Glomerular disease,163696,Action myoclonus-renal failure syndrome,HGNC:1665,SCARB2,Disease-causing germline mutation(s) (loss of function) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,171848,Polyneuropathy-hearing loss-ataxia-retinitis pigmentosa-cataract syndrome,HGNC:15868,ABHD12,Disease-causing germline mutation(s) in,Assessed
166,GARD:0006034,Charcot-Marie-Tooth disease,468661,Autosomal recessive spastic paraplegia type 74,HGNC:27302,IBA57,Disease-causing germline mutation(s) in,Assessed
2134,GARD:0008702,Atypical hemolytic uremic syndrome,93581,Atypical hemolytic uremic syndrome with anti-factor H antibodies,HGNC:4888,CFHR1,Disease-causing germline mutation(s) in,Assessed
93548,GARD:0012736,Glomerular disease,88917,X-linked Alport syndrome,HGNC:2207,COL4A5,Disease-causing germline mutation(s) in,Assessed
513,GARD:0009240,Childhood acute lymphoblastic leukemia,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,HGNC:5477,IGH,Disease-causing somatic mutation(s) in,Assessed
183660,GARD:0007628,Severe combined immunodeficiency,317425,Severe combined immunodeficiency due to DNA-PKcs deficiency,HGNC:9413,PRKDC,Disease-causing germline mutation(s) in,Assessed
182067,GARD:0006513,Glioma,251636,Ependymoma,HGNC:28449,ZFTA,Part of a fusion gene in,Assessed
140997,GARD:0010692,Orofaciodigital syndromes,434179,Orofaciodigital syndrome type 14,HGNC:24564,C2CD3,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,496790,Ocular anomalies-axonal neuropathy-developmental delay syndrome,HGNC:25567,ATAD3A,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93924,Lobar holoprosencephaly,HGNC:10848,SHH,Disease-causing germline mutation(s) in,Assessed
739,GARD:0005575,Prader-Willi syndrome,98754,Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15,HGNC:8101,OCA2,Role in the phenotype of,Assessed
2542,GARD:0012085,Microphthalmia,35612,Nanophthalmos,HGNC:24529,TMEM98,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93925,Alobar holoprosencephaly,HGNC:10848,SHH,Disease-causing germline mutation(s) in,Assessed
98277,GARD:0012758,Acute myeloid leukemia with recurrent genetic anomaly,102724,Acute myeloid leukemia with t(8;21)(q22;q22) translocation,HGNC:1833,CEBPA,Biomarker tested in,Assessed
739,GARD:0005575,Prader-Willi syndrome,177904,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2,HGNC:8101,OCA2,Role in the phenotype of,Assessed
98085,GARD:0008538,"46, XY disorders of sexual development",251510,"46,XY partial gonadal dysgenesis",HGNC:11311,SRY,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,220386,Semilobar holoprosencephaly,HGNC:10848,SHH,Disease-causing germline mutation(s) in,Assessed
519,GARD:0012757,Acute myeloid leukemia ,319480,Acute myeloid leukemia with CEBPA somatic mutations,HGNC:1833,CEBPA,Disease-causing somatic mutation(s) in,Assessed
88632,GARD:0010025,Anterior segment dysgenesis,782,Axenfeld-Rieger syndrome,HGNC:9005,PITX2,Disease-causing germline mutation(s) (gain of function) in,Assessed
247,GARD:0005847,Arrhythmogenic right ventricular cardiomyopathy,293888,"Familial isolated arrhythmogenic ventricular dysplasia, left dominant form",HGNC:3036,DSC2,Disease-causing germline mutation(s) in,Assessed
308166,GARD:0010923,Erythrokeratodermia variabilis et progressiva,317,Erythrokeratodermia variabilis,HGNC:4286,GJB4,Disease-causing germline mutation(s) in,Assessed
68356,GARD:0006895,Leukodystrophy,99854,Cree leukoencephalopathy,HGNC:3259,EIF2B3,Disease-causing germline mutation(s) in,Assessed
98562,GARD:0010505,Cryptophthalmos,98949,Complete cryptophthalmia,HGNC:25396,FREM2,Disease-causing germline mutation(s) (loss of function) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:28086,NDUFAF2,Disease-causing germline mutation(s) in,Assessed
98292,GARD:0006987,Mastocytosis,98850,Aggressive systemic mastocytosis,HGNC:1541,CBL,Disease-causing somatic mutation(s) in,Assessed
137,GARD:0010307,Congenital disorders of glycosylation,370959,Congenital muscular dystrophy with cerebellar involvement,HGNC:19743,POMT2,Disease-causing germline mutation(s) in,Assessed
2162,GARD:0006665,Holoprosencephaly,93925,Alobar holoprosencephaly,HGNC:9585,PTCH1,Disease-causing germline mutation(s) in,Assessed
98277,GARD:0012758,Acute myeloid leukemia with recurrent genetic anomaly,102724,Acute myeloid leukemia with t(8;21)(q22;q22) translocation,HGNC:3765,FLT3,Biomarker tested in,Assessed
2162,GARD:0006665,Holoprosencephaly,220386,Semilobar holoprosencephaly,HGNC:4165,GAS1,Disease-causing germline mutation(s) in,Assessed
97242,GARD:0009138,Congenital muscular dystrophy,370959,Congenital muscular dystrophy with cerebellar involvement,HGNC:26267,POMK,Disease-causing germline mutation(s) (loss of function) in,Assessed
253,GARD:0007687,Spondyloepiphyseal dysplasia,166100,Autosomal dominant otospondylomegaepiphyseal dysplasia,HGNC:2200,COL2A1,Candidate gene tested in,Not yet assessed
85458,GARD:0010266,Hereditary cerebral hemorrhage with amyloidosis,324723,"ABeta amyloidosis, Arctic type",HGNC:620,APP,Disease-causing germline mutation(s) in,Assessed
512,GARD:0003230,Metachromatic leukodystrophy,309271,"Metachromatic leukodystrophy, adult form",HGNC:713,ARSA,Disease-causing germline mutation(s) (loss of function) in,Assessed
98277,GARD:0012758,Acute myeloid leukemia with recurrent genetic anomaly,98831,Acute myeloid leukemia with 11q23 abnormalities,HGNC:7132,KMT2A,Role in the phenotype of,Assessed
220460,GARD:0008532,Attenuated familial adenomatous polyposis,401911,AXIN2-related attenuated familial adenomatous polyposis,HGNC:904,AXIN2,Disease-causing germline mutation(s) in,Assessed
738,GARD:0010353,Porphyria,443197,X-linked erythropoietic protoporphyria,HGNC:397,ALAS2,Disease-causing germline mutation(s) (gain of function) in,Assessed
137807,GARD:0000132,Primary cutaneous amyloidosis,353220,Familial primary localized cutaneous amyloidosis,HGNC:8507,OSMR,Disease-causing germline mutation(s) in,Assessed
217071,GARD:0008417,Renal cell carcinoma 4,404511,Clear cell papillary renal cell carcinoma,HGNC:26038,TMEM127,Major susceptibility factor in,Assessed
98473,GARD:0007922,Muscular dystrophy,206546,Symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers,HGNC:2928,DMD,Disease-causing germline mutation(s) in,Assessed
3394,GARD:0004898,Soft tissue sarcoma,370348,Peripheral primitive neuroectodermal tumor,HGNC:3749,FLI1,Part of a fusion gene in,Assessed
823,GARD:0007673,Spina bifida,268377,Total spina bifida aperta,HGNC:7436,MTHFR,Major susceptibility factor in,Assessed
442,GARD:0001487,Congenital hypothyroidism,329235,X-linked central congenital hypothyroidism with late-onset testicular enlargement,HGNC:5948,IGSF1,Disease-causing germline mutation(s) (loss of function) in,Assessed
216675,GARD:0007795,Transposition of the great arteries,216718,Isolated congenitally uncorrected transposition of the great arteries,HGNC:12874,ZIC3,Major susceptibility factor in,Assessed
182058,GARD:0012959,Primary orthostatic hypotension,98933,"Multiple system atrophy, parkinsonian type",HGNC:25223,COQ2,Major susceptibility factor in,Assessed
93969,GARD:0003475,Myelomeningocele,268758,Lumbosacral spina bifida cystica,HGNC:7436,MTHFR,Major susceptibility factor in,Assessed
506,GARD:0006877,Leigh syndrome,255241,Leigh syndrome with leukodystrophy,HGNC:7685,NDUFA2,Disease-causing germline mutation(s) in,Assessed
98292,GARD:0006987,Mastocytosis,90389,Telangiectasia macularis eruptiva perstans,HGNC:6342,KIT,Disease-causing germline mutation(s) in,Assessed
823,GARD:0007673,Spina bifida,268384,Thoracolumbosacral spina bifida aperta,HGNC:7436,MTHFR,Major susceptibility factor in,Assessed
93969,GARD:0003475,Myelomeningocele,268762,Cervical spina bifida cystica,HGNC:15512,VANGL1,Major susceptibility factor in,Assessed
685,GARD:0006637,Hereditary spastic paraplegia,320370,Autosomal recessive spastic paraplegia type 43,HGNC:25443,C19ORF12,Disease-causing germline mutation(s) in,Assessed
207015,GARD:0012733,Rare hereditary disease with peripheral neuropathy,255241,Leigh syndrome with leukodystrophy,HGNC:7693,NDUFA9,Disease-causing germline mutation(s) in,Assessed
183660,GARD:0007628,Severe combined immunodeficiency,275,Severe combined immunodeficiency due to DCLRE1C deficiency,HGNC:17642,DCLRE1C,Disease-causing germline mutation(s) in,Assessed
739,GARD:0005575,Prader-Willi syndrome,177904,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2,HGNC:6814,MAGEL2,Role in the phenotype of,Assessed
513,GARD:0000522,Acute lymphoblastic leukemia,99861,Precursor T-cell acute lymphoblastic leukemia,HGNC:16063,MLLT10,Part of a fusion gene in,Assessed
